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ABSTRACT
Traditionally the privacy of medical patients personal information is protected
through interpretations of the ‘limited access’ theory of privacy which in many cases
was instantiated through to secure storage of physical paper charts and records. With
the change of medium for capture and storage of personal medical information from
paper based to electronic medium, the ‘limited access’ approach to privacy is under
pressure due to the ease with which electronic information can be exchanged. The
medical doctor’s traditional ‘gatekeeper’ role to oversee patients’ personal
information is becoming harder to maintain with electronic health records. This is
particularly the case in the context of the secondary use of medical data. Secondary
uses of medical data are those uses not directly related to the delivery of healthcare to
an individual. These secondary uses are diverse and include those aimed at
improving societal knowledge of healthcare and medicine and far more commercial
orientated activities, such as optimising insurance premiums or financial accounting
associated with charges for medical services. Contemporary privacy theories move
beyond the ‘limited access’ privacy theory and are well suited to application within
the secondary use of medical data context. Meaningful engagement with
patients/consumers is of growing importance in this context and consumer surveys
attracting 1,573 responses from citizens in Australia and Canada investigated public
opinion regarding the application of contemporary privacy theory in the secondary
use of medical data. Survey results indicated that contemporary privacy theories can
be applied to the secondary use of medical data. Survey respondents indicated
diverse concerns and expectations regarding privacy with statistically significant
results across gender, education level, age and healthcare workers. A Privacy
Framework for secondary use of medical data is proposed. The framework is
founded on contemporary privacy theories and includes a multi-level consumer
engagement model informed by Australian and Canadian survey outcomes. This
study was undertaken within the post-positivist and interpretive paradigms and
utilized mixed methods with a concurrent triangulation design.
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In a computerized world we leave
electronic footprints everywhere and
data collected for one purpose can be
resurrected and used elsewhere. The
problem of computer privacy is to
keep proper vigilance on where such
information can and should go.

James Moor, 1997
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1 INTRODUCTION
1.1

Introduction

Traditionally the privacy of medical patients’ personal information has been
protected through application of the ‘limited access’ theory of privacy. With the
change of medium used for capture and storage of personal medical information
from paper to electronic the ‘limited access’ approach to privacy is under pressure
due to the ease with which electronic information can be exchanged.
The medical doctors’ traditional ‘gatekeeper’ role to oversee their patients’ personal
information is becoming harder to maintain with electronic health records. This is
particularly the case in the secondary use of medical data context. Secondary uses of
medical data are those uses not directly related to the delivery of healthcare to an
individual (Safran, Bloomrosen et al. 2006). These secondary uses are diverse and
include those associated with medical and health service research, more commercial,
profit-driven activities, and increasingly government societal surveillance.
Two contemporary privacy theories proposed by Tavani and Moor (2001) and
Nissenbaum (2010) move beyond the ‘limited access’ privacy theory and are well
suited to application within the secondary use of medical data context. There is little
published literature regarding the application of these theories to the ‘real-world’ and
this study makes a contribution by combining these two theories and applying them
to the secondary use of medical data.
Meaningful engagement with patients/consumers is of growing importance in the
secondary use of medical data as the secondary use stakeholders vie to have their
data use needs addressed. There is little published literature surrounding consumers
concerns and expectations regarding secondary use of their personal medical data.
The aim of this research is to investigate privacy matters in the secondary use of
medical data context with particular focus on the views of consumers. The study
design includes the use of mixed methods employing a self administered, hardcopy
consumer survey instrument to capture public opinion in Australia and Canada.
1

Statistically significant findings emerged across demographics including age, gender
and education level. Outputs from the research include a proposed privacy
framework for secondary use of medical data.
Future research opportunities, starting in 2012, include the application of the Privacy
Framework to two scenarios, the first in Australia and the second in Canada. The
first opportunity builds on the results of the consumer survey indicating that women
are more interested in engaging in secondary use matters and involves a General
Practice based trial of the privacy framework with female consumers. The second
opportunity relates specifically to the secondary use of physiological readings
captured by life support devices. This trial involves the application of the Privacy
Framework proposed in this thesis to support the capture, storage, transmission and
analysis of this data within the secondary use context for population based
retrospective analysis.
This chapter presents introductory material including the background and motivation
for research, an overview of the research approach, and comments on the contribution
to knowledge and structure of the thesis.
1.2

Background and Motivation for Research

The patient confidentiality aspect of the Hippocratic Oath, based on the premise of
limiting access to sensitive information, is under pressure in the emerging electronic
health records (EHR) environment. In the delivery of healthcare, facilitated by EHRs,
the privacy approach continues to be one of ‘limited access’ thus reflecting the
original interpretation of privacy offered by the Hippocratic Oath.
A paradigm shift away from ‘limited access’ privacy theory to a more contemporary
approach involving deeper consumer engagement may better serve the secondary use
of medical data objectives. Extending the ‘limited access’ approach to privacy in the
secondary use context may not be the most forward thinking option despite claims
from the healthcare and associated research sectors that ‘privacy is well understood’
as claimed by Lowerance (2003). Privacy researchers come from a broad range of
professions and many state that privacy is a slippery concept that is not well
understood and does not share a common definition (Warren and Brandeis 1890;
2

Westin 1967; Moor 1997; Willison 2003; Floridi 2006; Tavani 2007b; Willison,
Emerson et al. 2008; Shoemaker 2009; Nissenbaum 2010). This thesis explores more
contemporary, approaches to privacy that may better meet the conflicting secondary
use stakeholder expectations.
The movement away from paper based health records to electronic health records has
the effect of ‘greasing’ the data (Moor 1997) which facilitates the ready transfer of
sensitive, personal data from primary care contexts to secondary use contexts.
Examples of successful secondary use of medical data include discovery of links
between antidepressant use and suicide (Jick, Dean et al. 1995) and between
tranquilisers and road accidents (Barbone, McMahon et al. 1998) as reported by
Singleton and Wadsworth (2006). There are many stakeholders in the secondary use
context including, but not limited to: population health researchers, health service
researchers and planners, data brokerage organisations, insurance and pharmaceutical
sector stakeholders, multiple levels of Government, privacy advocates, and healthcare
consumers. Privacy advocates argue strongly for consumer engagement concerning
use of their medical data and issue warnings on the use of national de-facto identifiers
fearing Orwellian type developments in dataveillance / surveillance / uberveillance
(Magnusson 2004; Fernando 2009; Clarke 2010). Medical researchers argue strongly
for secondary use of medical data to be an extension of healthcare delivery aimed at
improving treatment for all members of society (Snider 1997; Al-Shahi and Warlow
2000; Doll and Peto 2001). Commercial entities seek access to the healthcare
information of citizens’ and present an array of justifications including profitability
for their organisations (IMS-Health 2008; BroganInc 2010; BroganInc 2011). The
literature review chapter of this thesis looks through various ‘lenses’ to provide
insight into each competing stakeholder’s perspective on the secondary use of
medical data. Consumers have rarely been given an opportunity to have their voices
heard in this secondary use debate (Ruyter, Louk et al. 2010).
It is widely acknowledged by the system analysis and design community that the
early analysis stage of the system development life cycle (SDLC) involves clear
problem definition leading to conceptual designs prior to physical implementation(s)
3

and support (Satzinger, Jackson et al. 2009). The need for clear problem definition
and conceptualisation is very important no matter which approach is taken to system
analysis and design i.e. Waterfall, spiral, agile. Gathering stakeholders’ system
requirements is an important task in the early phases of the SDLC. Conceptual
modelling precedes physical implementation. Jumping to the physical implementation
stage of the SDLC without sufficient work in the early problem definition and
conceptual modelling stage compromises the successful information system
implementation.

Project
planning phase

Analysis Phase
Design Phase
Implementation
phase

Support Phase

Figure 1: SDLC phases (adapted from Satzinger, Jackson et al. 2009, p. 40)

This study makes a contribution to the problem definition and conceptualisation of
future health information systems by addressing foundation privacy issues. By
separating the analysis phase problem definition from the traditional power brokers in
health information systems (i.e. the healthcare providers or government) it is possible
to have an independent consideration of secondary use privacy matters. The benefit of
this PhD study is that there are no corporate sponsors or paying clients to influence
the initial framing of the privacy challenge. For example, if a healthcare provider
commissioned the SDLC analysis phase they would define the problem as one of
needing to implement ‘limitations on access to patient data to deliver privacy’ , thus
continuing the ‘limited access’ privacy paradigm and bypassing the re-framing of
privacy that is possible with contemporary privacy theories.
It is noted that the vast majority of stakeholders involved in the specification of the
requirements of the Australian national ehealth records are medical professionals –
there has been little engagement with consumers. The research described in this thesis
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brings to the Australian context insight into the expectations of the overlooked
stakeholder – the consumer.
The bulk of the research described in this dissertation is positioned within the
Australian context. International experiences are considered in the literature review
and part of the survey component includes comparison between Australian and
Canadian consumer views.
1.3

Research Approach

The overall aim of this research study is to investigate privacy matters in the
secondary use of medical data context with particular focus on the views of
consumers which have previously been marginalised. Two overarching questions
drive this investigation:
Research Question 1
What are consumer’s expectations and concerns regarding secondary uses of their
medical data, particularly pertaining to privacy matters?
Research Question 2
Does the RALC privacy theory (Tavani and Moor 2001) and the Framework for
contextual integrity (Nissenbaum 2010) offer privacy concepts that can: (1) be
applied in the secondary use of medical data context; and (2) gain support from
interested consumers?
The overall exploratory nature of this study employed both post-positivist and
interpretive paradigms, utilizing a mixed methods methodology with a concurrent
triangulation design. The research undertaken in this study is exploratory rather than
confirmatory
Canada was chosen for comparison as there is a history of cultural comparison
studies between Australia and Canada including those with a focus on ethics and
society (Kidd and Shannon 1996; Miller 1998; Wood 2000; Austin 2008),
economics (Harchaoui, Jean et al. 2005), healthcare and training (Blendon, Schoen
et al. 2002; Philippon and Braithwaite 2008; McCurdy, Duggan et al. 2009) and
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teaching (Mitchell, Clarke et al. 2007). Given the cultural similarities between
Australia and Canada there is an opportunity to develop a shared privacy framework
for secondary use of medical data.
1.4

Contribution to knowledge

This thesis describes the first substantial study of Australian and Canadian consumer
views of secondary use of their medical data, particularly pertaining to privacy. The
study explores the contemporary privacy theories proposed by Tavani, Moor and
Nissenbaum (Moor 1997; Tavani 1999a; Tavani 1999b; Moor 2000; Tavani and
Moor 2001; Tavani 2003; Moor 2005; Tavani 2007a; Tavani 2007b; Nissenbaum
2010) within the secondary use of medical data context. The specific research
contributions of this study are:


The combination and application of the Restricted Access Limited Control
(RALC) (Tavani and Moor 2001) and contextual integrity (Nissenbaum
2010) privacy theory.



An exploratory investigation into Australian and Canadian consumer views
regarding secondary use of their medical data organised according to Tavani
and Moor’s tripartite model of privacy which includes the concept of
privacy, justification of privacy, and management of privacy.



A comparison between Australian and Canadian citizens views regarding the
secondary use of their medical data within the tripartite model of privacy.



A conceptual privacy framework for secondary use of medical data which
describes and organises key privacy concepts, actors, attributes and
information flows. This framework is grounded in the literature and is
refined by consumer survey findings. The framework includes a new
approach to engagement with consumers and demonstrates a shift away from
relying on interpretations of the ‘limited access’ privacy theory.

The outcomes from this study have implications for medical research, government
and policy makers, privacy advocates and privacy research, and information
systems.
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1.5

Structure of Thesis

The remainder of this thesis includes seven additional Chapters moving from the
conceptual study aspects to the consumer surveys and beyond to a proposed privacy

Study

Conceptual

framework and conclusions as illustrated in Figure 2.

Chapters

Introduction, Literature Review & Research Design

1-3

Chapters

Australian Consumer Survey Results and Analysis

Surveys

Exploratory

4-5

Outcomes

Study

Chapter 6

Canadian Consumer Survey Results, Analysis &
Comparison with Australian consumer survey

Chapter 7

Privacy Framework for Secondary Use of Medical Data

Chapter 8

Conclusions and Future Research

Figure 2: Outline of the thesis

Chapter 2 presents a literature review across the diverse domains that intersect when
considering privacy and secondary uses of medical data. Chapter 3 elaborates on the
chosen research methodology.
Chapter 4 presents the results of the Australian consumer survey with a joint
presentation of quantitative and qualitative results. These results include raw data
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and outcomes from statistical testing with significant results and deductive themes
found in consumers qualitative survey responses. The analysis of these Australian
results is presented in Chapter 5.
Chapter 6 presents the results and analysis of an identical Canadian consumer survey
conducted as part of this study. This Chapter also includes a comparative analysis
between the Australian and Canadian consumer opinions.
Chapter 7 proposes a privacy framework for secondary use of medical data using
existing contemporary privacy theory and the results of consumer surveys to inform
the framework. The final chapter, Chapter 8 considers study conclusions and areas of
future research.

1.6

Terms

When an individual engages with the healthcare sector they are described as ‘patients’
and frequently report a perceived passive role with a lack of control as healthcare
professionals go about the task of delivering healthcare services to the individual
(Johnson 2001; Torrey 2011). Hence the sometimes disempowering term ‘patient’ is
not the most ideal term and ‘consumer’ or ‘citizen’ have been adopted throughout this
thesis. It is acknowledged that the term ‘consumer’ may cause discomfort amongst
some providers in the healthcare sector who rail against the consumerism that is
emerging in healthcare delivery and attribute special, responsible, caring meaning to
the term ‘patient’ (Schattner 2011).
The terms ‘consumer’ and ‘citizen’ have been adopted in this thesis to re-enforce the
notion that an individual should not necessarily be cast in a passive role when it
comes to secondary use of their medical data.
The terms ‘data’ and ‘information’ are, as Turban and Aronson (2001) suggest,
sometimes used interchangeably. Turban and Aronson provide a common definition
for each:
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Data. Data items about things, events, activities and
transactions are recorded, classified and stored but are not
organized to convey any specific meaning. Data items can be
numeric, alphanumeric, figures, sounds or images.



Information. Information is data that have been organized so
that they have meaning for the recipient (Turban and Aronson
2001, p. 131).

These definitions of data and information are suitable for this study and
given the non-technical, more conceptual nature of this dissertation the
terms will be used interchangeably.
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2 LITERATURE REVIEW
2.1

Introduction

The intention of the literature review is to describe what is already known and what
remains unaddressed regarding information privacy matters pertaining to the
secondary use of medical data. This is a very broad and diverse area of research
ranging from privacy theory to societal impacts and implications of secondary use of
medical data. The purpose of the literature review is to arrive at specific research
questions. To aid this journey the literature review chapter has been organised into
four sections:
(1) A broad consideration of privacy theory with a focus on information privacy
(2) A review of information privacy in the secondary use of medical data context
(3) A review of multiple stakeholder points of view on information privacy matters
related to secondary use of medical data
(4) A summary of open research questions and assumptions arising from sections 1-3.
At first these may appear to be an unusual collection of areas to consider together in
one literature review. However emerging privacy theory from area (1) has the
potential to inform how information privacy is addressed in (2). The stakeholder
perspectives considered in (3) round out the literature review by providing diverse
perspectives on information privacy matters related to the secondary use of medical
data. Areas for further research are captured through sections (1) – (3) as open
research questions. The chapter concludes with a concise summary of open research
questions arising from the literature review. Each of these questions is mapped to
over arching research questions.
The scope of this literature review is limited to secondary use of medical data matters
rather than to the manner in which confidentiality is provided to patients during the
delivery of healthcare services. Healthcare delivery issues are best considered by the
members of the medical community responsible for the delivery of the services. The
importance of clinicians having access to all available information when treating
patients and delivering healthcare services is acknowledged.
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Figure 3 illustrates the structure of the literature review with the outcome of the
literature review being research assumptions and identified open research areas
informed by the reviewed sources.

Privacy with a
Focus on Information
Privacy

Privacy issues in
the secondary use of
medical data context

Medical Researcher
Stakeholder

Privacy Advocate

perspectives on
privacy matters

Government

related to secondary
use of medical data

Commercial Data Organisation
Consumer

LITERATURE REVIEW

RESEARCH

OPEN RESEARCH

ASSUMPTIONS

AREA

Figure 3: Structure of Literature Review with research assumptions and open research areas as
outcomes.
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2.2

Privacy with a focus on information privacy

Philosopher Herman Tavani provides an insightful phrase which is a useful starting
point for considering privacy matters: “Privacy is a concept that is neither clearly
understood nor easily defined” (Tavani 1999a, p. 11). Moor (2000) suggests that the
concept of privacy is culturally dependent and some cultures may value privacy and
other cultures may not. The research documented here is based upon accepting
privacy concepts as an important underlying moral philosophy associated with
human-rights based ethics which contribute a valuable dimension to Western culture
(Regan 1995; Cullen 2008; Maurushat 2008).
Publications concerning privacy matters in Western culture have been provided by
researchers across multiple disciplines including: law (Warren and Brandeis 1890;
Fried 1968; Rachels 1975; Gavison 1980; Kang 1998; Cohen 2000; Froomkin 2000)
political science (Regan 1995), philosophy (Westin 1967; Rachels 1975; Moor 2000;
Van den Hoven 2003; Floridi 2005; Floridi 2006), and socio-technical systems
(Tavani 1996b; Tavani 1999a; Tavani 1999b; Tavani and Moor 2001; Tavani 2003;
Moor 2005; Tavani 2007a; Tavani 2007b; Clarke 2010; Nissenbaum 2010; Clarke
2011a).
Figure 4 is a very simplified view of privacy to provide, at a glance, some insight into
the very complex domain of privacy.
The first, blue zone, uses Culver et al. (Culver, Moor et al. 1994) concise
conceptualisation of privacy where they argue that a person can be said to have
privacy if in a given situation or context they are offered protection from intrusion
and interference and information access by others.
The second, purple zone, describes two broad classifications that also assist in the
conceptualisation of privacy; being normative and descriptive privacy. In a
normatively private situation, individuals are protected by cultural norms such as
formal laws or informal policies. Normatively private situations often include zones
or contexts where normative protection is needed e.g. a patient in consultation with a
clinician or client in discussions with his/her lawyer. Descriptive privacy results in
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situations where individuals can expect privacy by natural means such as physical
barriers. Tavani and Moor suggest descriptive privacy is “privacy that exists as a
matter of fact” (Tavani and Moor 2001, p. 7).
The third, green zone, presents early theories of privacy that focussed on allowing an
individual complete control over all personal information, or limitations on the
persons who could gain access to personal information. Debate regarding privacy has
swung between argument for and against a particular approach to privacy with the
limitation theory (Gavison 1980; Allen 1988) and control theory (Westin 1967;
Rachels 1975) dominating.
The final (pink) zone includes three contemporary theories of informational privacy
that move beyond the control theory versus limitation theory debate and offer a more
holistic approach to privacy where the context (or infosphere in Floridi’s work)
emerges as a very important component of the privacy theory.
Nissenbaum moves the privacy debate beyond ‘control’ or ‘limitation/constraint’ by
noting the value of both and encouraging a move beyond this debate:

Common usage suggests that intuitions behind both the
constraint and control conceptions are sound: namely, that
control over information about oneself is an important
dimension of privacy, but so is the degree of access that
others have to this information, irrespective of who is in
control...In my view, the effect of these challenges, coupled
with persuasive arguments, is not to prove that one or the
other of these approaches is correct, but that both capture
essential aspects of privacy that we seem to care about. A
non-arbitrary resolution of this disagreement is not possible
(Nissenbaum 2010, p. 71).
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Individual has privacy in
a particular situation if

Protection from
interference

Protection from
information access
by others

they are offered 3

Protection from
intrusion

protections

Two broad classifications
of privacy situations

Normative privacy

Descriptive privacy

Zones of privacy

Early theories of privacy

More recently proposed information
privacy theory aimed at achieving
necessary protections by building on
earlier theories and normative and
descriptive privacy

Control theory

Floridi ontological
theory of information
privacy

Limitation theory

Nissenbaum contextual
integrity theory of
informational privacy

Figure 4: Graphical representation of select privacy concepts
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Moor & Tavani hybrid
RALC theory of privacy

The blue zone in Figure 4 refers to Culver et al. (Culver, Moor et al. 1994)
conceptualisation of privacy that draws attention to the issue of informational
privacy:

An individual or group has normative privacy in a situation with
regard to others if and only if in that situation the individual or
group is normatively protected from intrusion, interference, and
information access by others (Culver, Moor et al. 1994, p. 6).
That quote acknowledges the aspect of privacy that was raised by Warren and
Brandeis (1890) in their seminal paper on the rights of an individual to be left alone
and free from intrusion and interference. In addition, this quote raises the notion of
information privacy. Charles Fried (1968) suggested that personal information can be
conceptualised on a continuum from more to less intimate and more to less sensitive.
In contrast others have split information into dichotomies of ‘personal’ versus
‘public’ and zones of privacy (Gerstein 1984) with privacy expectations varying
according to the classification of the information type.
This thesis relates to informational privacy; specifically electronic medical
information privacy. Tavani has particular interest in cyber technologies and privacy
and in 2007 he highlighted the impact that information technology has had on
information privacy with respect to:





The amount of personal information that can be gathered
The speed at which personal information can be transmitted
The duration of time that information can be retained
The kind of information that can be transferred (Tavani 2007a)

All of these issues raised by Tanavi have relevance to the specific context under
consideration for this study i.e. secondary use of medical data. Prior to Tavani’s 2007
publication Moor provided a useful description of the challenge posed to
informational privacy when he described the way that information is greased when it
is computerised.
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When information is computerised, it is greased to slide easily
and quickly to many ports of call. This makes information
retrieval quick and convenient. But legitimate concerns about
privacy arise when this speed and convenience lead to the
improper exposure of information. Greased information is
information that moves like lightning and is hard to hold onto
(Moor 1997, p. 27).
Tavani and Moor have proposed a hybrid privacy theory in a series of individual and
jointly authored publications (Moor 1997; Tavani 1999b; Moor 2000; Tavani and
Moor 2001). These researchers sought to identify the fundamental, essential
components necessary in a privacy theory. One outcome of their research is a
tripartite model to describe a sufficient theory of privacy which they suggest must
include three core aspects:

A good theory of privacy has at least three components: an
account of the concept of privacy, an account of the justification
for privacy, and an account of the management of privacy. This
tripartite structure of the theory of privacy is important to keep
in mind because each part of the theory performs a different
function. To give an account of one of the parts is not to give an
account of the others (Tavani and Moor 2001, p. 6).
Figure 5 is a visual representation of the tripartite privacy model proposed by Tavani
and Moor, illustrating that the concept, justification, and management of privacy are
complimentary and essential components of a privacy theory.

Concept of
privacy

Tripartite
Privacy
Model

Justification of
privacy

Management of privacy

Figure 5: Visual representation of the tripartite privacy model
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Much of the literature regarding privacy considers one aspect of the tripartite model,
for example the justification for privacy, rather than recognising the importance of the
simultaneous existence of all three elements of concept, management and
justification. For example, Kang (1998, p.1203) considered the extent to which an
individual has control over the processing (acquisition, disclosure and use)

of

personal information. That could be considered ‘management’ of privacy. Reinman
(1976) considered privacy to be the condition under which other people are deprived
of access to either some information about individuals or some experience of the
individual. That aspect could be considered important to the ‘concept’ of privacy. A
further example is the work of Van de Hoven (2003) who suggested moral reasons
why privacy deserves protection, which would be considered ‘justification’ of
privacy.
Tavani and Moor (2001) consider individual control is important in both the
justification and the management of privacy and they also defend the importance of
restricted access in terms of the concept of privacy.
The privacy theory building research undertaken by Tavani and Moor has resulted in
a context sensitive, hybrid Restricted Access/Limited Control (RALC) privacy theory
(Tavani and Moor 2001). These philosophers go on to emphasise the importance of
separating privacy from control with control having three possible means of
expression; through choice, consent and correction. They go on to suggest that simply
identifying the concept of control with privacy is misleading as it is not possible for
an individual to exert control over the rapidly growing volumes of personal electronic
data resident on information systems worldwide. Normative privacy concepts
combine with the nuanced interpretation of control resulting in Tavani and Moor’s
hybrid Restricted Access/Limited Control (RALC) privacy theory.
A strength of

Moor and Tavani’s work is that they tackled the fundamental,

important matter of developing a privacy theory rather than devising particular
justifications or recommendations for the management of privacy that are suitable for
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particular contexts. Tavani was particularly determined to take a holistic view with
the aim of providing a theory that can be effective in a wide range of contexts with
adequate provision to respond to constantly developing cyber technologies that can
bring insufficient conceptualisations of privacy undone (Tavani 1999a; Tavani 1999b;
Tavani 2000; Tavani 2003; Tavani 2007a).
Similar to Tavani and Moor’s privacy theory, Nissenbaum (2004; 2010) also takes an
holistic view of information privacy theory with an emphasis on the importance of the
privacy context.

Nissenbaum proposes ‘contextual integrity’ as an alternative

conception of information privacy. Her approach is comprehensive with a goal of
providing a decision heuristic to guide evaluation of information privacy.
Nissenbaum proposes informational norms which govern activities in contexts which
she refers to as ‘context-relative informational norms’. Context-relative informational
norms are characterized by four key parameters:
(1) Contexts, (2) Actors, (3) Attributes and (4) Transmission principles.
Actors: There are three types of actors: (1) senders of information (2) recipients of
information and (3) information subjects.
Attributes (Information types): Analysis of attributes in contextual integrity is more
nuanced than the private or public dichotomy of information. Informational norms
render certain attributes appropriate or inappropriate under certain conditions.
Nissenbaum suggests that attributes co-evolve with contexts.
Transmission Principles: a constraint on the flow of information from party to party
in a context. This parameter expresses terms and conditions under which such
transfers should occur.
The idea that privacy implies a limitation of access by others is similar to
Nissenbaums concept of an informational norm. In Nissenbaums theory,
diminishment of access is just one way that information flow may be governed.
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Informational norms are far more comprehensive as they describe not only when
access is reduced but it also enables specification of (1) what (2) about whom and (3)
against whom.
Nissenbaum sets her privacy theory apart from others as she has “…not fully adopted
any one of the standard theories as a framework for the intuitive notion of a
context…”(Nissenbaum 2010, p. 132).

The definition provided for contexts is

comprehensive:

Contexts are structured social settings characterized by
canonical activities, roles, relationships, power structures,
norms (or rules), and internal values (goals, ends, purposes)
(Nissenbaum 2010, p. 132).
Shoemaker (2009) critiqued the RALC proposal from Tavani and Moor, and
Nissenbaum’s contextual integrity saying the proposals were too vague in relying on
shared understandings of normatively private zones and contexts. The secondary use
of medical data provides an interesting opportunity to further consider this particular
criticism made by Shoemaker. The internal values (goals, ends, purposes) of the
many stakeholders with an interest in secondary use of consumers’ medical data are
quite different. For example the goals, ends and purposes of medical researchers are
generally oriented around societal benefit through increased knowledge of disease
and treatments. The goals, ends and purposes of the insurance industry use of medical
data are more oriented towards profitability and minimisation of future liability.
These stakeholders are operating in the shared context of secondary use of medical
data but with very different internal values.
The application of the privacy theories of Moor, Tavani and Nissenbaum in the
secondary use of medical data context is an open research area. The application of
these contemporary theories to the secondary use of medical data provide an
opportunity to see how stakeholders with different internal values can operate within
a shared context.

19

Shoemaker (2009) also argued that the control theory of privacy was less problematic
than the limitation and hybrid RALC theory of privacy. Shoemaker introduces the
concept of ‘unauthorised exposure of one’s identity’ as a more useful approach than
that in RALC and contextual integrity approaches to information privacy.
Luciano Floridi (2005) proposed an ontological theory of informational privacy based
on information ethics. In a follow-up publication Floridi (2006) provides a concise
summary of his theory including the concept of ontological friction:

To summarise: given a certain amount of personal information
available in (a region of) the infosphere I, the lower the
ontological friction in I, the higher the accessibility of personal
information about the agents embedded in I, the smaller the
informational gap among them, and the lower the level of
informational privacy implementable about each of them. Put
simply, informational privacy is a function of the ontological
friction in the infosphere (Floridi 2006, p. 110).
Despite the use of illustrative examples in Floridi, Shoemaker, Moor, Nissenbaum
and Tavani’s publications there is little in the way of further publications that have
explored the real world application of the proposed informational privacy theories
(Grodzinsky and Tavani 2010a; Grodzinsky and Tavani 2010b). Taking the abstract
informational privacy theories and applying them in the real world would add value
to the body of knowledge surrounding informational privacy and this remains an open
research area.
Applying Shoemaker and Floridi’s privacy theories to the real world would be
possible, however, the more tangible, less esoteric nature of Nissenbaum, Tavani and
Moor’s theories provide a useful bridge to the ‘real world’.
As a result of considering the potential for application of contemporary privacy
theory to the secondary use of medical data, this research proposes that the following
research question exists:
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Open Research Question
1. Can Moor and Tavani’s Restricted Access/Limited
Control (RALC) and Nissenbaum’s contextual integrity
privacy theories be applied to the secondary use of
medical data?

2.3

Privacy in the secondary use of medical data context

This section of the literature review transitions from broader privacy concepts to
specific consideration in healthcare and specifically the privacy of medical data. The
consideration of privacy presented in the previous section makes it clear that there is
far more to privacy than simply the ‘limitation theory’. The Hippocratic Oath has
long guided medical doctors in the delivery of care to patients and the oath includes a
specific reference to the provision of confidentiality:
Whatever I see or hear in the lives of my patients, whether in
connection with my professional practice or not, which ought
not to be spoken of outside, I will keep secret, as considering all
such things to be private (as translated by North (2002)).
While not all medical schools include the recitation of the Hippocratic Oath at
graduation, the matter of patient privacy does continue to have importance. For
example, Cornell University continues the tradition with an updated version of the
oath that continues to include reference to patient confidentiality:
That whatsoever I shall see or hear of the lives of my patients
that is not fitting to be spoken, I will keep in confidence; (Weill
Cornell Medical College 2005).
In support of the confidentiality aspect of the Hippocratic Oath, medical practitioners
have kept their patients personal information private by restricting access to the
information recorded on paper based health records. That approach applies the
‘limitation theory’ of privacy as depicted in the green zone of Figure 4. That
paradigm of restricted or limited access to patient information and the expectation
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that it provides necessary patient privacy is inadequate with the move to an electronic
medium for holding medical records, as discussed by Marwick (1996).
Lowrance (1997), echoing the concerns described by Marwick, provides a useful
overview of the flow of consumer data through a data journey:

Although physicians, and staff nominally under their
supervision, still collect much of the most intimate data, they
are not necessarily any longer in position to control the
movements, uses or fate of the data. Data from a routine
patient encounter with the healthcare system quickly are
transmitted among care-providers and their local institutions,
various technical support services, the paying institutions,
and a variety of supervisors, inspectors, and researchers –
many far removed from the data subject, many not medically
certified, and possibly many not sworn to confidentiality
(Lowrance 1997, p. 19).
Croll (2011) agrees that the limited access approach was relatively easy to implement
when health records were stored on hardcopy documents and stored in physicians or
hospital data repositories. A shift in the established school of thought adopted by the
medical profession requires a move away from the limitation theory of privacy
towards a more comprehensive information privacy theory. This could aid in
adequately support the adoption of electronic health records where the information is
available in multiple contexts without the medical practitioner acting as ‘gate keeper’
in the manner described by Magnusson (2004).
Clinicians and researchers around the world are wrestling with the collision of health
privacy and the emerging information and communication technologies. These
researchers include those in Ireland (Buckley, Murphy et al. 2011), the United States
of America (Appelbaum 2000; Bansal, Zahedi et al. 2008b), Australia (Hansen,
Gurney et al. 2011; Showell 2011),

Germany (Iacono 2007), The Netherlands
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(Townend 2010), Portugal (Falcao-Reis, Cost-Pereira et al. 2008), Scotland (Fraser
2003), Greece and Denmark (Orphanoudaki, Voss et al. 2007).
2.3.1

Partnering with consumers for research

Emerging research suggests the way forward regarding secondary uses of medical
data would best be served by ensuring consumers are better informed about
secondary uses of their data and, perhaps, by viewing consumers as partners in the
research process (Whiddett, Hunter et al. 2007; Buckley 2008; Ruyter, Louk et al.
2010; Townend 2010; Shelton 2011). That involvement may include acknowledging
the value of consumers’ data; whether it is possible to identify the individual or
whether the data forms a small component of a vast array of suitable anonymised
data. The work of Ruyter, Louk et al. (2010) calls for the European Data Protection
Directive (EDPD) (95/96/EC) to reconceptualise the secondary use of medical data
as an everyday type activity rather than one requiring an ‘exemption’. This would
draw on consumers as partners who could view medical data storage in large
biobanks as the default choice to support a ‘research track’. Trinidad, Fullerton et al.
(2011) published a view where citizens could be regarded as ‘research participants’
rather than ‘research subjects’.

We propose a shift from paternalistic protections to
respectful engagement with individuals and groups whose
conceptions of risk, benefit, and harm deserve consideration.
Such an approach would treat participants as true
stakeholders in research, who willingly take on risk because
they see potential benefits to society outweighing potential
harms (Trinidad, Fullerton et al. 2011, p. 288).
That is an empowering attitude shift for consumers in terms of secondary use of their
medical data. Buckley (2008) also makes a persuasive argument for greater
understanding of medical research amongst the general public to aid engagement.
Robert H. Shelton gives a commentary, in a non-peer reviewed publication, that
urges medical researchers to confront this issue ‘head-on’:
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Rather than viewing privacy concerns as an impediment,
policy-makers, scientists, and HIT specialists should embrace
privacy as an opportunity that, if addressed, can enhance the
flow of information. Confronting this issue head-on by
establishing an effective electronic process for consent – one
that honours each patient’s specific privacy needs and desires
– can enhance patient participation in research, expand
access to data and biological samples, reduce the costs and
time associated with the recruitment of patients for clinical
trials and accelerate the discovery of new treatments (Shelton
2011, p. 1).
Shelton goes on to describe a pilot study where patients were given an opportunity to
register their detailed privacy preferences concerning access to their medical
information using electronic platforms that provide a digital consent process. No
details of the small pilot study were published. However similar initiatives are likely
to become a broadening research area and this thesis investigates a similarly
motivated consumer empowered approach.
2.3.2

Anonymised data

The use of anonymised data for secondary use is widespread amongst many
stakeholders including health researchers, health economists, insurance and
pharmaceutical organisations and healthcare providers. Often consumer consent is
not sought if the data to be used for a secondary purpose is to be anonymised. An
alternative is to use identifiable data where it is possible to recognise the individuals
concerned. The medical research community operate within an ethical framework
that would generally seek a consumers consent prior to using identifiable data. Other
secondary use stakeholders may not operate within such containing ethical
frameworks.
Several of the contemporary privacy theories previously presented have direct impact
for this research when considering the appropriate use of anonymised data. In
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particular Nissenbaum’s contextual integrity assists in unpacking the anonymisation
of data as a means of delivering privacy to a consumer. The actors involved in the
process of medical data anonymisation are: healthcare provider (sender), the
secondary user (recipient) and the consumer (information subject). The contexts vary
from commercial oriented eg. insurance organisations who often aggregate data to
detect trends to aid in optimising premiums to health researchers working towards
more utilitarian goals. Using Nissenbaums ‘contextual integrity’ approach to privacy,
an information subject would be able to influence the attributes and transmission
principles according to context to establish suitable privacy. The use of anonymised
data may be consistent with the context, actors, attributes and transmission principles
required to provide privacy to the information subject. Alternatively the context,
actors, attributes and transmission principles may indicate that the use of anonymised
data is not suitable to provide privacy to the information subject. The widespread use
of anonymised data certainly rests comfortably with the ‘restricted access’ approach
to privacy which is based on the early concept of privacy whereby if you can’t
identify an individual there is no problem. Contemporary theories of privacy are
more nuanced.
A simple scenario using anonymised data illustrates – if a consumers medical data is
anonymised and then aggregated with similar consumer data, over a period of time
patterns can emerge across the attributes that comprise the aggregated, anonymised
datasets. That would result in the emergence of intelligence that was unrecognised
when dealing with one single consumer health record. If the operating context was
health research that would likely be viewed positively. In contrast, if the context was
commercial, say a personal insurance context, the use of seemingly innocuous
anonymised data takes on a whole new dimension. Business intelligence models
developed using aggregated, anonymised data can deliver far more power than may
have been imagined with the single anonymous health record. Anonymised data is
not as safe as many citizens believe. This thesis acknowledges the suitability of
anonymised data in some secondary use context – but not all.
Returning to the contemporary privacy research of Moor and Tavani, they suggest
that “Privacy is fundamentally about protection from intrusion and information
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gathering by others.” (Tavani and Moor 2001, p. 6). These researchers do not
propose that “Privacy is fundamentally about protection from intrusion and
identifiable information gathering by others”. Anonymised information gathering by
secondary use stakeholders may have a negative impact on information subjects
when considering the power of aggregated data. These issues move well beyond the
simplistic concept that as long as an individual is not personally identified there can
be no problem using their data.
This thesis seeks to explore the application of contemporary privacy theories to the
secondary use of medical data to inform the debate regarding future use of both
anonymised and identifiable consumer health information. The next section of the
literature review presents multiple perspectives on the secondary use of medical data.
To be able to progress this challenging field of research it is necessary to engage in
the debate from multiple points of view.
2.4

Stakeholder perspectives on privacy in the secondary use of medical data
context

This section contains five sub-sections where stakeholder points of view regarding
privacy and the secondary use of medical data are considered. The stakeholders
considered are:
1. medical researchers
2. privacy advocates
3. commercial organisations
4. the Australian government and
5. consumers
The recent European based research of Townend (2010) is initially presented as his
work includes multiple stakeholder perspectives through conceptual vectors, with the
consumer vector the most under represented.
Townend (2010) explores three competing vectors in the health privacy domain.
1. The healthcare vector (e.g. medical research)
2. The commercial use vector (e.g. insurance industry)
3. The public opinion vector
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Townend’s focus was particularly on genetic data, however his insights are also very
applicable to broader healthcare data. Townend used the privacy concepts introduced
in the first part of this literature review to explore the tensions between these three
vectors. A three-fold analysis of the traditional elements of privacy are considered;
including privacy as a normative engine in society, and privacy as a relationally
flexible boundary keeper between individuals in society and these are expressed
through transactional areas including ‘physical’ privacy, ‘informational’ privacy,
’decisional’ privacy and ’proprietary’ privacy (Townend 2010).
The healthcare vector (medical research)
Townend posits that the history of the development of the healthcare vector started
with protecting the physical integrity of research participants and then progressed to
add informational and decisional privacy. That vector is configured around laws and
regulations that relate to data protection, informed consent, and good practice. The
medical research vector also adopts norms about the responsibility of citizens to
participate in the health enterprise. The notion of balancing individual rights to
privacy against common good dominates here.
The commercial use vector
Townend (2010) suggested that the commercial vector starts with property and
proprietary privacy. “Data are given a commodity value through the addition of
labor”, such as analysis and synthesis of data. The consumer and the healthcare
provider are accommodated on Townend’s commercial use vector with the capacity
to shift backwards and forwards to indicate which party has the greater proprietary
privacy claim. That vector is configured around laws relating to health law or
intellectual property law. Decisional and informational privacy are important on this
vector. Data protection law is employed within this vector and supports the flow of
personal data as a commodity and enabler of commercial ‘activity’. Normative
privacy is important here with individual autonomy for consumers as embedded in
the European socio-legal arrangements.
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The public opinion vector
As Townend (2010) suggested, the public opinion vector is the most under developed
and hence is clearly an area for further research. The diverse range of opinions
expressed by citizens about secondary uses of their data is accommodated within that
vector. Townend noted there are few surveys identifying respondents’ opinions about
this subject in Europe. That vector is stronger on normative privacy than the other
two vectors. Townend considers public trust and finds confidence underpin
information based medical research and hence regulations must support the broadest
possible spectrum of opinions held and not just the majorities. That contrasts with the
medical research approach to privacy that tend to adopt binary approaches such as
consent, offering little accommodation for diverse consumer opinion.
As a result of the recognition of the under developed public opinion vector this
research proposes that the following research question exists:
Open Research Questions
2. How diverse are consumer views regarding privacy and the
use of their personal medical data for secondary purposes?

2.4.1

The medical researcher lens: research at risk

The knowledge of medical researchers and associates, supported by the use of
sophisticated information technologies, has without doubt brought great benefit to
human society through retrospective, observational studies. With the rapid growth in
capture and storage of electronic medical data and ongoing developments in medical
research there is enormous potential for future enhancement of our understanding of
human health. This thesis seeks to support this work through developing an
understanding of the possibilities for engagement between consumers, researchers,
technologies and contemporary privacy theories.
The application of sophisticated information technology tools and software to
capture, store and analyse large datasets, including medical datasets, has prompted
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the creation of privacy protecting legislation. With the advent of legislative
requirements in many nations concerning the use of personal medical records for
secondary purposes, healthcare providers and medical researchers have published
numerous concerns about limitations arising from the legislation (Melton 1997; Dyer
2009; Buckley, Murphy et al. 2011). Following legislative amendments, medical
researchers have reported difficulties in gaining access to consumers’ medical data
for secondary purposes and highlight the constraint this applies to retrospective,
observational research (McCarthy, Shatin et al. 1999; Al-Shahi and Warlow 2000;
Helliwell 2001; Croll 2007; Dyer 2009; Buckley, Murphy et al. 2011)
2.4.1.1 Getting the balance right and challenges to research
Medical researchers engage in debate about how to ‘get-the-balance-right’ between
the privacy needs of an individual and the broader societal benefit that can arise from
using medical data to advance understanding of human health to achieve better
health outcomes for all (Melton 1997; Walton, Doll et al. 1999; Lowrance 2003;
Whiddett, Hunter et al. 2007; Zeps, Iacopetta et al. 2007; Dyer 2009; Buckley,
Murphy et al. 2011).
The 2004 the Australian National Health and Medical Research Council (NHMRC)
privacy consultation with stakeholders involved a survey that was administered to
188 medical and health service researchers; 112 individuals responded to the survey
(60% response rate). Most respondents had been conducting research for an average
of 13 years. No claims were made about this being a representative sample. This
research found common issues related to data access, consent and scientific rigour:

The most common issues raised related to restricted access to
registries or databases hindering research by affecting
scientific rigor. Access to registries was commonly linked to
recruitment and consent. Where consent was not possible, or
was difficult or problematic, privacy legislation was
considered to impede recruitment. Sampling was identified as
a major factor affecting scientific rigor. Sample bias
undermines confidence in the generalisability of results to the
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study population (Campbell Research And Consulting 2004,
p. 12).
In addition, apart from hindering the scientific rigour, a recurring theme in the
medical researcher’s responses to the NHMRC survey is the matter of the
administrative burden created by privacy legislation. Of the research respondents,
73% identified an increased administrative burden arising from Commonwealth
privacy legislation (Campbell Research And Consulting 2004, p. 15).

The administrative burden was reflected in additional cost in
terms of staff time, overall time taken for approval and start
up of research and the associated cost of changed research
practices to accommodate privacy requirement (Campbell
Research And Consulting 2004, p. 13).
These Australian researchers suggested improvements to legislation and guidelines to
reduce the tensions between privacy and medical research. There was no reported
consideration of viewing consumers as research partners and there was no
consideration of the broader societal notions of increased surveillance through linked
databases coming from the medical and health service researchers surveyed.
One survey question specifically explored the ‘getting-the-balance-right’ debate. The
medical research community expressed stronger feelings about the disadvantage of
privacy legislation than did other groups such as allied health professionals and peak
bodies. This is graphically illustrated in one of the charts from the NHMRC 2005
report, refer to Figure 6 which reproduces Figure 10 from the NHMRC report
(Campbell Research And Consulting 2004, p.42).
The study groups in that figure are:
ST3 – medical & allied health professionals;
ST4 - medical and health service researchers;
ST5 – data custodians;
ST6 – ethics committee members and
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ST7 – peak bodies.
The ST4 group of medical and health service researchers clearly provided the
strongest disagreement with the NHMRC survey statement “The current privacy
framework strikes the right balance between protecting the rights of individuals and
enabling effective health research”.

Figure 6: Balance between privacy and research (reproduced from Campbell Research and
Consulting 2004)

“In general, research respondents favoured automatic access to individual
information without obtaining specific consent” (Campbell Research And Consulting
2004, p. 13). That contrasts sharply with the consumer stakeholder study outcomes
reported in earlier sections of the NHMRC report.
Rodwin (2009) argues the case for public ownership of patient data, similar to the
medical and health service researchers above, with secondary use of medical data
seen as a public good.
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There are a large number of publications available considering the ‘getting-thebalance-right’ debate. The health research community are very influential in setting
the direction and nature of secondary use of consumers medical data.
Gordis, Gold and Seltser (1977) argued that retrospective observational type studies
were hindered due to the growing impact of privacy concerns as reported in the
American Journal of Epidemiology:

In recent years, however, widespread societal concern for
privacy and confidentiality, often manifest in confusing or
ambiguous regulations, has made many types of epidemiologic
and other medical investigations increasingly difficult to conduct
and, in fact, now threatens to make such studies virtually
impossible (Gordis, Gold et al. 1977, p. 163).
The Gordis paper continues with a list of significant epidemiological studies
facilitated by secondary use of medical information, often with individually
identifiable data. Those researchers use a single lens to view the matters discussed;
that of an epidemiologist, with no regard for other points-of-view. These
epidemiologist argue for access to medical information that includes individually
identifiable information “because access to these records is only a first step in
ascertaining and identifying these patients so that they can be subsequently contacted
and , with their informed consent, interviewed and studied” (Gordis, Gold et al.
1977, p. 166). The British General Medical Council moved towards sharing of
patient information with expressed permission which prompted Doll and Peto (2001)
to write to the editor of the British Medical Journal stating:

The right to medical care should, we suggest, generally
continue to include the responsibility to allow the information
gained in its course to be used for the benefit of others who
develop a similar disease, or are at risk of developing it.
Confidential sharing of information about patients between
doctors and bona fide medical research workers (with
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exceptions only in particular cases) has done no harm and
has achieved much good. Why destroy it? (Doll and Peto
2001, p. 730).
That note is again written through a single lens without acknowledging the broader
stakeholders who also lay claims (of varying veracity) to the need to access
consumers’ medical records. The tone of that article is best captured through the
header ‘Rights involve responsibilities for patients’. Consumers are being told that
they have both a right to healthcare and a responsibility to others and should thus
allow their personal medical information to be available for research. It is clear that
the clinicians have utilitarian motivations. That is similar to the view taken by
Lowrance in the Nuffield Trust report (Lowrance 2002). Earlier Al-Shahi and
Warlow (2000) expressed a view that called for public consultation to investigate the
ideal balance between individual confidentiality and data protection, and the
legitimate use of patient-identifiable data without consent.
Researchers’ concerns regarding access to data can be broadly categorised into those
pertaining to compromised research design, consent bias, small data volumes, delays
in implementing studies, and associated costs and audit versus research issues. AlShahi and Warlow raised these issues in the British Medical Journal:

A blanket requirement for anonymisation of data, as well as
informed consent from all individuals to use identifiable data
about them would jeopardise the methodological integrity of
research and audit (Al-Shahi and Warlow 2000, p. 1031).
The undesired introduction of ‘consent bias’ and effects on validity of research
design are also often reported (Buckley, Murphy et al. 2011). That issue arises when
researchers can only gain access to consumers who have consented to having their
data used in studies. It is possible that bias may be introduced into study designs as
there may be a group of individuals with common characteristics who refuse to
participate. Any evidence generated by such a study would perhaps not be
generalisable due to the swaying of results by the missing cohort.
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Other concerns relate to the smaller volumes of data available for research when
consumer consent is required - such as the publications of McCarthy et al. who state:

Efforts to protect patient privacy may come into conflict with
the ability to produce timely and valid research to safeguard
and improve public health (McCarthy, Shatin et al. 1999, p.
417).
Medical researchers report on the impact of the delays to undertaking research
studies

and

increased

costs

when

consumer

privacy

matters,

including

implementation of consent mechanisms, impede research (Melton 1997; McCarthy,
Shatin et al. 1999; Croll 2007; Metcalfe, Martin et al. 2008; Morton, Smith et al.
2009).
The fine line between what is considered research rather than a quality audit is also
commented upon. For example, Morton et al. (2009) comments about broad
Australian Law Reform Commission proposals to limit all research where research is
broadly considered to be the compilation of

statistics. That definition could

potentially compromise practice audits and quality reviews which form an essential
part of healthcare delivery contexts.
The Nuffield Trust report paragraph labelled Privacy, confidentiality, and related
notions does not acknowledge possible existence of privacy theory beyond ‘limited
access’. Lowrance opens with the statement “Privacy is a widely understood and
deeply felt, but elusive, concept” (Lowrance 2002, p. 7). Many privacy researchers
would disagree that privacy is a well understood concept (Tavani 1999a) as
described at the start of this literature review.
Lowrance summarises a number of foundation assumptions related to privacy:
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Privacy is a relative status, and claims to it must be
negotiated against countering claims such as rights of others
or collective societal goods (Lowrance 2002, p. 8).

Data may be about a patient, for instance, but that person
does not “own” the data in the sense that they are his in
some exclusive proprietary way to take away, sell or destroy
(Lowrance 2002, p. 3).

If data are not identifiable the data are not ‘personal’, and
unless safeguards are compromised the data-subjects stand
only a very low risk of being harmed (Lowrance 2002, p. 24).

If data aren’t identifiable they aren’t ‘personal’, and a
variety of rights, obligations and sanctions that apply to
personal data are not relevant. Research on anonymised data
is just research on cases, not persons (Lowrance 2002, p.
27).
Investigation of consumers response to the above set of assumptions and statements
is an open research area as little evidence is available to present consumers views on
these matters.
The Nuffield Trust report (Lowrance 2002) attracted some negative feedback from
medical researchers concerned with privacy in healthcare. Following the publication
of Lowrance’s Nuffield Trust report, Willison (2003) criticized an implicit
assumption underlying the report – that researchers’ interests are aligned with those
of the public. Willison argues that “researchers interests cannot be equated with those
of the public” (Willison 2003, S1:20) particularly when they are increasingly
engaged in commercial research. In addition Willison does not agree with
Lowrance’s depiction of privacy as an individual rather than societal concern:
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The report pits this societal interest against the privacy
interests of a minority of individuals who choose to withhold
their own data from analysis while benefitting from the
largesse of others who have contributed their data. These
individuals are then exhorted to be more civic-minded
(Willison 2003,S1:19).
Willison continues by disagreeing with the manner in which Lowrance has framed
privacy as an interest of selfish individuals when so much research exists to depict
privacy as a broad societal interest. Willison states: “A high regard for privacy has
been associated with ancient Greece, English Protestantism and common law
traditions and with American constitutionalism” (Willison 2003, S1:20).
As a result of recognising the imperatives behind medical research and the frequent
use of anonymised data this research proposes that the following research question
exists:
Open Research Question
3. What are consumer views regarding a sense of altruism
towards the use of medical data ‘for the common good’,
consumer ownership of medical data, and the use of
anonymised data?

2.4.1.2 Human Research Ethics Committees (HREC)
HREC are expected to advise researchers on any research studies that involve people
and personal data concerning individuals. That places HREC in the front line of
secondary uses of medical data. The exponential growth of medical data and
subsequent booming interest in using data for secondary purposes may have
outstripped the HREC ability to keep pace with the number of such request.
The role of Human Research and Ethics Committees (HREC) have been criticized by
some as being over-protective and hindering beneficial research (Campbell Research
And Consulting 2004; Croll 2007). The role of the HREC is to protect the rights of
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consumers whose very personal, sensitive medical information is sought for a wide
range of secondary uses. There is some variation in the way that HREC apply ethics
guidelines which adds weight to the criticisms (Zeps, Iacopetta et al. 2007; Willison,
Emerson et al. 2008).
Prior research publications, largely coming from the medical research community,
question if HREC include members with suitable skills to make the necessary
decisions (Zeps, Iacopetta et al. 2007; Cullen 2008). For example, Metcalfe et al.
(2008) report that the particular UK Patient Information Advisory Group (PIAG),
deciding if permission should be granted to access patient records without consent,
did not include a legal experts. Metcalfe et al. (2008) highlight that this committee
changed its interpretation of the law over time.
Research by Willison et al. (2008) involved face-to-face interviews with Canadian
research ethics boards (REBs) and administrators affiliated with medicine faculties at
Canadian Universities. During these interviews, structured questions regarding a case
study explored participants’ expectations regarding consent and associated matters.
The results of that study also indicate a large variation across REBs regarding
requirements for consumer consent. To illustrate; fourteen sites (47%) required
individual patient consent and eleven sites (38%) did not require consent for
secondary data use. Willison et al. suggest that training and collaboration across
REBs would be beneficial:

REBs need training in best practices for protecting privacy and
confidentiality in health research. A forum for REB chairs to
confidentially share concerns and decisions about specific
studies could also reduce variation in decisions (Willison,
Emerson et al. 2008, p. 308).
A more recent publication sharing experiences from a secondary data use project
across seven clinical centres in five countries provides a concise reflection on HREC
operation:
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To a certain extent, the ethical requirements placed on a
research project are prone to the subjective interpretations by
local ethics committees of the general principles encapsulated in
the guidelines to which they work (Elger, Lavindrasana et al.
2010, p. 236).
In the Australian context, researchers suggested “Ethics committees do not fully
understand privacy legislation and generally oppose access to health information
without consent” (Croll and Croll 2006, p. 2). The 2007 submission from the Health
Informatics Society of Australia (HISA) to the Australian Law Reform Commission
(ALRC) regarding the review of Australian Privacy Law considers the capabilities of
HREC. That report notes the important role played by HREC but also notes the
inconsistency and delays associated with these committees:
Concern has been raised that currently there is not sufficient
consistency across the various HRECs and many do not have
the necessary skills and resources to carry out the proposed
functions as proposed by the ALRC discussion paper. In
particular, concern has been raised about how to avoid the
inevitable bureaucratic backlog associated with HRECs
unless these issues are adequately addressed (Croll 2007, p.
5).
The HISA submission also reports on an earlier submission by the National Health
and Medical Research Council (NHMRC) urging a rethink on HREC operation:

ALRC reconsider the role of HRECs in decisions about the
privacy implications of the collection, use or disclosure of health
information in research. The NHMRC is of the view that these
considerations could be managed without intervention by an
HREC although we have not yet identified a replacement
mechanism at the stage.(58.120) as reported in (Croll 2007, p.
12).
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The HISA report flags an opportunity to develop an innovative mechanism to replace
HREC intervention when considering privacy matters and this remains an open
research area. That mechanism will be further investigated via this PhD research with
particular emphasis placed on consumer engagement in the development and
operation of such a mechanism. The potential domains for use of such an alternative
mechanism is wide, as indicated by the numerous national contexts where HREC
issues have been raised. Any alternate mechanism to HREC, as suggested by Croll,
would aid in overcoming the documented inconsistencies between the operation of
HRECs as raised by Elger et al. (2010) and Willison et al. (2008). Development of a
mechanism to support consumers stating their preferences for secondary use would
offer some relief to the volume of data access requests HREC process and aid in
overcoming delays in gaining approvals, as described in Section 2.4.1.
As a result of the issues regarding operation of HREC this research proposes that the
following research question exists:
Open Research Question
4. Are consumers interested in a mechanism that would offer an
opportunity for them to provide some direction regarding use of their
medical data, rather than relying on HREC operation?

Each of the stakeholder groups brings a different set of ‘values’ to the secondary use
of medical data context. Nissenbaum’s privacy research, as previously discussed,
includes values as an important aspect of any context with the values including the
goals, ends and purposes. Nisenbaum’s work implies that each context has a single
set of values and an open research area surrounds the understanding of a context
where various stakeholders operate within one context but operate with very
different ‘values’. Much of the tension in the secondary use of medical data relates
to the conflicting ‘values’ each stakeholder brings to the shared context.
The values, using Nissenbaums (2010) interpretation, driving medical researchers
involvement within the secondary use of medical data context are generally about
advancing the body of knowledge related to human health. When medical
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researchers engage with consumers, seeking their support of research activities, this
is the type of purpose or goal usually presented. There are published accounts of
consumers accepting these values from medical researchers resulting in consumers
consenting to have their personal data included in secondary use activities (Robling,
Hood et al. 2004; Barrett, Cassell et al. 2006; Baird, Jackson et al. 2009).
That presentation of the values of medical researchers is somewhat oversimplified
with the importance of collaborations between medical researchers and organisations
that have a commercial interest in exploitation of research outcomes not emphasised.
Medical research can journey from values of an altruistic nature at the outset to
morphing (perhaps necessarily) into more commercial values at a later date. The
values of the stakeholder have thus shifted from initially altruistic (as marketed to
consumers) to far more commercial in nature.
The impact of stakeholder values on possible engagement with consumers in the
secondary use of medical data context is an open research area further pursued
through this thesis.
As a result of the consideration of stakeholder values and consumer acceptance of
these values, this research proposes that the following research questions exist:

Open Research Questions
5a. Can consumers discern the ‘values’ that different stakeholders
bring to the secondary use of medical data?
5b. Does this impact on their willingness to contribute personal
data for secondary use?
2.4.2

The privacy advocate lens: an Orwellian future

Privacy advocates can be found across a range of professions (including medical
research) and there are few individuals who state ‘privacy advocate’ as their
profession. This has a negative impact on the advocacy or championing of privacy
issues. Privacy advocates have formed organisations to aid their shared objectives
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regarding privacy. Such organisations include the Australian Privacy Foundation
(APF), Privacy International (Privacy International), the Privacy Rights Clearing
House (Privacy Rights Clearing House) and Electronic Privacy Information Centre
(EPIC). These groups look beyond the present to future implications of the adoption
of technology and provide comprehensive portals to a vast array of policy
documents, privacy related legal proceedings, and media reports regarding privacy
matters. Privacy advocates contribute material to newspapers (Stout and Zeller 2006;
Dash 2007; Staff-Reporter 2008; Dearne 2010; Staff-Reporter 2011), on-line
publications (Electronic Privacy Information Centre ; Australian Privacy Foundation
1998) and calls for government submissions on privacy matters (Fernando 2011a;
Clarke 2011c). Frequently privacy advocacy groups respond to Government
initiatives that are inadequate in terms of consumer health privacy with
representations made to government hearings such as that made by Clarke and
Fernando to the Australian Senate Community Affairs Legislation Committee
concerning the Healthcare Identifiers Bill 2010 and, most recently, Personally
Controlled Health Records (Parliament of Australia 2012). Privacy advocacy groups
call for patient autonomy and strongly disagree with the notion that individual rights
must be lessened to receive healthcare (Fernando 2009; Fernando 2011b).

Issues raised by privacy advocates include, but are not limited to, issues regarding:
lack of transparency; inconsistency with democratic society; harms to dignity; rapid
advances of technology outpacing privacy legislation and data ownership. Research
publications have reported that when an individual does not know ‘who’ has access
to their medical data or ‘how’ their data may be used for secondary purposes, they
are less willing to share (Schneider, Kerwin et al. 2009; Tarini, Goldenberg et al.
2010). It has also been suggested that this lack of transparency may lead to patients
not disclosing essential information required for their healthcare with possible
adverse effects (Woodward 1995; Steeves 2004; Sutcliffe 2006). Nehf (2003)
describes a web of anxieties people face as a result of diminishing privacy, and lack
of transparency and control:
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The more cognizable and immediate problem with a loss of
information privacy, and the problem that is most likely to
produce a political resolution, is our inability to avoid
circumstances in which others control information that can
affect us in material ways – whether we get a job, become
licensed to practise a profession, obtain a critical loan or
fall victim to identity theft. We cannot avoid the collection
and circulation of information that can profoundly affect
our lives. We feel that we have little or no voice or choice
in the data collection and sharing process. We do not know
who has what information, how they got it, what purposes
or motives those entities have, or what will be done with the
information in the future. Even if the information in
databases is accurate and complete in all relevant aspects,
it can still harm us if it falls into the wrong hands or if it is
used for a purpose we did not envision when we disclosed it
(Nehf 2003, p. 26).
The anxieties described by Nehf are particularly apparent when considering the
secondary use of medical data. Patients provide very sensitive, confidential, personal
information to their medical doctors in the traditional patient-doctor relationship.
This information moves from this initial protective context into the secondary use
context without the privacy protection afforded in the initial context, with such
moves often not transparent to consumers. Privacy advocates seek to minimise the
situations in which consumers are exposed to the anxieties described by Nehf.
As a result of the anxieties described by Nehf and of concerns raised by privacy
advocates this research proposes that the following research question exists:
Open Research Question
6. Are consumers feeling the anxieties described by Nehf due to loss of
privacy?
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Harms to dignity resulting from inappropriate use of personal information have been
raised by a range of privacy advocates. For example, Trinidad, Fullerton et al.
(2011) draw attention to claims of harm including “breaches of autonomy and
privacy, stigmatization or other negative social consequences and uninvited
challenges against deeply held beliefs”. Consumers perceived harms to dignity have
not been widely canvassed and as Croll and Morarji (2006) advises, consumer’s
perceptions – even if ill informed – are possible barriers to secondary use of medical
data.
Rapid advances in information technology often outpace slow moving legislation and
challenge organisations information privacy and data governance mechanisms
(Fernando 2004; Trope, Power et al. 2007). That rapid advance has frequently left
privacy concerns unaddressed (Clarke 2011a; Clarke 2011b) . Members of the legal
profession are often called upon to assist in legislating on privacy issues. That
profession looks through a broad societal lens and provide a valuable contribution to
the protection of the Western cultural notion of privacy as a right for all citizens, as
noted in the opening literature review section addressing privacy in general. The
research of Magnusson is informative in illustrating how legislation can be
inadequate. Magnusson describes challenges to health information privacy shifting
through three broad conceptual shifts from (1) patient-centred health records to (2)
multi-function health data holdings and finally (3) trans-organisational data flows to
facilitate national linkage and surveillance (Magnusson 2004). Magnusson notes the
inadequacy of legislation in dealing with the accompanying shift in secondary use of
an individual’s medical data from extraordinary in (1) to routine in (3).

2.4.2.1 Ownership of data
Rodwin (2009) presents the advantages of public ownership of medical data and
dismisses patients from having exclusive property rights to their medical data due to
the prohibitive cost of navigating such ownership in the collection of data. Section
1.3.1 of this Literature Review Chapter considered viewing consumers as partners
rather than research subjects and that concept is relevant to ownership of data
matters. In contrast to Rodwins public ownership approach to data, Ruyter et al.
(2010) encourage meaningful engagement with consumers as stakeholders in the
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data. Ruyter et al. (2010) discussions surround the notion that in a liberal society
citizens need an organisation to distrust itself. From that foundation of distrust the
organisation would establish mechanisms to ensure that the organisation is worthy of
the trust of the public. Ruyter et al. (2010) go on to suggest that a secondary use
‘interactive opt-out’ register would enable citizens to express their distrust in an
organisation and empower them to remove themselves from secondary use of their
medical data. That ‘opt-out’ register is a mechanism that allows individuals to
exercise a freedom of choice and some sense of ownership over their medical data.
Metcalfe et al. (2008) calls for a similar opt-out mechanism for the UK. The opt-out
paradigm would challenge the current European regulatory framework paradigm
which relies on patient consent mechanisms. Discussion considers a ‘register of
sensitivities’ where consumers can respond to questions to indicate their particular
sensitivities to secondary data use. The example given is consumers responding to
the question “I would like my data to be used for the following types of research:”
and then a series of areas of medical research are offered with corresponding tick
boxes (Ruyter, Louk et al. 2010, p. 307).
Trinidad et al. (2011) make a number of recommendations that provide consumers
with some sense of ownership over their medical data, including:
1. Methods to ensure that participants are informed about the use of their data in
research, including potential inclusion in data repositories, and to grant the
opportunity to decline participation in wide sharing;
2. Mechanisms to provide access to current information about how samples are
being used on either an individual or study-wide basis;
3. Transparent, accountable oversight processes that include community
representation; and
4. Opportunities for participants to provide input concerning stewardship of
their data e.g. dialogue between researchers and participants, ongoing
community consultation, or deliberative processes.
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As a result of the suggestions put forward by Trinidad et al. (2011) and Ruyter et al.
(2010) emphasis on consumer engagement, this research proposes that the following
research question exists:
Open Research Question
7. Are consumers willing to engage regarding secondary use of their
medical data?
A landmark legal case in Australia poses a challenge to the concept of consumers
having ownership over their medical information. The Case of Breen vs Williams
was litigated as a test on behalf of thousands of Australia consumers who suffered
problems following the use of breast implants supplied by the Dow Corning
Corporation. The consumers suffered as a result of silicon leakage and other
problems associated with the implants. An Australian woman, Ms Breen, sought to
be involved in compensation via a US court-approved agreement distributing $4.2
billion United States Dollar (USD) settlement worldwide. Ms Breen did not allege
any breach of duty on the part of the defendant – her cosmetic surgeon in Australia,
Dr Williams. Her claim was against the US manufacturer of the breast implants. Dr
Williams refused to allow Ms Breen to copy her medical records. The case came to
an end when

The High Court held unanimously that a patient has no
general right to inspect or copy medical records documenting
the patients medical history and relevant relationship with a
healthcare provider (Magnusson and Opie 1998, p. 99).
Opie and Magnusson quote the joint judgements from Judges Gaudron and
McHugh JJ:

Many [people], Ms Breen among them, no doubt think that a
patient should have access to [the medical records that
concern them], subject to limited exceptions. (Magnusson and
Opie 1998, p. 100).
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It is not clear what the Australian public opinion is about the Breen V’s Williams case
and this research seeks to gather feedback on this matter from the general public to
add to knowledge in this complex data ownership related matter.
The perceived ownership of medical records is a vexing issue. Rosenbaum (2010)
describes a study of more than 500 United States of America Health Insurance
Portability and Accountability Act (HIPAA) Privacy Rule cases and finds that one of
the most common cases involves healthcare providers resisting the release of data to
patients. This is largely due to liability concerns. The publications of Beckerman et
al. (Beckerman, Potts et al. 2008) and Terry (2009) report that US healthcare
providers and health plans tend to resist broad health information transparency as
reported by Rosenbaum (2010). Rodwin emphasises the commercial importance of
medical data (Rodwin 2009). Hall (Hall 2009) also wrestles with the US legal
uncertainties of medical data ownership reflecting on the transition from paper based
to electronic medical record keeping and resultant uncertainty of ownership.
As a result of consideration of the data ownership and associated decision making
this research proposes that the following research questions exist:
Open Research Question
8. Do consumers agree that medical records belong to their doctors?
9. Do consumers seek more empowerment as suggested by privacy
advocates?
The next section of the literature review considers the role that government plays in
the privacy of citizen health information and the use of personal medical data beyond
delivering healthcare to the individual.

2.4.3

The government lens: big brother or privacy protector?

The bulk of the research positioning associated with this thesis is in Australia and
this section of the literature review focuses on the Australian context and the manner
in which the Australian Government is positioned between privacy advocates;
largely the Australian Law Reform Commission, (ALRC) and the healthcare
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community. Tension exists between the ALRC goal of protecting citizens’ privacy
and personal identification requirements for developing effective information
systems to support the delivery of healthcare to citizens. Societal surveillance is
facilitated by the development of national identifiers, such as those frequently used
for healthcare systems. The primary purpose of the identifiers is the accurate
identification of consumers as they interact with the health system. However, given
the key role of government entities such as Medicare in processing health related
transactions for the bulk of Australian citizens, the development of vast databases of
identifiable medical data result. Section 1.4.2.1 of this thesis considered data
ownership issues and as the custodian of vast volumes of healthcare data generated
by the Australian healthcare system the Government has become an important data
custodian. The Government has a challenge in simultaneously governing and
legislating across: citizen privacy, digital surveillance, healthcare and secondary use
of medical data requirements. The notion of monitoring Australian health system
performance is currently under debate in the Medical Journal of Australia
(Braithwaite and Mannion 2011; Jorm and Frommer 2011).
Similar tensions have arisen in the United States of America (USA). The Clinton
administration supported the creation of unique national healthcare identifiers but in
the summer of 1998 this support was reserved until Congress established
comprehensive legislation to protect patient privacy (Ng 2000).
The Australian Government has not taken a similar approach to the USA, rather the
legislation authorising the creation of national healthcare identifiers was completed
prior to the completion of legislation concerning privacy.
A patchwork of Commonwealth and State legislation operates in the scope of
secondary uses of medical data. For example, National Privacy Principles appear in
Schedule 3 of the Australian Privacy Act 1988 (Cth) (Australian Government 1988).
These privacy principles apply to private sector handling of data; collection, use and
disclosure; data quality; data security; openness; access and correction; identifiers;
anonymity; transborder data flows and sensitive information. The Information
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Privacy Principles (IPP) are documented in Section 14 of the Privacy Act 1988 (Cth).
These principles apply to Australian and ACT government agencies:
Principle 1- Manner and purpose of collection of personal information
Principle 2- Solicitation of personal information from individual concerned
Principle 3- Solicitation of personal information generally
Principle 4 - Storage and security of personal information
Principle 5 - Information relating to records kept by record-keeper
Principle 6 - Access to records containing personal information
Principle 7 - Alteration of records containing personal information
Principle 8 - Record-keeper to check accuracy etc of personal information before
use
Principle 9 - Personal information to be used only for relevant purposes
Principle 10 - Limits on use of personal information
Principle 11 - Limits on disclosure of personal information
Aspects of the IPP and Privacy Act have been ‘worked around’ to enable healthcare
identifier creation. The introduction of electronic health records (EHR) has proven to
be a challenge in Australia, as it has been elsewhere in the world (Gunter and Terry
2005; Kalra 2006; Hayrinen, Saranto et al. 2008; Ludwick, Manca et al. 2010; Baird,
North et al. 2011). The benefits of such information systems are strongly argued as
providing a benefit to both individual healthcare consumers and society as a whole.
An important step towards the introduction of the Australian EHR was undertaken in
2010 with the passing of the Healthcare Identifiers Act (HIA) through the Australian
Parliament. Individual and Provider Identifiers are fundamental building blocks of
the information systems, including EHR, that provide the vast volumes of data
needed for corporate and trans-organisational and national performance monitoring.
These identifiers also enable levels of surveillance that are uncomfortable to many
citizens with an interest in privacy.
In parallel to the above developments in the healthcare sector, the Australian Law
Reform Commission (ALRC) has wrestled with the concept of privacy in the 21st
century. In particular the ALRC considered the challenges associated with
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maintaining two separate sets of privacy principles where both do not always take a
consistent approach to privacy matters. Following extensive consultation with
community members and policy and law makers, the ALRC proposed a set of eleven
Unified Privacy Principles (UPP) for Australia (Australian Law Reform Commission
2008). The objective was to unify and enhance the provision of the Commonwealth
sector Information Privacy Principles (IPP) and the private sector National Privacy
Principles (NPP).
The Healthcare identifiers and privacy: Discussion paper on proposals for
legislative support was issued by the Australian Health Ministers’ Advisory Council
in July 2009. This paper described legislative proposals to support the creation and
implementation of Australian national healthcare identifiers and associated
arrangements for privacy of health information. Included in this proposal is the
creation of an Individual Healthcare Identifier (IHI) for every Australian.
The discussion paper puts forward the case for establishment of the national
healthcare identifiers with the associated Health Identifier Service expected to be
operational by mid 2010. It was noted in the Executive Summary of the Healthcare
identifiers and privacy: Discussion paper on proposals for legislative support that
“Discussions between governments about a national privacy framework across all
jurisdictions and its implementation may not be completed by that time” (Australian
Health Ministers Advisory Council 2009, p. 3). A well established national privacy
framework would have been advantageous for consumers both now and in the future
as the identifiers are more widely adopted.
The Discussion paper states that “assignment of IHIs will be authorised by
legislation and individual consent will not be sought” (Australian Health Ministers
Advisory Council 2009, p. 25). The arguments for this are sound from an
information systems point of view; that is, from the outset the health data
management goals would be best served by a complete, valid and comprehensive set
of individual identifiers. That approach can also be seen as very ‘heavy-handed’ and
somewhat paternalistic and an ‘opt-out’ option for Australian consumers who did not
wish to participate in the de facto national identifiers could also have been argued
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strongly. Arguments against the failed Australia Card (Clarke 1988) are pertinent
here but will not be revisited.
The discussion paper also describes how healthcare providers will be given approval
to adopt the new Individual Healthcare Identifiers in their health information
systems. That suggestion is in direct conflict with the Australian Law Reform
Commission (ALRC) policy objective that prevents the adoption of such identifiers
due to concern regarding data linkage and the future potential for surveillance. That
is also in direct conflict with the risks raised by the Australian Privacy Commissioner
where the issues with shared identifier use are not initially obvious but become more
apparent over time with broader adoption by a growing number of organisations.
That has direct implications for secondary use of medical data as linkage across IHI’s
is much easier when multiple information systems adopt the same unique identifier
for individuals. The Discussion paper also acknowledges that this aspect of the
Healthcare Identifier proposal is at odds with the Commonwealth Privacy Act 1988:

Specific authority will be given to private sector healthcare provider
organisations to adopt, use or disclose and IHI or HPI-I for health
information management and communication purposes. This is to
overcome a restriction in the present Commonwealth Privacy Act
1988 (3).
The draft Exposure Healthcare Identifiers Bill was available for scrutiny and
comment across the Christmas-New Year period from mid December 2009 to 7 Jan
2010. The brief consultation across the traditional holiday period was not ideal for
consumer engagement. The 2010 Healthcare Identifiers Act was enacted in July 2010
with all Australians allocated a sixteen digit unique identifier. The impact of this on
future Australian society is alarming yet this legislation has passed fairly quietly
through Australian Federal Parliament.
Table 1 provides a timeline to illustrate the parallel journey these two important
national endeavours have taken over the last few years.
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Table 1: Influential documents in two parallel activities of national importance: ALRC Privacy
Principles and 2010 Healthcare Identifiers Bill
Published
Document
May 2008

Australian Law Reform Commission Model Unified Privacy Principles.

July 2009

Healthcare identifiers and privacy: Discussion paper on proposals for legislative support.

June 2010

Exposure Australian Privacy Principles.

July 2010
Due July

Healthcare Identifiers Act 2010.
Draft released for comment: in mid Dec 2009, Submissions closed: 7 Jan 2010.
Senate Committee report on Exposure Australian Privacy Principles.

2011

Given that the citizens were not given an option to opt-out of the national identifiers
and that organisations are authorised to adopt the national identifier within their
information systems a privacy framework for secondary use becomes increasingly
important.
Richard Sobel, writing The Demeaning of Identity and Personhood in National
Identification Systems in the Harvard Journal of Law and Technology (Sobel 2002),
states that the development of national identification systems “contradict the
constitutional and philosophical bases of democratic government and undermine the
fundamental foundations of political and personal identity” (Sobel 2002, p. 320).
As a result of the Government’s approach to medical information privacy
management this research proposes that the following research question exists:
Open Research Question
10. What are the consumer views on the Government taking on the
data stewardship role, overseeing secondary use of medical data?
2.4.4

The commercial lens: profit through secondary use of medical data

Commercial uses of medical data include health service product development,
pharmaceutical development, insurance industry purposes, direct marketing and
market surveillance. In Australia there are specific legislative provisions (Privacy
Act 1988 and Schedule 3 National Privacy Principles and Section 14 National
Privacy Principles) to prevent the disclosure or use of individual’s medical
information for direct marketing without consumers consent.
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Commercial health sector organisations consolidate an individual patient’s data for
secondary uses and then use the data as a revenue source by selling the results of data
analyses and reports to interested parties in industries in the pharmaceutical and
healthcare sectors. The particular details of commercial arrangements between
hospitals supplying data and the commercial data brokers are not readily available
for scrutiny. These commercial agreements would also cover the matter of on-selling
patient data to ‘fourth’ parties – these are referred to as ‘fourth’ parties rather than
‘third’ parties because the consumer is party 1, the healthcare provider is party 2 and
the commercial data broker is party 3.
An example of a commercial organisation that broker/trade in consumer’s health data
is IMS Brogan Ottawa, Canada (BroganInc 2010). Brogan Inc was acquired by IMS
Health in 2010 and Rodwin (2009) reported that IMS Health operates in more than
100 countries and earned more than $2 billion United States Dollars (USD) selling
medical data in 2006. The 2008 Annual Report for IMS Health reported revenue of
$2.3 billion USD (IMS-Health 2008).
IMS Brogan is a “leading provider of market intelligence to the pharmaceutical and
healthcare industries” (BroganInc 2010). In mid 2008 this organisation requested
information from the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa,
Canada. Similar datasets had already been acquired from 100 other hospitals across
Canada as reported by Dr Khaled El Emam (Silversides 2009). This appears to be
largely a self regulating industry with each organisation making statements similar to
that expressed in Silversides’ (2009) Canadian journal article:

The firm also brokers’ prescription drug information obtained
from

public

drug

plans,

insurance

companies

and

pharmacies… the company (Brogan Inc) began collecting
hospital data five years ago and has taken “extraordinary
measures” to clean up and standardize information
(Silversides 2009, E287).
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Research into consumer’s reaction to the operation of data brokerage organisations,
such as IMS Health and the commercial data supply department in Medicare
Australia, is not widely available. There are examples where consumers have become
aware of secondary use of their medical information and they have strongly objected.
For example, Sadan reported an example of two Washington D.C pharmacy chains,
CVS and Giant Foods, sending consumers’ prescription records to Elensy which is a
marketing organisation. Elensy mailed reminders to patients to refill their
prescriptions and provided unsolicited information about new drugs (Sadan 2000).
The consumers were unaware that their personal prescription information was being
used for such commercial secondary uses. The pharmacy chains cancelled this
commercial secondary use following adverse publicity (Lo and Alpers 2000).
As early as 1997 Rhindfleish (1997) raised the matter of commercial use of medical
data:
It may be argued there is nothing wrong with using
healthcare information to make prudent and profitable
business decisions. It’s merely capitalism at work. But these
uses conflict deeply with the confidential understandings
most patients have when they sign consent forms... We should
at the very least openly discuss and decide these policy issues
at a national level (Rindfleish 1997, p. 87).
The emergence of data brokerage organisations such as IMS Health, appears to have
‘flown under the radar’ and there is little evidence of national debate in the US and
Canada over the operation of such organisations. Elger et al. (2010) acknowledged
the journey that personal medical data often takes from clinical care through to
commercial dealings. Those researchers suggest that it is important to inform
consumers of the potential commercial use of their data at the time consumers
provide informed consent. Elger et al. claim “such information at the outset
incorporated in the consent is protective of the interests of downstream business
entities” (Elger, Lavindrasana et al. 2010, p. 234).
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If data moves from a non-commercial context to a commercial context consumers
should be informed of relevant actors and activities – as described by Nissenbaum
(2010) – to aid in gauging levels of privacy concern. An organisation that has
adopted this approach to clarifying context and actors and roles and activities is the
Australian Schizophrenia Research Institute (ASRI). The ASRI has initiated the
Australian Schizophrenia Research Bank, which “aims to collect and link genetic,
neuroanatomical, cognitive and clinical information from people with schizophrenia
and healthy, non-psychiatric control volunteers to support research into the genetics
of schizophrenia” (Australian Schizophrenia Research Institute). The Australian
Schizophrenia Research Institute called for donations to a Research Bank and a
timetable was described that showed a widening use of the collected data as adapted
and summarised in below:

Date
April 2008
June 2009
July 2010

July 2011

Table 2: Australian Schizophrenia Research Bank data release schedule
Data Users
Australian Schizophrenia Research Bank Chief Investigators (ASRBCI) are able to access their
locally collected samples/data
(ASRBCI) are able to access the entire sample/data collection. (ASRBCI) and non-commercial
NSW based investigators only are able to recruit volunteers from the Bank.
All non-commercial Australian researchers are able to access the entire sample/data collection.
Studies may involve collaboration with researchers from overseas; however the actual analysis of
data and/or samples must be carried out in an Australian institution, with the first Chief
Investigator on the application residing in Australia. All non-commercial Australian researchers are
able to recruit volunteers from the Bank in QLD, WA, VIC and ACT
Projected opening date for access to the entire sample/data collection to international researchers
and commercial entities. After access is extended to all researchers, priority may still be given to
local Australian and/or non-commercial researchers. Projected opening date for access to
recruiting volunteers by Australian commercial entities. After access is extended to all
researchers, priority may still be given to non-commercial researchers

Adapted from
http://www.schizophreniaresearch.org.au/bank/index.php?r=5&menu=Access+Process&p=4

The Australian Schizophrenia Research Bank Guidelines for researchers clarifies that
the access to data is covered by a cost recovery mechanism with a tiered system of
costs.
That provides further insight into the values journey; away from altruistic
motivations towards commercial motivations as first described in the medical
researcher stakeholder section. It is possible that similar future commercial use of
consumers’ data may influence the willingness of consumers to participate in
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research. This is an unaddressed, open research area that will be further pursued via
the research presented in this thesis.
The commercial matters intersects with the data ownership matters previously raised
in this literature review. In an attempt to clarify commercial stakeholders access to
data for secondary purposes, Rosenbaum (2010) offers a number of ways forward to
resolve what she sees as a ‘data ownership’ versus ‘data access’ debate in the US:
Option 1: provide incentives for data access through payment for the information.
That involves suitable data stewards purchasing health information that researchers
expect to be useful in assisting with patient safety, population health and analysis of
comparative effectiveness of treatment. In this approach the information that is
output/created during the delivery of healthcare is commodified and the government
could negotiate with interested ‘buyers’ over the scope, terms of access and
secondary uses. Rosenbaum claims that the strength of this approach is the
recognition of data ownership rights regarding the healthcare data.
As Rosenbaum notes, taxpayers may not be enamoured with this option as they
would effectively pay twice; the first time when supporting federal health programs,
and the second to access the healthcare data that their expenditure created.
Option 2: treat the information output from healthcare delivery “as a public good,
available for use by entities structured and operated in accordance with principles of
data stewardship” (Rosenbaum 2010, p. 1452).
That option would likely assist the altruistic values of medical researchers but does
not meet the needs of commercial organisations.

Health data governed by submission requirements could be
aggregated, managed and prepared for use by data stewardship
entities which in turn could freely licence the data for use by
researchers who are able to demonstrate compliance with data
stewardship responsibilities (Rosenbaum 2010, p. 1452).
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This second option does not endorse the notion that healthcare providers can on sell
the data gathered during the provision of healthcare and there is likely to be a rift in
this area between government funded healthcare providers and private healthcare
providers.
A report from Pricewaterhouse Coopers (PwC) (2009) focussed on secondary use of
medical data, the opening statement gives a broad insight into commercial
possibilities with health data fuelling new business opportunities:

A handful of forward-thinking healthcare organizations have
understood that the data they have been amassing in their
various IT systems holds enormous potential outside of their
enterprises. They have launched into uncharted territory by
using their data for secondary purposes such as clinical-studies
validation and post-market surveillance of drugs. Absent any
model to follow, they developed their own guidelines and
infrastructure. As more organizations implement health IT, more
data will be produced and the potential for secondary use of that
data will grow, as well. In the near future, organizations may be
asked to submit data to participate in initiatives or
collaborations, or use their data to create business opportunities
(PricewaterhouseCoopers 2009, p. 3).
The PwC report continues with statements reflecting on the commercial value of the
healthcare data held by health sector organisations in terms of business opportunities,
“Secondary data use offers business and collaboration opportunities, potential
benefits to all stakeholders” (PricewaterhouseCoopers 2009, p. 3). The report
addressed incentive payments to physicians to ensure consumer medical data is
recorded, “Alignment of incentives for the clinical community and payment reform
to collect, share and use data are paramount to expanding secondary use of data”
(PricewaterhouseCoopers 2009, p. 20). That report provides a very commercial lens
on the secondary use of medical data, and calls for frameworks to be established by
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private organisations to ensure maximum return on investment on IT systems and
effective secondary data use.
The commercial reuse of data (including anonymised data) gathered in confidential
doctor-patient scenarios requires further research and consumers views on this matter
will be pursued through this research.
As a result of the emergence of commercially driven secondary uses of medical data
this research proposes that the following research question exists:

Open Research Question
11. What are the consumer views regarding commercial, profit driven,
secondary use of data gathered through healthcare delivery?

2.4.5

The consumer lens: hearing the ‘voice’ of consumers

As reported by Buckley (2008) there is a trend towards personal choice for
consumers in areas such as housing, schooling and healthcare. These personal
choices are empowering. Over recent decades, attempts have been made to reduce
medical paternalism and thus empower consumers when they engage with healthcare
professionals. That notion of partnership needs to be carried forward into the
secondary use arena. Treating consumers as partners in the secondary use of medical
data and engaging them in the decision making, as suggested by Mechanic (1998),
should facilitate the development of trust that will lubricate the information flows
necessary to support large scale secondary use. As described in Section 2.3.1, very
recently there have been calls to re-conceptualise consumers as partners in research
rather than as research subjects. Some of these calls have come from within the
medical community.
As Townend (2010) and Buckley et al. (2011) recently observed, there has been little
research into consumer opinion regarding issues surrounding secondary use of their
medical information.

57

Yet few large studies among representative samples of
national populations have been conducted, so it is difficult to
draw robust conclusions about approaches to confidentiality
and consent that may be generally acceptable (Buckley,
Murphy et al. 2011, p. 50).
The next section of this thesis provides a sample of the research that has been
undertaken by various stakeholders into consumer’s opinions regarding secondary
use of medical data and privacy matters.

2.4.5.1 Consumer surveys
The surveys included here are not specifically about secondary uses of medical data;
however, a small number have included a couple of questions regarding secondary
use and related privacy matters. The term ‘secondary use’ has not necessarily been
used in the surveys; however, upon examining the questions and results we do see
outcomes that inform the gathering of information about secondary uses.
Mulligan (2001) reported on a 1999 cross-sectional descriptive, household survey
conducted in South Australia to investigate consumers attitudes towards doctors and
hospitals acting as data custodians, and unauthorised release of information from
health services. Participants were 3013 randomly selected residents aged over 15
years. With regard to doctors and hospitals as data custodians, Mulligan reports:

While most participants expressed confidence in doctors or
hospitals to keep and use information responsibly, nearly one in
10 participants did not share this confidence. There was no
significant difference between men and women in level of
confidence, but there were significant differences in confidence
with age: participants aged 25-34 years were significantly less
confident about doctors and hospitals as data custodians than
those in other age groups (P < 0.001) (Mulligan 2001, p. 638).
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During 2002 and 2003, a Canadian study (Perera, Holbrook et al. 2011) investigated
patients’ and physicians’ attitudes towards sharing electronic patient data for
healthcare delivery and secondary uses. Reasons for the gap between conduct of the
study and publishing outcomes is not known. The study design included a beforeafter survey of patients and providers in practices using electronic health records
enrolled in a clinical trial in Ontario, Canada. Participants included 511 patients and
46 physicians. Thirteen questions in four general domains investigated attitudes
towards:


the privacy of electronic health records,



outsider’s use of patient’s health information,



the sharing of patient’s information within the health care system,



and the overall perception of benefits versus harms of computerization in
health care.

Very broadly, the outcome of that study was that the majority of physicians and
patients valued the use of electronic health records in the delivery of care. A large
minority had concerns about the secondary use of de-identified information. As
Perera et al. report:

Both patients and physicians were more cautious about the use
of the patient’s health information by outsiders for research
purposes – even with personal identifiers removed. Sixty-seven
percent of patients and 79% of physicians did not want private
insurance companies to have access to the patient’s information,
45% of patients and 70% of physicians did not want the
pharmaceutical industry to have access to the information, and
40% of patients and 23% of physicians did not want the
government (source of public insurance) to have access to the
patient’s information (Perera, Holbrook et al. 2011, p. 96).
The Australian National Health and Medical Research Council (NHMRC) conducted
consultation with stakeholders in February and March 2004 with the objective of
providing a comprehensive assessment of the key privacy regulation issues for
consumers, researchers, and other stakeholders ready for use in a submission to an
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upcoming privacy review. The focus of the study was on attitudes toward privacy in
healthcare and medical research. Qualitative aspects of this study included nine focus
groups with consumers classified into two broad groups; health consumers and the
general public. All health consumer groups included participants with current or
previous involvement in medical research. Qualitative findings included low
awarenss of privacy legislation, confusing privacy and confidentiality, and lack of
trust of medical research use of personal data. Quantitative aspects included
computer assisted telephone interviews (CATI) with 301 members of the general
public and 60 health consumers. The quantitative results confirmed the qualitative
study. There was a substantial minority of consumers who were concerned about the
potential misuse of their health information.
There was general acceptance of approved researchers access and data matching
medical information from disparate databases. There remained a substantial minority
who considered such access to be unacceptable. There was generally an attitude of
support for research but a substantial minority of consumers did not want automatic
access to data.
Results were presented in a comparative analysis stakeholder report (Campbell
Research And Consulting 2004). In the domain of secondary uses of medical data the
NHMRC consultation found:

Consumer attitudes toward linked databases were, in general,
cautious. Considering the potential risk of misuses of linked
databases and the possible problems arising from database
linkage, the overall view was that linking databases should be
avoided. Consumers did not think that technical solutions to
preserve individual privacy (they could only think of deidentification and allocation of a number) would be sufficient
to prevent abuses if unethical research was to be undertaken
(Campbell Research And Consulting 2004, p. 4).
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That comparative study also found that persons who are high users of the health
system, including persons with life threatening, serious or communicable diseases,
were looking for greater involvement in decision making regarding use of their data
for research.
In 2004, Canadian researchers conducted a series of four focus groups to evaluate a
patient decision aid designed to capture information regarding the health information
a consumer is willing to share (Tracy, Dantas et al. 2004). The focus groups attracted
28 participants and data was analysed using qualitative methods. The outcomes
included mistrust expressed by participants regarding how their information would
be used and protected, suggestions to allow customisation of the use of data for
specific needs rather than allowing complete access, and optimism of the tool to aid
regulation of health information.
The California Healthcare Foundation 2005 National Consumer Health Privacy
Survey (Bishop, Holmes et al. 2005) does not specifically focus on secondary use of
medical data. However, the results of this survey do inform our understanding of the
broader health privacy context in the United States. In summary:


Consumers remain concerned about the privacy of their health information



Recent privacy breaches have raised the level of concern



Employee concern about misuse of medical claim information rose
dramatically



Consumers are unfamiliar with HIPAA protections



Privacy-protective behaviours persist



Consumers will share their personal medical information.

A 2007 study undertaken in Canada, commissioned by the Office of the Privacy
Commissioner and Canada Health Infoway, included broad objectives:


perceptions of personal privacy and privacy of personal health information;



awareness of laws / oversight bodies in relation to personal health
information;



perceptions and experiences related to electronic health information;
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secondary use of electronic health information; and



the public’s level of trust, comfort and tolerance for the electronic health
record
(EKOS Research Associates 2007, p. 1).

The fourth objective focussed on secondary use of electronic health information for
health research. The Canadian research involved 20 minute telephone surveys with
2,469 Canadians in June-July 2007. Regarding secondary use of electronic medical
information for health research, 84% of respondents supported this use if names and
addresses are removed. The support rate drops to 50% if personal details are not
removed. The linking of health information with broader personal information, such
as education level and income, was not widely supported by respondents.
In 2010, New Zealand based researchers, Parkin and Paul (2011), convened a group
of nine members of the general public into a citizens jury to consider secondary use
of identifiable data without consumer consent. The research sessions ran across three
days and the outcome was a unanimous decision of the jury to support identifiable
consumer data use without consent. Parkin and Paul came to the conclusion that
contextualising data use influenced participants:

… the framing of the public interest and privacy
considerations – in the context of scientific, legal, ethical,
clinical and consumer input – and the opportunity to
deliberate, may explain why the conclusions of the jury differ
from public opinion surveys about secondary uses of medical
information (Parkin and Paul 2011, p. 150).
In late 2011, Buckley et al. (2011) reported on a mixed methods study, conducted in
Ireland, which investigated general public attitudes towards research using General
Practitioners (GP) records. Focus groups were used to determine major themes and
then a postal survey was despatched. The hardcopy questionnaire that had been
distributed to residences was completed by 1,575 respondents. A 40% response rate
was achieved and attitudes were diverse, with a large majority indicating:
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68% were unwilling to allow GPs to decide which researchers could access
patient identifiable medical data



89.5% agreed to ongoing consent arrangements for use of anonymous data by
researchers without a study-by-study consent

The conclusion from that study is that sufficient consumers are likely to opt in to a
prior consent arrangement with GPs to enable the use of consumer data for valid,
consent-dependent observational studies.
Those consumer surveys do not provide a comprehensive understanding of citizens’
views on secondary use of their electronic medical data. Little attempt has been made
to determine consumers’ expectations or concerns for privacy and none of these
surveys has moved beyond the limited access privacy theory. Clearly this is an open
research area.
The next sections of the consumer lens will consider trust and consent as these are
integral to appreciating the consumer perspective.

2.4.5.2 Intangible Consumer Trust
Trust is an intangible concept that is very important in secondary use of medical data
research. Lack of trust in a secondary use could prevent a consumer from agreeing to
use of their personal data. This section considers the literature regarding trust as
applicable to consumers and re-use of their medical data. In the secondary use of
medical data context consumers trust is a lubricant that enhances the flow of
information for secondary purposes. When approached to contribute personal
medical data for secondary purposes, a consumer is more likely to agree if they have
trust in the party requesting information; hence more readily allowing the release of
requested data and lubricating the secondary use processes.
The work of Bansal, Zahedi and Gefen (2008a; 2008b) considers the impact of
privacy policy statements and privacy assurance cues on increasing trust and
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individual decisions to disclose information online. The consumers’ initial level of
privacy concern is found to influence the readiness to accept privacy assurances. This
research specifically considers the importance of context:

While understandability of privacy-policy statement has no
effect on trust in e-commerce and finance contexts, it plays a
significant role in the health context (Bansal, Zahedi et al.
2008a, p. 15).
An important conclusion from this work has implications for the establishment of
consumers trust in secondary uses of their medical data, particularly to privacypolicy statements: “The statement should address issues related to the way private
data is collected, the way errors are handled, and assurances about secondary use,
unauthorized access, and use of private data” (Bansal, Zahedi et al. 2008a, p. 16).
The authors warn that the underlying study has limited generalisability because the
study sample is based on college students in the Midwest USA. The researchers
highlight the importance of a holistic strategy in dealing with consumers’ privacy
concerns.
Damschroder et al. (2007) also found that the level of trust that a patient has in
healthcare providers influences decisions regarding secondary use. That research
focussed on a survey of members of the military who are cared for by US Veterans
Affairs (VA) healthcare providers. Mechanic (1998) also suggests that consumers
level of trust in an organisation relates to how well consumers privacy is protected.
Buckley et al. (2011) contribute by reporting that “University researchers are
reportedly regarded more positively than pharmaceutical industry researchers.
Concerns exist about employers, schools or insurance companies seeking access to
personal health information”.
Croll has also published regarding fragile nature of consumer trust in eHealth (Croll
and Morarji 2006; Croll and Croll 2007; Croll 2008). In a more recent publication,
Croll illustrates the relationship between trust, confidentiality, privacy and security in
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healthcare (Croll 2011). In the 2011 publication Privacy Impact Assessments – the
Organisational versus the Individual’s viewpoints, Croll includes trust in a formal
approach to privacy analysis which aids the development of Privacy Impact
Assessments (PIA). Croll encourages a focus on individuals to obtain the full benefit
of a Privacy Impact Assessment and he warns “The risk of ignoring people’s
concerns can be a real show stopper for emerging projects, especially in health”
(Croll 2008, p. 5).
William Lowrance has provided a clear statement regarding the broad importance of
trust and consent particularly to secondary use of data for research:

As consent of any form implies confidence, and confidence
implies trust, the ramifications of confidentiality and trust
must be considered along with consent. These fundamentals
apply to far more than secondary use of data in research, but
they are crucial to it (Lowrance 2003, p. S1:6).
The qualitative study conducted by the Australian NHMRC (Campbell Research And
Consulting 2004) with consumer focus groups found that when it came to trust in
medical research, consumers had low levels of trust which the report writer attributed
to a lack of knowledge of medical research:

Most consumers were unsure about what medical research
encompasses … the lack of familiarity with medical research
tended to generate a degree of mistrust among consumers, and
contributed to their conservative approach to the application of
privacy principles (Campbell Research And Consulting 2004, p.
5).
Given that many of the consumer cohort had previously participated in medical
research, (Campbell Research And Consulting 2004, p. 3), that conclusion regarding
trust may not be entirely appropriate. Camp, Nissenbaum and McGrath (2002) posit
that the secondary use of medical data context calls upon the consumer to trust their
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physician, organisations collecting, storing and using their medical data, and
ubiquitous computer technology.
As a result of the recognition of the importance of consumer trust in health
information management and medical research this research proposes that the
following research questions exist:
Open Research Question
12a. Do consumers trust healthcare and related workers in the handling
of their health information?
12b. How does trust impact on willingness to engage in secondary use?

The next section of this literature review considers consent because, as Lowrance
(2003) states, trust and consent are closely coupled and are needed to lubricate the
flow of medical data for secondary purposes as described by Dinev et al. (2006).
2.4.5.3 Consumer Consent
While trust is intangible, consent mechanisms are tangible and convey a sense of
trust. The connection between the importance of trust and patient consent for
secondary use was emphasised by the American Medical Association in 1998 when
they argued that “Trust is essential to the patient-physician relationship, and
confidentiality of communications is a cornerstone of that trust” and “consents
should specify the information to be shared, with whom, and for what purpose”
(Mitka 1998, p. 1897). There are nuanced notions of consent including express
consent versus implied consent and detailed consent versus broad consent.
Doll (Doll and Peto 2001) suggests that by accepting the provision of healthcare
consumers are giving implied consent to the use of their data for the advancement of
medical knowledge to benefit society. The Icelandic Healthcare Database was
constructed based on a similar assumption with a presumed consent model (Gulcher
and Stefansson 2000). Gulcher et al. note “Some argue that presumed consent is
inconsistent with the right of individuals to decide for themselves and actually
amounts to no consent at all” (p. 1827).
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The NHMRC investigation into the impact of privacy regulation on NHMRC
stakeholders included a qualitative study of consumers’ opinions. The outcomes of
the study include:


Participants reported that the act of requesting consent
represented a demonstration of respect by medical practitioners.
Health professionals should request consent as a matter of
“courtesy” (assuming consumers are medically able to give their
consent). However consumers (especially consumers from the
General Public) did not see themselves as having the expertise to
give consent on any other basis.



When written consent is requested, consumers understood this
procedure to be mostly a form of protection for the medical
professionals against future litigation risks (Campbell Research
And Consulting 2004, p. 3).



Consumers did not want to be contacted directly by researchers.
They were also quite concerned about how their medical
information may be used, and wished to be asked for consent via
their treating practitioner prior to their medical information
being used by researchers (Campbell Research And Consulting
2004, p. 4).

Beskow and Dean (2008) researched the opinions of 40 consumers on key issues of
consent related to a consumer donating medical information and bio-samples to a
registry. The issues included the frequency of update of donor contact information,
types of medical information consumers would consent to donate, issues that would
lead to donors withdrawing from studies, types of research that the donors would
support, contact about additional research, perceived risks with being involved,
commercialisation, and consumer access to research results.
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Despite the small number of participants this research is informative and draws
attention to the complexity of consumer consent and provides an open research area
for further investigation. The outcomes of a recent Australian survey into personally
controlled health records also identifies patient, informed consent as an open issue
(Pettigrew, Roman et al. 2010).
As a result of the consumer survey results and researcher publications regarding
consent this research proposes that the following research question exists:
Open Research Question
13. What are consumers’ views regarding consent for secondary use of
their medical data, in particular how engaged do the consumers want to
be in providing consent instructions/directions?

Consumers were the final group of stakeholders to be considered in this literature
review and the next thesis section presents a summary of the open research questions
highlighted throughout the literature review.
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2.5

Summary of Open Research Questions

The open research questions identified through the literature review are summarised
in Table 3.

Literature

Table 3: Summary of Research Questions Arising from the Literature Review
Research Question arising from Literature Review

Review section
2.2

1

2.4

2

2.4.1.3

3

2.4.1.4

4

2.4.1.5

5a

2.4.1.5

5b

2.4.2.1

6

2.4.2.3

7

2.4.2.4

8

2.4.2.4

9

2.4.3.3

10

2.4.4

11

2.4.5.2

12a

2.4.5.2

12b

2.4.5.3

13

Can Tavani’s and Moor’s Restricted Access/Limited Control (RALC)
and Nissenbaum’s contextual integrity privacy theories be applied to
the secondary use of medical data context?
How diverse are consumer views regarding privacy and the
use of their personal medical data for secondary purposes?
What are consumer views regarding a sense of altruism
towards the use of medical data ‘for the common good’
consumer ownership of medical data and the use of
anonymised data?
Are consumers interested in a mechanism that would offer an
opportunity for them to provide some direction regarding use of their
medical data, rather than relying on HREC operation?
Can consumers discern the ‘values’ that different stakeholders
bring to the secondary use of medical data?
Does this impact on their willingness to contribute personal data for
secondary use?
Are consumers feeling the anxieties described by Nehf due to loss of
privacy?
Are consumers willing to engage regarding secondary use of their
medical data?
Do consumers agree that medical records belong to their doctors?
Do consumers seek more empowerment as suggested by privacy
advocates?
What are the consumer views on the Government taking on the data
stewardship role; overseeing secondary use of medical data?
What are the consumer views regarding commercial, profit driven,
secondary use of data gathered through healthcare delivery?
Do consumers trust healthcare and related workers in the handling of
their health information?
How does trust impact on willingness to engage in secondary use?
What are consumers’ views regarding consent for secondary use of their
medical data; in particular how engaged do the consumers want to be in
providing consent instructions/directions?

The open research questions arising from the literature review provide an overall
research objective:

To better understand consumers’ views of secondary uses of medical data with a
particular focus on privacy matters.
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Two specific research questions were articulated to offer an opportunity to
investigate the literature review open research questions. Table 4: Mapping to
broader study Research Questions 1 and 2, summarises the mapping of the thirteen
open research questions to the research questions used for this study.

Table 4: Mapping to broader study Research Questions 1 and 2
Mapping of Research Questions
Arising from the Literature Review
Study Research Question 1

2, 3, 4, 5a, 5b, 6, 7, 8, 9, 10, 11, 12a,

What are consumers’ expectations and concerns regarding

12b, 13

secondary uses of their medical data; particularly with
respect to privacy matters?
Study Research Question 2

1, 2, 4, 7, 9, 12a, 12b, 13

Does the RALC theory (Tavani and Moor 2001) and the
framework for contextual integrity (Nissenbaum 2010) offer
privacy concepts that can: (1) be applied in the secondary
use of medical data context and (2) gain support from
interested consumers?

Some of the open research questions, such as question 2: How diverse are consumer
views regarding privacy and the use of their personal medical data for secondary
purposes? contribute to both of the study research questions. This open research
question contributes to both Study Research Question 1 and 2 as further research will
help describe both the expectations and concerns of consumers and also investigate
the suitability of the privacy theories in supporting possibly diverse consumer views
regarding privacy and secondary data use.
2.6

Conclusion

In conclusion, there are very diverse views amongst stakeholders with an interest in
the secondary use of medical data. Changes in legislation regarding consumer
privacy have impacted on the secondary use of data and the medical research
community lament lost and hindered opportunities for advancing healthcare
knowledge. Privacy advocates, including lawyers responsible for leading legislative
changes, continue to express frustration regarding the level of dis-empowerment
experienced by consumers in this context. Few studies have attempted to consider
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consumers’ opinions regarding the secondary use of their medical data by
stakeholders including commercially oriented and government surveillance type
activities.
The ‘limited access’ privacy theory has served the medical profession well for
centuries however the shift to electronic medium for data storage has challenged the
adequacy of this privacy theory. Contemporary privacy theories offer opportunities
for fresh interpretations of privacy and these theories have emerged at a time when
there are simultaneous calls for greater engagement with consumers regarding
secondary use of medical data, especially for altruistic research purposes. The
contemporary privacy theories may aid deeper, more meaningful engagement with
consumers and allow society to move to a more sophisticated understanding of
privacy.
The remainder of this thesis explores these complex, inter-related issues, beginning
with the next chapter that elaborates on the research methodology adopted for this
study.
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3 RESEARCH METHODOLOGY
3.1

Introduction

This chapter begins with consideration of the major research questions then moves to
consideration of the broad research epistemology, chosen methodology, and specific
study design including data collection and analysis. Alternate research design choices
are considered throughout and justifications for the chosen approach are provided.
This thesis describes the exploratory research conducted within a post-positivist and
interpretive espistomology using mixed methods. A hardcopy, self administered
survey investigating public opinion regarding secondary use of medical data was
distributed to citizens in Australia and Canada. Use of quantitative and qualitative
survey data, gathered concurrently, facilitated triangulation. A Likert scale was used
to capture public opinion expressed in response to thirty attitudinal statements.
Survey psychometrics investigated internal reliability and validity of the survey.
Focus groups and pilots studies were conducted in Australia and Canada. Null
hypothesis driven analyses were conducted across respondent demographics and
between the two Nations surveys.
3.2

Background

This chapter describes the important aspects of the research design that guided the
conduct of this study. The research described here makes two basic assumptions that
arise from the literature:
Assumption 1: with increased use of health information systems, consumer
medical data will be increasingly used for secondary purposes; and
Assumption 2: a shift from regarding consumers as research subjects to
research partners will benefit society in the longer term.
Assumption 1 is supported by Magnusson (2004), Lowerance (Lowrance 1997;
Lowrance 2002; Lowrance 2003) and O’Keefe and Connolly (O'Keefe 2008;
O'Keefe and Connolly 2010), and Assumption 2 is supported by Townend (2010)
and Ruyter (Ruyter, Louk et al. 2010).
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3.3

The Research Question

The overall research objective is to better understand consumer’s views of secondary
uses of medical data with a particular focus on privacy matters. The research
questions were posed to provide the consumer perspective on information systems,
legal and health professionals responsible for designing electronic health records, and
on supporting data governance frameworks and enabling legislation.
Tavani and Moor’s (2001) Restricted Access/Limited Control (RALC) privacy
theory has philosophical foundations that enable support of Assumption 2 above,
hence RALC will be further explored through the consumer survey.

Research Question 1
What are consumer’s expectations and concerns regarding secondary uses of their
medical data, particularly with respect to privacy matters?
Research Question 2
Does the RALC theory (Tavani and Moor 2001) and the framework for contextual
integrity (Nissenbaum 2010) offer privacy concepts that can: (1) be applied in the
secondary use of medical data context and (2) gain support from interested
consumers?

3.4

The Study Design

The next section describes the overall exploratory nature of this study which employs
both post-positivist and interpretive paradigms and utilizes a mixed methods
methodology with a concurrent triangulation design.
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Exploratory Research

Underlying epistemology:
Post‐Positivist + Interpretive
Methodology:
Mixed Methods
Study design:
Concurrent Triangulation
Figure 7: Overview of Research Design

The investigation of consumers’ views regarding secondary use of their medical data
is an exploratory study. As Myers (2011) reports, Hair et al. (1995) describe
exploratory studies as those which define possible relationships in a general form. In
contrast Hair et el (1995) describe confirmatory studies as those with a goal of
testing or confirming an a priori relationship. The aspects of the study that relate to
the RALC privacy theory do not seek to confirm the validity of the theory - that
would be confirmatory research. Rather the RALC privacy theory is used in an
exploratory manner with broad notions from the theory informing the construct of
‘real-life’ secondary data use scenarios which consumers are asked to consider.
Tavani and Moor (2001) offer the tripartite approach to considering privacy matters
which considers Privacy Concepts, Privacy Justification and Privacy Management.
This tripartite approach guides the exploration of consumers view on secondary use
of medical data and provides a useful framework for the consumer survey described
in Chapters 4, 5 and 6.
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3.4.1

Epistomology

The underlying epistemology draws from post-positivist and interpretive approaches.
The combination of these paradigms is not unusual within information systems
research (Straub ; Straub, Gefen et al. 2004; Myers 2011; Myers and Klein 2011).
The post-positivist epistemology is suitable for this study as the positivist approach where knowledge is only derived through observation and measurement - is
inadequate because consumer opinion and perceptions can only be approximated.
Post-positivist approaches acknowledge that observations and measurements are
imperfect and employ triangulation to measure phenomena in multiple ways (Straub ;
Straub, Gefen et al. 2004). The qualitative and quantitative mixed methods used in
this study aim to address the issue of ‘data triangulation’.
Interpretive aspects of this study acknowledge that attempts are made here to
understand phenomena through the meanings that people assign to them - shared
meanings that are in fact social constructs (Orlikowski and Baroudi 1991; Myers
2011). The material included in the literature review chapter has been organised to
present the multiple, disparate points of view regarding secondary use of medical
data thus re-enforcing the value placed on interpretive approaches. The inclusion of
open comments sections in the consumer surveys also provides opportunities for
consumers to elaborate on their interpretations. The present study aims to lead to an
understanding of the secondary data-use context and specifically from a consumer
perspective using their existing shared meanings. This interpretive approach is
consistent with Deem (2002) as reported by Creswell:

Interpretive research involves using issues, language, and
approaches to research that empower the participants,
recognize their silenced voices, honor their individual
differences, and position both the researcher’s and the
participant’s views in a historical/personal/political context
(Creswell et al. 2006, p. 5).
This study gives consumers an opportunity to have their diverse opinions heard and,
thus, attempts to empower the study participants.
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3.4.2

Mixed Methods

This study used a mixed method design with both qualitative and quantitative
methods employed. As observed by Creswell mixed methods research has gained
popularity because “ ... more insight can be gained from the combination of
qualitative and quantitative research than either form by itself. Their combination
provides an expanded understanding of research problems” (Creswell 2009, p. 203).
Creswell (2009) draws our attention to the evolution of the mixed method by
reflecting on earlier research. In the late 1950s, Campbell and Fiske (1959) employed
a multi-trait-multimethod matrix in their research. In the late 1970’s Jick (1979)
described the converging, or triangulating, of different quantitative and qualitative
data sources.
More recently Tashakkorri, Teddlie, Creswell and Plano Clark have contributed to
the development of mixed methods as a distinct methodology of inquiry in single
author publications (Creswell 2008; Creswell 2009; Plano Clark 2010) and
collaborative publications (Tashakkori and Teddlie 1998; Creswell, Plano Clark et al.
2003; Creswell, Fetters et al. 2004; Creswell, Shope et al. 2006; Creswell and
Tashakkori 2007; Plano Clark and Creswell 2008; Plano Clark, Garrett et al. 2010).
The mixed method approach has gained acceptance within the health research
community (Creswell, Fetters et al. 2004; Creswell 2009) and, given that health is
the context for this study, it is reasonable to use this method.
As Creswell notes in numerous publications there are challenges posed by the mixed
methods methodology including: extensive data collection, time intensive nature of
both text and numeric data, and requirement for the researcher to be familiar with
both quantitative and qualitative methods.
Each of these challenges is apparent in this study; questionnaires were despatched
across Australia and Canada for the pilot and final surveys and capturing and
analysing the ordinal and text data in returned surveys was time consuming with
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additional human resources used for the qualitative analysis. A solid understanding
of quantitative and qualitative design, capture and analysis skills was required.
Creswell calls for consideration of the issue of timing, weighting and mixing when
designing a mixed methods study. A concurrent triangulation design was used for
this study with quantitative and qualitative data collected and analysed at the same
time; as described by Creswell (2008; 2009).
The quantitative and qualitative aspects were given equal priority and both addressed
the same research questions. Data analysis was conducted separately and integration
took place at the data interpretation stage. Creswell’s concurrent triangulation design,
using the standard mixed method notation, is reproduced in Figure 8.

Concurrent Triangulation Design (a)
QUAN

+

QUAN
Data Collection
QUAN
Data Analysis

QUAL
QUAL
Data Collection

Data Results Compared

QUAL
Data Analysis

Figure 8: Creswell’s Concurrent Triangulation Design

The overall research design used for this study is illustrated in Figure 9. It includes
the important integrated analysis of both qualitative and quantitative results for each
nation prior to the comparative analysis.
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Research Proposal
Literature Review

Ethics Application

Draft Survey Instrument
Focus Group Testing
Australian and Canadian Pilot Consumer Survey
Refinement of Survey Instrument
Australian and Canadian Final Consumer Survey

Australian
Quantitative Data

Australian
Qualitative Data

Canadian
Quantitative Data

Canadian
Qualitative Data

Australian
Quantitative
Analysis

Australian
Qualitative
Analysis

Canadian
Quantitative
Analysis

Canadian
Qualitative
Analysis

Integrated
Australian
Analysis

Integrated
Canadian
Analysis
Comparative
Analysis

Research Study
Outcome

Comparative
Outcome

Figure 9: Research Design, including concurrent triangulation.
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3.4.3

Why include a comparative study with Canada?

There is a history of cultural comparison studies between Australia and Canada
including those with a focus on ethics and society (Kidd and Shannon 1996; Miller
1998; Wood 2000; Austin 2008), economics (Harchaoui, Jean et al. 2005), healthcare
and training (Blendon, Schoen et al. 2002; Philippon and Braithwaite 2008;
McCurdy, Duggan et al. 2009) and teaching (Mitchell, Clarke et al. 2007). The
comparative study continues the exploratory approach underpinning this research
study. The exploration continues by comparing Australian and Canadian consumer
views on secondary use of their medical data.
The earlier Canadian consumer health related research conducted by Willison (2003),
Willison, Keshavjee et al. (2003), Willison, Schwartz et al. (2007) and Willison,
Emerson et al. (2009) provided useful background information which informed the
design of the consumer survey used in this study. The results of the earlier Canadian
work also provided opportunities for comparison of Australian consumer views with
those of Canadians.
The cultural similarities may also provide an opportunity to develop shared, national
privacy and secondary use of medical data frameworks and guidelines. The
consumer focussed research questions driving this study are suitable for exploration
in both Canada and Australia and results will provide more insight into consumers
views in both Nations.

3.5

The Survey

This section introduces the survey used in this study and describes the design
decisions, validity and reliability issues and data analysis methods used with the
survey.
3.5.1

Designing the Survey

The approach taken to the design and deployment of the public opinion survey is
informed by the work of researchers such as Fink (2005), Bourque and Fielder
(2003) and Svensson (2001). Online surveys, telephone surveys, and face-to-face
interviews were all possible methods that could have been used to capture public
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opinion. Bourque and Fielder (2003) suggest the advantages and disadvantages of
self-administered surveys mailed to residential addresses.
To provide an ordered approach to presenting many of the design decisions related to
the pilot and final surveys used in this study Table 5 has been compiled. The first and
second columns of the table presents the issues pertaining to self administered mail
surveys as suggested by Boureque and Fielder (2003). The third column considers
how these issues were dealt with for the pilot and final surveys used in this study.
This table is intended to provide an overview of the survey activity and further
details of some aspects are elaborated upon in later sections.
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Table 5: Bourque and Fielder (2003) self administered survey matters and comments on application in the pilot and final surveys
Bourque and Fielder comments on mail surveys

Comments for the consumer public opinion survey deployed in this study

Advantages
Cost

Lower cost than in-person and telephone
interview; costs are 75% and 50% lower
respectively.

Online survey would be less costly but some citizens such as those who are aged or poor may
be overlooked due to unavailability of internet access. Also need valid emailing lists for
invitations to participate in the survey and these were not available for this study.

Wider geographic coverage as trained
interviewers not needed for in-person
interviews.

The Australian and Canadian postal services were used to deliver surveys and hence enabled
wide geographic coverage from the centre of large cities such as Melbourne and Vancouver to
remote areas such as Whitehorse in the Yukon and Alice Springs in the Northern Territory of
Australia.

Lower unit cost of mail survey combined with
mail ability to cover wider geographic area
allows study of larger sample size.

The cost of surveys in Australia was lower than Canada as the University of Wollongong had in
place a reply-paid mail contract. This enabled respondents to return the survey at no cost to the
respondent and the University was only charged for postage on the surveys that were returned.
In Canada the UOIT did not have a similar contract with Canada Post , therefore all return
addressed envelopes included in the survey packages had to have postage affixed prior to
despatch.

Sampling
Geographic
coverage

Larger samples

Sample size estimates for both Australia and Canada, using a confidence level of 95% and
5.0% margin of error, are 384. The Australian final survey exceeded the sample size estimate
(1158) however the Canadian final survey did not reach sample size (203).
Wider coverage
within sample
population

Increase in recent years in reluctance of
people to talk to strangers on the phone –
especially in urban areas. Also reluctance to
be available at a specific time is overcome with
mail survey as it can be completed at
respondent’s convenience.

Having the flexibility to complete the survey at a time of convenience to the respondent is a
great advantage over trying to book interview times. This is apparent as some of the returned
surveys included comments such as “Sorry for the delay in returning the survey – I’ve been
overseas, hope it is not too late to be included!”
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Bourque and Fielder comments on mail surveys

Comments for the consumer public opinion survey deployed in this study
In addition to the sampling advantages noted by Bourque and Fielder the opportunity to offer a
more personal connection was possible with the addressing of survey packages. The majority
of Australian pilot and final survey packages were despatched with hand-written addresses.
This was done in an attempt to engage with the householders in a less mechanistic manner.
The Canadian pilot surveys were also hand addressed. Computer generated print labels were
used for the Canadian final survey. Australian respondents noted the hand written addresses –
this is apparent through open ended comments complimenting the research team on such
dedication and commitment.

Implementation
Fewer personnel required. Minimal equipment
needed – compare with the Computer-assisted
telephone interviewing (CATI) needed for
phone interviews. Technical skills needed to
implement on-line survey.

Data entry was a large task with the mail surveys. If an online survey had been used the data
captured would have generated a clean data set not requiring any additional resources for data
entry.

When members of the general public receive
surveys at the same time the potential
influence of events outside or unrelated to the
study is reduced and can be assumed to be
equal for all recipients.

The Canadian surveys were despatched across a time frame of a couple of weeks. The
Australian surveys were despatched to different parts of Australia across a timeframe of a few
months. The open ended comments received on the Canadian pilot study indicate that
respondents were aware of a current issue in Ontario related to the cost over runs of the roll-out
of electronic health records (EHR) in Ontario. During the week of the pilot survey the Ontario
Minister responsible for EHR resigned. The pilot study was entirely conducted in Ontario hence
the sample population was exposed to the same event. During the timeframe of the longer
Australia wide roll out there were no similar influencing events.

Some studies have suggested that people are
more likely to give complete and truthful
information on sensitive topics in a self
administered questionnaire. In contrast, more
recent studies suggest that capable
interviewers and secure online methods are
also effective in collecting responses to
sensitive topics.

Some of the open ended comments elicited via the public opinion survey offer very personal
experiences and reflections on close family members and the sensitive topic of medical
information. It is clear that at least some respondents have been very comfortable sharing such
sensitive information through the self administered survey.

Timing

Sensitive
topics
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Bourque and Fielder comments on mail surveys

Comments for the consumer public opinion survey deployed in this study

Disadvantages
Sampling
Availability of
lists

The importance of probability rather than
convenience samples is emphasised –
particularly when the aim is to generalise to a
particular population.

Final surveys for both Australia and Canada attempted to engage with a diverse population and
the demographics captured helps to profile the responses. The survey packages were
despatched to urban, regional, rural and remote communities and to low medium and high socio
economic status communities in every state and territory of Australia and the English speaking
provinces of Canada.
Bourque and Fielder (2003) do not thoroughly consider the difficulties in accessing an available
list of accurate addresses. Generation of accurate residential address information was a
challenge for this study and this issue is documented thoroughly in Section 3.5.7.4 of the thesis.

Response rates

Literacy and
language

One of the greatest and most studied
disadvantages of mail questionnaires is low
response rates – no greater than 20% should
be expected when no incentives are included.
Even in the best case, response rates for mail
are lower than telephone or in-person
interviews.

The Australian and Canadian pilot surveys in this study generated response rates of 34.8% and
21.5% respectively. This included the use of a small incentive, which was not included in the
final surveys, which resulted in a 23.6% response rate for Australia and a 12.8% response rate
for Canada.

Response rates are particularly poor in studies
targeted at general community samples due to
poor literacy amongst population. Older
citizens may have visual acuity problems and
others may suffer from dyslexia and the effort
required to read and respond to the survey
may be too great.

An objective of this study was to ensure that a diverse group of citizens were able to engage
with the survey – particular attention was paid to the literacy and language used in the survey.
Where ever possible simple language constructs and wording were used to provide maximum
opportunity for engagement with consumers.
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Bourque and Fielder comments on mail surveys

Comments for the consumer public opinion survey deployed in this study

Questionnaire
construction
Objective
The objective of the study must be clear and
there should be a reasonable expectation that
respondents will have some interest in the
objective otherwise response rates will be
poor.

The objective of this study was specified in the covering letter and the response rates tend to
suggest that there was interest in the secondary use of medical data.

Self-administered questionnaires must be
shorter than questionnaires administered in
other ways. Most of the questions need to be
closed-ended as only highly motivated
respondents will be willing to answer open
ended questions. The self-administered
questionnaire must stand alone – all
information respondents may need must be
provided on the questionnaire itself as there is
no interviewer available to provide
clarification. The questionnaire should not
have branches or skips.

One of the goals in creating the survey was too keep it to just a few pages in length. The
candidate survey questions were prioritised and the most influential questions were selected –
many were not included due to the importance of keeping the survey of a size that most citizens
would think was possible to complete within the estimated ten minutes. Thirty two questions
were included and only two were open ended. It was possible to complete the survey without
additional explanatory material. A design decision was made to not include a glossary of terms
and definitions as this would have started to shape the responses. No branches or skips were
included in the survey – citizens were asked to respond to every statement and the ‘don’t know’
option was included on the Likert scale.

In self-administered survey everything is
simultaneously available to the respondent –
this contrasts with online and interviewer
controlled surveys. Using self-administered
surveys is difficult when order effect may be
an issue. This is when one set of questions is
likely to contaminate, bias, or influence
respondents’ answers to another section of
the questionnaire.

There is no hierarchy or order inherent is the survey questions. The survey started out with
some of the most simple syntax to give respondents some sense of being able to readily
understand and respond to the attitudinal statements.

Format

Order effects
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Bourque and Fielder comments on mail surveys

Comments for the consumer public opinion survey deployed in this study

Administration
Lack of control
over who
responds

Single biggest disadvantage of self
administered questionnaires is that once the
survey is despatched the researcher has no
control over who completes the survey.
Researchers must accept completed
questionnaires ‘on faith’.

The surveys returned in this study were received and accepted ‘on faith’. Inclusion of the
optional demographics capture for only one person is a gentle reminder that only one person
should complete the survey. Some citizens worked around this limitation of the study design by
photocopying the survey and returning two completed surveys in one envelope. Others
provided single responses to the attitudinal statements and went on to provide two selections in
the demographics and wrote open ended comments that “we worked together to complete the
survey” – thus illustrating the disadvantage raised by Bourque and Fielder. No respondent
demographics were recorded when it was clear that respondents had tried to record multiple
sets of demographics on one survey.

Generally it takes a minimum of two weeks
after each mail out for completed
questionnaires to be returned. If surveyor uses
follow up mailing to increase response rates
the survey period may extend out to two or
three months. In contrast telephone surveys
can be conducted relatively quickly.

Follow up mailings were not used in this study. The delay in return of surveys did not have a
negative impact on the conduct of this study. As resources were limited to support the surveying
the researcher moved in a cyclical way between compiling valid address list, preparing surveys,
despatching and data entry of returned surveys. These tasks took place over many months for
the pilot and final surveys.

Quick
turnaround
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There are three components to the survey:
Component 1: thirty attitudinal statements utilizing a Likert scale
Component 2: two open ended questions
Component 3: an optional demographic component.
The open ended questions provided respondents an opportunity to explain, justify or
add further information to the quantitative responses. A copy of the survey instrument
used in the Australian final survey is presented later in this chapter. The focus here is
on discussing the journey to the final survey instrument.
3.5.2

Survey Psychometrics

This section investigates the validity and reliability of the consumer public opinion
survey instrument. This involves an empirical test regarding reliability to measure
internal consistency and the second is consideration of the validity of scale. Guidance
for the task of assessing and interpreting the consumer survey psychometrics has been
drawn from work of Litwin (Litwin 2003). As described by Litwin “Psychometrics
provides survey researchers with a way to quantify the precision of the measurement
of qualitative concepts, such as consumer satisfaction, depression and marital
interaction” (Litwin 2003, p. 1). This approach is ideally suited to the interpretive
research undertaken in this study of public opinion regarding secondary use of
medical data. As Litwin states “Strictly speaking, it is difficult to assess the quality of
the data we collect. It is easier to assess the accuracy of the survey instrument that is
used to collect the data. This assessment consists primarily of looking at the reliability
and the validity of the survey instrument” (Litwin 2003, p. 3), hence the next sections
consider the reliability and validity of the survey instrument.
There are a variety of approaches to evaluate the reliability characteristics of a survey
instrument including test-retest, alternate form, and internal reliability. The test-retest
approach is not feasible for this research given the anonymous nature of the diverse
populations. The alternate form method, as described by Litwin, also relies on being
86

able to administer the items or scales to the same population at a later time to enable
calculation of correlation coefficients between the two alternate forms. Again this
approach was not feasible for this study. The internal consistency reliability
psychometric measure was used for this study as it was expected that only a single
engagement with the population would be possible.
The reliability measure was applied to groups of items that measure different aspects
of the same concept. For example there were multiple statements (items) related to
consumer anxiety within the broader privacy concept in the survey instrument used
for this study. Internal consistency metrics indicate how well the different statements
measure the same issue – in this example consumer anxiety over privacy. Cronbach’s
coefficient alpha was used to measure internal consistency reliability among the
privacy concept, justification and management tripartite components to form a single
scale. Table 6 illustrates the association of multiple survey items to a related
construct. For example, five statements explore consumers views on anxiety which
contributes to the broader tripartite concept of privacy construct. More detail on the
pilot survey statements that comprise each tripartite component are provided in thesis
Section 3.5.3.2. The high level details are presented here to give insight into the
efforts made to address survey validity and reliability.
The Cronbach alpha calculations were conducted using SPSS 17.0. Satisfactory
levels of Cronbach Alpha metrics for exploratory research are acceptable at 0.6
(Nunnally 1978; Nunnally and Berstein 1994). The broad reconsideration of
Cronbach alpha presented by Spiliotopoulou (2009) was also influential in the present
study. Table 6 presents the survey constructs, organised within appropriate tripartite
privacy components, for both the Australian and Canadian pilot survey scales.
Chapter 4 includes the internal reliability scales for the Australian final survey and
Chapter 6 includes the same for the Canadian final survey.
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Tripartite

Construct

Table 6: Pilot survey internal reliability scale
Code
Australian
Canadian

Component
Concept
Justification

Cronbach Alpha

Cronbach Alpha

(α)

(α)

Number of
items

Anxiety

C-A

0.761

0.695

5

Sensitivity

C-S

-0.022

0.265

2

Rights based

J-RB

0.579

0.508

2

Balance

J-B

0.454

0.603

2

Provide

J-PF

0.431

0.702

2

Control

M-C

0.668

0.712

7

Commercial

M-CD

0.162

0.274

3

M-DS

0.002

0.581

4

M-U

0.297

0.459

3

feedback
Management

data use
Data
Stewardship
Altruism

The Australian and Canadian pilot survey results indicated that adjustments would be
necessary to the survey prior to national deployment to improve the internal
reliability. The adjustments made are further discussed in Section 3.5.4
Improvements to Survey Design Resulting from the Pilot Survey.
There are several approaches to investigating survey validity including face, content,
criterion and construct (Litwin 2003; Fink 2005). Criterion validity was not
undertaken as there was no comparative instrument available. Construct validity
involves a theoretical measure of how meaningful a survey instrument is and can
generally be established after years of experience with numerous investigators
(Litwin 2003, p. 43). As this is the inaugural consumer survey on secondary use of
medical data this was not pursued at this time. Face validity, the most casual measure
of a survey’s accuracy (Litwin 2003), was considered by the focus groups. Face
validity included consideration of the validity issues as summarised by Fink (2005);
Does it seem to ask all the required questions? Does it use the appropriate language
and language level to do so? The findings from the focus groups are discussed in
Section 3.5.3.1 below.
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Content validity was addressed by two individuals - a General Practice medical
practitioner and an information systems lecturer at an Australian University. Both
individuals made recommendations regarding the subject matter of the survey which
led to improvements prior to pilot study deployment.
The qualitative data contributing to this study has relied on process and triangulation
for establishment of validity, as suggested by Byrne (2002). These issues are
discussed fully later in this chapter.

3.5.3

Focus Groups and Pilot Testing the Survey

The survey used in this study is the instrument used to explore consumer attitudes
towards secondary use of their medical data. There were few existing survey
instruments exploring this domain to guide the development of the survey for this
study. The survey aimed to engage with consumers of varying education level across
diverse communities in Australia and Canada. Using complex academic level English
language was to be avoided as many citizens would find such an approach
disengaging. The input of many consumers was sought on the design, wording and
length of the survey. This was achieved through multiple focus groups. Once the
survey had been adjusted following focus group comments the instrument was then
deployed in a pilot study to ‘test-the-water’ with the broader community. The sample
populations chosen for the pilot survey were closely located to the host Universities
as it was expected the local communities would likely engage with the survey when it
arrived unsolicited in residential letterboxes. The response rate from citizens familiar
with the Universities would likely be more positive than in geographic areas further
afield. This assumption was explored through the deployment of the pilot survey to
Darwin. The pilot survey results offered more opportunities for improvement and
adjustments were made prior to deployment of the final surveys. Every effort, through
focus groups and pilot studies, was made to offer consumers a survey instrument that
they could readily understand and complete. As Litwin (2003) and Fink (2005)
suggest, the use of focus groups and pilot testing improves the likelihood of success.
This section describes the focus groups and pilot studies conducted in both Australia
and Canada.
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3.5.3.1

Focus Groups

Australia
All three components of the survey were included in a draft that was prepared and
administered to small focus groups in June-July 2009. The diverse focus group
participants were purposefully selected, by the principal researcher, to capture
“information rich” feedback. The Australian focus groups included a diverse
population that included teenagers, octogenarians, non-English speaking backgrounds
(Norwegian and Chinese), women, men, post graduate educated, less than 12 years of
high school education, healthcare workers, non- healthcare workers, and residents of
New South Wales and of Western Australia.
The focus groups provided valuable insight into the format and content of the survey.
For example, the male octogenarian involved suggested that many of his elderly
friends, particularly those suffering dementia, would struggle to concentrate through
the entire survey. The wording of some statements was criticized for being too
complex. In addition, the problem of common methods bias was raised by some in the
focus groups as they found that the nature and ordering of the statements caused the
respondents to try and respond in such a way that they would avoid cognitive
dissonance. The statements were reworded and reordered for the pilot study to try and
overcome this common methods bias.
The dot point instructions were well received and focus group members appreciated
the clarification that there were no ‘right’ or ‘wrong’ answers and they felt
comfortable expressing their opinion. Some focus group participants felt that the
questions were repeated with slightly different phrasing. Time to complete the survey
was on average 10 minutes. The New South Wales focus group participants had the
researcher available in the room to provide any clarification if needed on the intent of
the questions however no such clarification was sought. The West Australian focus
group participants received the survey via Australia Post and commented that the
entire package was ‘neat and easily understood’. It was important to have remote
members of the focus group to test the consumer response to the unexpected arrival of
the survey package.
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Canada
The Canadian pilot survey was tested with a convenience sample of staff and students
and family members associated with the Health Informatics Research Group at UOIT.
The task for this focus group was to comment on how accessible the language would
be to Canadians and to update the Canada specific aspects. Survey Component 1,
‘attitudinal statements', was adjusted to reflect references to the appropriate level of
the Canadian Government. Survey Component 3, ‘optional demographics’, required
adjustment for use in Canada to better reflect education levels and to provide suitable
anonymity with postal codes. The full Canadian Postal code narrows in to small
residential areas, sometimes as few as a dozen homes, and this was not a suitable
level of anonymity; hence only the first three alphanumerics of the postal code were
requested. These three alphanumerics provided sufficient information to locate
respondents to a broad geographic area similar to an Australian postcode.
As Straub , Litwin (2003) and Fink (2005) suggest, the use of focus groups and pilot
testing improves the likelihood of success.
3.5.3.2 Australian and Canadian Pilot Survey
Australia
Between August and November 2009, 482 hardcopy self-administered surveys were
distributed to sample populations in residential blocks in regional NSW and Darwin;
the capital city of Australia’s Northern Territory. High, medium and low socioeconomic areas were surveyed in urban and regional populations. A survey
completion incentive was included in the survey packages despatched for the pilot
survey. US research indicated that inclusion of a $1USD note in hardcopy surveys
improved response rates. As Australia no longer uses this currency an equivalent item
was sought. Two Australian postage stamps were included in the pilot surveys as an
incentive. The Australia Post reply paid service was used to ensure that respondents
did not have to pay the postage on returned surveys. The number of surveys returned
was 168 giving a response rate of 34.8%.
Component 1 of the pilot survey included the thirty attitudinal statements used in the
focus groups with re-wording for clarity on the unclear statements identified by focus
group participants. A seven point Likert scale was used in the pilot survey instrument
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ranging through ‘strongly disagree’, ‘disagree’, ‘tend to disagree’, ‘neutral’, ‘tend to
agree’, ‘agree’ and ‘strongly agree’. An eighth option of ‘Don’t know’ was also
included.
Canada
During October and November 2009, 250 hardcopy self-administered surveys were
distributed to sample populations in residential blocks in Ontario, Canada. The urban
areas around the University of Ontario Institute of Technology were included in the
pilot survey population. In an approach identical to that used in Australia, two Canada
Post postage stamps were included in the pilot surveys as an incentive. All preaddressed return envelopes had Canada Post stamps attached to ensure that
respondents did not have to pay the postage on returned surveys. A response rate of
21.5% was achieved. The structure of the Canadian Pilot Survey was identical to the
Australian Pilot Survey with minor changes made for the Canadian context.
Table 7 summarises the demographics of both the Australian and Canadian pilot
survey respondents. One of the aims of the survey design was to ensure that a diverse
range of education levels could engage with the survey instrument and it was pleasing
to note that 44% of the Australian respondents had high school or trade indicated as
their highest level of education and 40.9% of the Canadian respondents had college or
trade indicated as their highest level of education.
Table 7: Pilot survey respondent demographics
Australia
Respondent characteristics

Canada

Frequency

Percentage of

Frequency

Percentage of

(n)

total

(n)

total

Gender
Female

119

70.8%

28

63.6%

Male

48

28.6%

14

31.8%

Not specified

1

0.6%

2

4.5%

18-25

3

1.8%

2

4.5%

26-39

17

10.1%

17

38.6%

40-50

38

22.6%

11

25.0%

51-65

72

42.9%

9

20.5%

66-80

31

18.5%

4

9.1%

Over 80

4

2.4%

0

Unknown

3

1.8%

1

Age

92

2.3%

Highest Level of Education
Left school before Year 10

10

6.0%

n/a

n/a

Year 10

33

19.6%

3

6.8%

Year 12

19

11.3%

10

22.7%

Trade Qualification

12

7.1%

5

11.4%

Professional Qualification

35

20.8%

2

4.5%

Bachelor Degree

41

24.4%

14

31.8%

Postgraduate

14

8.3%

9

20.5%

Unknown

4

2.4%

1

2.3%

Yes

25

14.9%

6

13.6%

No

143

85.1%

38

86.4%

Worked in healthcare sector

This indicated that the survey instrument was gaining the interest of broad members
of the community. The majority of respondents were female; 70.8% in Australia and
63.6% in Canada. This is not surprising as it is frequently women who engage with
health related studies (Arora and McHorney 2000). Response rates from citizens aged
18-25 were disappointing and it may be that alternate survey methods, such as online
or social networking tools, may provide more engagement with this age group. On the
other end of the age scale it was heartening to see Australian citizens aged over 80
years were prepared to complete the survey. Given the warning provided by the
octogenarian in the focus group is was pleasing to see these older consumers
presenting their opinion. Unfortunately no octogenarian Canadians responded.
The pilot survey attracted similar percentage of respondents self-reporting as having
worked in the healthcare sector in Australia (14.9%) and Canada (13.6%). This
response level allows consumers to be identified as those who have worked in the
healthcare sector and those who have not. This has implications for likely
conceptualisation of privacy with healthcare workers very familiar with the ‘limited
access’ approach to privacy management.
As previously described the tripartite approach to privacy issues has guided the
development of the consumer survey used in the pilot study. The first tripartite
component presented explores the concept of privacy held by consumers. The
literature review indicates that consumers experience anxiety and are more sensitive
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about privacy matters regarding data that could be potentially stigmatising and these
issues are explored through seven statements as summarised in Table 8.
Table 8: Survey statements related to the tripartite ‘Concept of Privacy’ and
‘Justification of Privacy’

Privacy
Tripartite
Component
Concept

Construct

Code

Survey
Statement
Number

Anxiety

C-A1

6

C-A2

8

C-A3

9

C-A4

25

C-A5

5

C-S1

27

C-S2

28

J-RB1

1

J-RB2

3

J-B1

12

J-B2

20

J-PF1

21

J-PF2

22

Sensitivity

Justification

Rights
Based

I am concerned that my medical information may be
stolen.
I worry about medical receptionists reading my
medical information.
I worry about computer staff being able to read my
medical information when they are looking after
medical systems.
I would never agree to donate my medical
information to anyone because I worry about
potential misuse of the information.
I am influenced by media reports about medical
information that is stolen or not kept private and
confidential.
The collection of genetic /DNA type medical
information is likely to be a higher risk to my personal
privacy than other types of medical information.
If members of my family were unwell I would agree
that my genetic/DNA medical information could be
used to assist the family member.
I believe that I have a ‘right’ to personal privacy.
I have the ‘right’ to share my medical information with
others.
If information about my health can be used to help
others who are suffering ill-health then I believe my
information should be used to help those people.

Balance
“common
good”

Provide
feedback

Pilot Survey Statement

I support the idea of medical information donation
when the information is used in a way that benefits
society.
If I donated my medical information for medical
research I would expect the researchers to be able to
contact my Doctor if they found something potentially
poor about my health.
If I donated my medical information for medical
research I would want this to always be totally
anonymous and would not expect any information to
come back to me from the medical researchers.

The survey statements related to the tripartite component of ‘privacy justification’ are
also included in Table 8.
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Table 9: Survey Statements related ‘Privacy Management’- control and commercial data use
constructs
Privacy
Survey
Construct
Code Statement
Pilot Survey Statement
Tripartite
Component
Number
If I donated my medical information for research I
would want to choose the level of privacy I
Management
Control
M-C1
15
required. For example I may choose (1) ‘always
anonymous’ or (2) ‘name and OHIP number can
always be used’.
If my health information could be made anonymous
by removing things like my name, address, phone
M-C2
13
number and OHIP number I would be more likely to
agree for the information to be used for medical
research.
If I give consent for my health information to be
used for research I want to be able to say who can
M-C3
17
use my information like ‘medical researchers’,
‘drug companies’, ‘university researchers’ or
‘insurance companies’.
If people agree to donate their data for medical
M-C4
23
research there must be a way for them to stop the
donation agreement.
If people agree to donate their data for medical
M-C5
24
research from time to time they must be asked if
they want to continue to donate.
I support the idea of people being given a personal
M-C6
14
choice about ‘donating’ their medical information
for research.
If I was in hospital and a medical device was used
to care for me – like a heart monitor or oxygen
saturation monitor – I would agree for the
M-C7
26
information displayed on the screen to be saved in
an anonymous way and used for medical research
purposes.
Commercial
MUsing my donated medical information for profit
18
making purposes is not OK.
data use
CD1
I would expect to be paid if I provided my medical
information to someone who was using the
information for profit making purposes. In this case
my data should not be considered a donation.
Insurance companies should be allowed to use
donated anonymous data to help them assess
insurance costs.

MCD2

19

MCD3

29

The ‘Privacy Management’ related statements appear in Table 9 and Table 10. Table
10 presents the statements pertaining to the data stewardship aspects of privacy
management and the underlying sense of altruism amongst consumers.
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Table 10: Survey statements related to ‘Privacy Management’- data stewardship and
altruism constructs
Privacy
Tripartite
Component

Construct

Code

Data

M-

stewardship

DS1

Survey
Statement
Number
2

MDS2

16

MDS3

4

MDS4
Altruism

7

M-U1

10

M-U2

11

M-U3

30

Pilot Survey Statement
I think that my medical records belong to me – they
don’t just belong to my Doctor(s).
If I trust my Doctor I would let him/her decide who
can use my anonymous medical information for
research.
The only reason my health information should be
recorded is to help look after me.
Storing my medical information on paper files in my
Doctor’s office protects my privacy better than
when information is kept on computers.
I support the idea of people making money
donations to support medical research.
I support the idea of people making voluntary blood
donations.
People who have some experience with serious
illness are more likely to support the donation of
medical information for research purposes.

The altruism statements have been included due to the reliance health researchers
have on a citizen’s sense of altruism to allow secondary data use to support research.
Statements 10, 11 and 30 broadly explore public opinion regarding altruism
concerning financial donations to support medical research, blood donation and
medical information.

3.5.3.3 Analysis of Pilot Survey
The purpose of the pilot studies was to test the validity, and reliability of the survey
statements and to gain some insight into citizen interest in responding to the
unsolicited surveys. that the response rates were encouraging and would hopefully
continue with the final surveys. It is not proposed to include comprehensive pilot
survey results in this thesis; the following are a selection of examples to illustrate the
type of research decisions made surrounding the pilot survey and progression to the
final surveys.
Quantitative
A selection of descriptive statistics is reported here as these aided in the evaluation of
the pilot survey and helped inform the choice of statements to be carried forward to
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the final surveys. Consumers responded positively to the Statement 1 - ‘I believe that
I have a ‘right’ to personal privacy’, Figure 10 depicts summary response frequency
as a percentage. This statement explores the consumers perceptions of privacy – do
they perceive privacy in a manner similar to Warren and Brandeis (1890) with a basis
in an individuals legal ‘rights’? The result is that Australian and Canadian citizens are
overwhelmingly in agreement with this justification of privacy.
Statem ent1: I believe that I have a 'right' to personal privacy
80%
% of respondents

70%
60%
50%

Canada

40%

Australia

30%
20%
10%
0%
Don't
know

Strongly Disagree Tend to Neutral
Disagree
Disagree

Tend to
Agree

Agree

Strongly
Agree

Figure 10: Pilot survey response to Statement 1

One of the few earlier surveys (EKOS Research Associates 2007) to consider the
consumers’ views on access to their medical information indicated more concern
regarding IT staff access than concern about medical receptionist access to personal
information. Statements 8 and 9 in the pilot survey sought similar attitudinal data to
aid in understanding the tripartite concept of privacy, particularly anxiety aspects.
The two statements are ‘I worry about medical receptionists reading my medical
information’ and ‘ I worry about computer staff being able to read my medical
information when they are looking after medical systems’. As Figure 11 illustrates,
Canadian pilot survey respondents are expressing concern regarding IT staff
accessing patients medical information. This result varies with earlier Canadian
research (EKOS Research Associates 2007) where access by IT professionals caused
more concern than access by medical receptionists.
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Statement 8 and Statement 9: Canada
35%

% of respondents

30%
25%
20%

Canada-receptionist
Canada-IT staff

15%
10%
5%
0%
Don't
know

Strongly
Disagree

Disagree

Tend to
Disagree

Neutral

Tend to
Agree

Agree

Strongly
Agree

Figure 11: Pilot survey Canadian response to Statements 8 and 9

The Australian pilot study results indicate Australian respondents were more
concerned regarding IT staff having access to their medical information.
Statement 8 and Statement 9: Australia
30%

% of respondents

25%
20%
Australia-receptionist

15%

Australia-IT staff

10%
5%
0%
Don't
know

Strongly
Disagree

Disagree

Tend to
Disagree

Neutral

Tend to
Agree

Agree

Strongly
Agree

Figure 12: Pilot survey Australian response to Statement 8 and 9

An unanticipated outcome from the pilot survey was a clear difference of opinion
across consumer education levels regarding anxiety over potential theft of medical
information. Post graduate level educated respondents strongly disagree with the
Statement 6 - ‘I am concerned that my medical information may be stolen’. Twenty
percent of respondents who left school prior to completing 10 years of schooling
strongly agree with the statement. Table 11 presents a cross tabulation of Highest
Level of Education and Australian consumer attitudinal response.
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Table 11: Australian Cross tabulation of Highest Education Level and Statement 6 response
Q6. I am concerned that my medical information may be stolen.
Tend

Highest Education
Strongly
disagree

to
Disagree

disagree

Tend to
Neutral

25.0%
Left before Year10

agree

Agree

25.0%

50.0%

Strongly

Don't

agree

know

20.0%

10.0%

20.0%

20.0%

10.0%

20.0%

Year 10/4thForm

6.1%

12.1%

18.2%

24.2%

12.1%

21.2%

3.0%

Year12/6thForm/Leaving

5.3%

5.3%

5.3%

21.1%

31.6%

21.1%

10.5%

Trade Qualification

18.2%

9.1%

27.3%

18.2%

18.2%

9.1%

Professional Qualification

22.9%

20.0%

20.0%

14.3%

17.1%

2.9%

2.9%

2.5%

27.5%

15.0%

35.0%

7.5%

12.5%

15.4%

15.4%

23.1%

38.5%

3.6%

18.8%

15.2%

26.1%

4.2%

1.2%

Bachelor Degree
Postgraduate
Total

3.0%

7.7%
13.9%

17.0%

Chapters 4, 5 and 6 further investigate this emergent outcome as highest level of
education, as apparent in this early pilot study analysis, is an important factor in
consumers’ concepts of privacy and expectations regarding management of privacy.
Consumers’ views regarding altruism and ‘for the common good’ utilitarian
attitudes were displayed through the surveys as they voiced support for blood
donations and financial donations to support medical research. Statements 10 and 11
‘I support the idea of people making money donations to support medical research’
and ‘I support the idea of people making voluntary blood donations’ were used to
capture consumer views.
Given the poor internal reliability associated with the altruism construct these
statements were removed from the final surveys. Consumer responses to the two
open-ended survey questions provided an opportunity for the elaboration of their
views and altruism is a deductive qualitative theme described in the next thesis
section and Chapters 4, 5 and 6. Hence, despite the poor quantitative results
regarding altruism, this important issue has been better addressed with the
qualitative methods.
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Qualitative
In the pilot Australian and Canadian studies three qualitative researchers were
involved in analysing and classifying the qualitative data. Inclusion of multiple
qualitative data evaluators contributes ‘investigator triangulation’ thus strengthening
the overall validity. The themes used for encoding were generated in a deductive
manner from the literature that informed the survey design. Any emergent themes
were noted by the qualitative encoders. To enhance reliability the encoded qualitative
themes found in each qualitative survey submission, as identified by each qualitative
researcher, were compared and where discrepancies existed the researchers discussed
the classifications until an agreed set of themes for each returned survey were agreed.
As a researcher read through the survey comments they annotated the survey number
against the theme and once this was completed a tally was included. This approach
was sufficient for the small number of surveys in the pilot study, however a more
rigorous approach was adopted for the final surveys.
3.5.4

Improvements to Survey Design Resulting from the Pilot Survey

The reason for conducting the pilot studies was to improve the consumer public
opinion survey instrument. This section discusses changes made to the survey prior to
national deployment.
The seven point Likert scale was reduced to a five point scale for the final survey.
There is debate surrounding the ideal scale for surveys (Rossiter 2002; Bergkvist and
Rossiter 2007). Originally the seven point Likert response scale was included due to
the expectation that it would be possible to record greater discrimination in categories
of the statement responses.

Pilot survey data analysis indicated little benefit in

maintaining the seven point scale and hence the scale was reduced to five points for
the final surveys. The reduction in number of Likert response categories also
simplified the visual appearance of the survey instrument and it was hoped that this
would lead to further engagement with consumers.
The poor internal reliability of some parts of the survey, as reported earlier led to
removal of some statements and replacement with alternate statements. For example
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the construct exploring consumers opinion regarding altruism was removed. With
Cronbach Alpha (α) = .297 for Australia and .459 for Canada, these statements were
not offering acceptable levels of internal reliability. Similarly the statements
pertaining to data stewardship resulted in very low Cronbach Alpha (α) = .002 for
Australia and .459 for Canada. In this case there was such a discrepancy between the
two pilot survey results the Australian results took precedent due to the larger sample
size in Australia (168) as compared to Canada (44). The larger sample size was likely
more indicative of performance on the final survey. Similarly the commercial data
use construct resulted in poor internal reliability with Cronbach Alpha (α) = .162 for
Australia and .274 for Canada. The negative Cronbach Alpha on the Australian
sensitivity construct indicates a negative covariance amongst the two items
(statements), which violates the reliability model assumption. After checking the item
coding and entered data no explanation could be found for this negative Australian
value. This construct was removed from the final surveys. All of the constructs were
analysed and their merit for inclusion in the final surveys considered, leading to
changes to the statements prior to final survey deployment.
The construct relating to the provision of feedback from research studies to
consumers was closer to the internal reliability threshold for an exploratory study
however these statements were re-worked in an attempt to boost the performance of
the overall survey. These statements were also reconsidered as they were perhaps
more appropriately placed in the ‘privacy management’ rather than ‘privacy
justification’ tripartite component.
The inclusion of an incentive was also dropped from the final survey. It is difficult to
quantify the impact that the incentive had on the survey response rate. Some
respondents wrote polite notes such as “Thanks for the stamps – I would have
completed the survey even if you had not sent me the stamps”. Given that such
sentiment was expressed and there was no clear advantage the incentives were not
used in the final surveys.
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3.5.5

Revised Survey Constructs

Following the survey focus group and pilot testing the final version of the survey
was determined and Table 12 summarises the privacy tripartite components,
associated constructs, codes and survey statements to be included in the final
Australian and Canadian surveys.

Privacy

Construct

Table 12: Final survey constructs
Survey Statement
Code Survey
Statement

Tripartite

Number

Component
Concept

Anxiety

Limited

C-A1

5

C-A2

6

C-A3

8

C-A4

9

C-A5

25

C-A6

27

C-LA1

10

C-LA2

11

J-RB1

1

J-RB2

3

J-RB3

4

J-B1

12

J-B2

26

J-B3

28

Access

Justification

Rights

If an unauthorised person gained access to my
medical information then I would feel that my privacy
had been violated.
I am concerned that my medical information may be
stolen.
I worry about medical receptionists reading my
medical information.
I worry about computer staff being able to read my
medical information when they are looking after
medical systems.
I would never agree to donate my medical information
to anyone because I worry about potential misuse of
the information.
I worry about insurance companies getting access to
medical information because they may not use
information in a way that benefits society.
In Australia my healthcare providers try to protect my
privacy by restricting access to my medical
information.
It seems that my healthcare providers feel that the
fewer people who see my medical information the
higher the level of privacy they have provided for me.
I believe that I have a ‘right’ to personal privacy.

Based

Balance
‘common
good’ and
individual

I have the ‘right’ to share my medical information with
others.
I expect Australian laws and healthcare guidelines to
protect my personal privacy.
If information about my health can be used to help
others who are suffering ill-health then I believe my
information should be used to help those people.
I support the idea of medical information donation
when the information is used in a way that benefits
society.
Using medical information for the ‘common good’ is
OK but I worry about the risk to a person’s privacy.
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Privacy

Construct

Code

Survey Statement

Statement

Tripartite

Number

Component
Management

Survey

Control

Data

M-C1

16

M-C2

13

M-C3

14

M-C4

17

M-C5

19

M-C6

20

M-C7

21

M-C8

22

M-C9

23

M-C10

29

M-C11

15

M-DS1

24

M-DS2

7

M-DS3

30

M-DS4

2

M-DS5

18

Stewardship

If I donated my medical information for research I
would want to choose the level of privacy I required.
For example I may choose (1) ‘always anonymous’ or
(2) ‘name and Medicare number can always be used’.
If my health information could be made anonymous by
removing things like my name, address, phone
number and Medicare number I would be more likely
to agree for the information to be used for medical
research.
I feel that I continue to have privacy even when other
people have access to my personal information if I am
the one who has granted the other people access.
If I give consent for my health information to be used
for research I want to be able to say who can use my
information like
‘medical researchers’, ‘drug
companies’, ‘university researchers’ or ‘insurance
companies’.
A person must be able to choose to keep their medical
information private and never consent to release their
medical information for any purpose.
If I donated my medical information for research I
would like to give my consent once - at the time of
‘signing up’ as a data donor.
If people agree to donate their data for medical
research there must be a way for them to stop the
donation agreement at any time.
If people agree to donate their data for medical
research from time to time they must be asked if they
want to continue to donate.
If I choose to donate my medical information then
healthcare providers should release the information
according to my instructions.
I should be able to see my medical information and it
should be easy to correct any mistakes in the
information.
I support the idea of people being given a personal
choice about ‘donating’ their medical information for
research.
I would be happy to let the Australian Government
decide who can use my medical information.
When my medical information is stored on a computer
owned by a healthcare provider they should not
assume that they ‘own’ the information.
A legal judge in Australia decided that the notes
written about a patient, by a Doctor, are owned by the
Doctor not the patient. This decision seems
reasonable to me.
I think that my medical records belong to me – they
don’t just belong to my healthcare providers.
Any medical research groups who want to use
‘donated’ data must comply with the wishes of the
person who has ‘donated’ the data.
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3.5.6

Survey Ethical Considerations

Ethics approval to conduct the survey was requested from the University of
Wollongong Human Research Ethics Committee (HREC). This committee is
accredited by the Australian National Health and Medical Research Council and
operates according to the Australian National Statement on Ethical Conduct in
Research Involving Humans (NHMRC 2007).
An initial research approval was provided by the University of Wollongong in mid
2009, a copy is included in Appendix A. An ethics renewal was required in 2010
and a final report on ethical aspects of research was completed and submitted to the
HREC in August 2011. Ethics approval was also required to conduct the Canadian
aspects of this study and the University of Ontario Institute of Technology (UOIT)
Research Ethics Board (REB) provided approval. This REB ensures research in
Canada is conducted in compliance with the Tri-Council Policy Statement: Integrity
in Research and Scholarship. The UOIT REB provided initial approval for this
study in 2009 and a renewal was applied for and granted in 2010.
The survey used in this study was anonymous with respondents asked to provide nonmandatory, non-identifying demographic characteristics via survey component 2.
Given the nature of this research, providing research participants with a mechanism to
enable engagement in a non-identifying manner was very important. All of the
returned surveys from Australia and Canada are held securely within the School of
Information Systems and Technology at the University of Wollongong. These
surveys are to be securely stored for the next five years and cannot be used as part of
any other research study.

3.5.7

The Final Survey

The organisation of the survey questions broadly moves through concept, justification
and management of privacy reflecting the RALC constructs. All of the gathered
survey data contributes empirical knowledge to Townend’s consumer vector (2010).
The final Australian survey can be found in Appendix B.
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3.5.7.1 Cover Letter
A one page cover letter was included in the survey packages. The cover letter
introduced the survey topic to residents, estimated the time it would take to complete
the survey, and provided names, photographs, home Faculties, email addresses and
telephone numbers for the researchers. Residents were also told that ethics approval
had been granted and contact phone numbers were provided for the Institutional
ethics officers. The cover letters for the Australian and Canadian surveys can be
found in Appendix C.
3.5.7.2 Component 1: Attitudinal Statements
Component 1 investigated the respondents’ opinions regarding abstract and tangible
aspects of privacy within the secondary use of medical data context. No preliminary
information was provided to respondents. The survey is a snapshot of citizen’s
current perceptions of privacy without any attempt to shape the notion of privacy or
data ownership, legal rights or suitable secondary uses through background or
preliminary discussion. The absence of early opinion forming materials, that are
sometimes used by researchers to frame issues prior to asking respondents to
complete the survey, have been purposefully avoided. Respondents used their
‘common knowledge’ interpretation of the attitudinal statements.
This is a valid approach as there is ongoing debate regarding the definition and
evolving meaning of privacy in the Information Age as described in the Literature
Review of this thesis. The capture of citizens’ opinions as expressed via this survey
instrument may provide a ‘baseline’ position that can be used in future research
regarding public opinion as our understanding of privacy evolves. Figure 13, Figure
14 and Figure 15 present the first three pages of the Australian final survey
instrument.
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Figure 13: Page 1 of Australian final survey

The statements on the survey do not explore the tripartite privacy components and
constructs in sequential order. For example Statement 6 explores consumer concepts
of privacy, particularly their concern about theft of medical information. This
statement is followed by Statement 7 which explores responses to data stewardship.
This is followed by a return to the anxiety aspects of the concept of privacy with
Statements 8 and 9. Page 1 finishes with a statement exploring consumers awareness
of the ‘limited access’ approach to privacy that dominates the health sector.
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Figure 14: Page 2 of the Australian final survey

Consistent with this approach, ‘everyday language’ has been used in the survey to
assist in engagement with the general public. Expression in the first person was used
to aid in respondents’ personal engagement. This research did not use any of the
specific questions found in the earlier surveys described in the Literature Review.
However, this survey does explore the surveyed themes of data ownership,
confidentiality and consent broadly explored in earlier surveys.
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Figure 15: Page 3 of the Australian final survey

A potential issue regarding the choice of a five point Likert scale is that central
tendency bias may lead to consumers avoiding the extreme response categories with
a tendency to select the central ‘neutral’ response. A four point scale could have
been used to force a choice upon the respondent. This was not adopted as a ‘neutral’
response is reasonable when the consumer does not have an opinion as positive or
negative. This outcome is as informative as a positive or negative response, hence
the five point scale. The ‘Don’t know’ item is also informative as with no
background explanatory information provided it is possible that respondents will be
faced with statements where they ‘Don’t know’ how to respond. A scale with both
positively and negatively keyed comments helps to overcome acquiescence bias and,
where possible, a variety of statements have been included in this survey.
Moor and Tavani’s Restricted Access/Limited Control (RALC) theory informed the
construct of many of the attitudinal questions. ‘Concept’ of privacy, ‘justification’ of
privacy and ‘management’ of privacy are the broad RALC notions explored through
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survey component 1. There are also statements exploring consumer response to the
landmark Breen V Williams outcomes and to Magnusson’s Trans-Organisational
Concept (2002; 2004).
3.5.7.3 Component 2: Open ended questions
Open ended questions are used in Component 2. The first open ended prompt used
was “Do you have any concerns regarding the collection and re-use of medical
data?” and the second question was “Other Comments?” A full A4 page was
allocated to capturing responses to these open ended questions. Some respondents
filled the entire page with their hand written responses and others chose not to
provide any comments.
The purpose of including Component 2 was to offer respondents an opportunity to
enrich their quantitative responses to Component 1 with narrative descriptions and
elucidation of their opinions.
Component 3: Optional demographics
Component 3 provided an opportunity for respondents to provide demographic
characteristics. This component appeared in the survey at the end of Component 1
and prior to the start of Component 2, as illustrated in Figure 16. Capturing this data
enabled stratified analysis of both the qualitative and quantitative survey data.

Figure 16: Survey Component 3

Respondents were asked to self identify if they had ever worked in the healthcare
sector. This is a very broad classification and future research could benefit from a
more rigorous approach to classifying employment categories of health workers.
Healthcare workers are well educated in terms of traditional restricted access
approaches to privacy and this training and experience is likely to bias their opinions
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as expressed in their responses to the survey. As described in the Literature Review,
healthcare workers have a particular view of secondary use of medical data and the
inclusion of this demographic should enable comparison of healthcare workers
against general population.
3.5.7.4 The Final Survey Procedure
This section of the chapter describes the procedures followed in developing and
deploying the surveys in Australia and Canada. The results of the surveys and
analysis of results are presented in Chapters 4, 5 and 6. One of the biggest practical
challenges of this research was establishing valid address lists. The same approach
could not be used in both Australia and Canada due to different postal arrangements,
and citizens’ directory information from Australia Post and Canada Post also varied.
Australia
Three approaches were taken to create the list of valid residential addresses for the
pilot and final surveys.
1. Residential blocks were selected and the survey package envelopes were
preaddressed with all details except the property number. The research team
walked down the selected streets and added the accurate property numbers,
such as Unit 4A or 1/200 to the pre-addressed envelopes. Simultaneously the
accurate property numbers were recorded on a running sheet to complete the
details for each mapped residential block. These areas included some
Melbourne suburbs, Sydney suburbs, areas within the Illawarra and Southern
Highlands and Darwin. This approach was used for all Australian pilot
surveys.
2. Google maps streetview tool was used to identify (where possible) the
accurate street numbers for targeted survey streets. The survey packages
were prepared – including the Google maps streetview house number – and
delivered by Australia Post. This approach enabled the conduct of the survey
in areas well beyond the research teams such as Perth, Hobart, Benalla,
Adelaide and Alice Springs.

110

3. If the research team could elicit help in gathering accurate street numbers in
areas of interest for this survey then colleagues visiting the targeted areas
would gather accurate address details – pass these on to the research team
and survey packages would be despatched. These areas included parts of
Darwin, Brisbane, Perth, Adelaide and Melbourne.
4. The Telstra White Pages telephone directory was also used to assist in
finding accurate street addresses. This approach was used for geographic
areas that were small and well defined by their suburb name to enable
development of mailing lists that were restricted to a few residential blocks,
for example Fern Tree Gully in Victoria and Stanwell Park in New South
Wales.
The second approach was the most inaccurate and resulted in the highest rate of
returned mail. Once the surveys had been distributed, the Australia Post prepaid
envelopes, included in the survey packs, were used to return all mail to the
researcher.
To ensure the broadest possible engagement with the community, the sample
populations included low, medium and high socio-economic status areas in urban,
regional and remote areas. There was diversity amongst the nature of the dwellings
including: single residential dwellings, high rise blocks of units, rural properties, and
duplex dwellings. Any property displaying a ‘no junk mail’ sign was omitted from
the study.
Canada
In Canada most residential properties, particularly those in new areas, do not have
post boxes out the front of houses. There are consolidated post boxes at the end of
streets and the only entity authorised to put anything into the boxes is Canada Post.
Junk mail is not a problem for Canadian households. This restriction caused some
challenges for this study as the intention was to keep the cost of the pilot studies as
low as possible by having the research team deliver the survey packages to
letterboxes.
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Two approaches were taken to create the list of valid residential addresses for the
pilot and final surveys.
1. A small number of residential areas near the University of Ontario Institute
of Technology (UOIT) in Oshawa, Ontario, were selected for the Canadian
pilot study. The research team walked the streets compiling a list of valid
residential addresses. The research packages were prepared and despatched
via Canada Post.
2. The internet based telephone directory used in Canada (whitepages 2011)
offers functionality called ‘address & neighbours’ and this tool was used to
develop valid street addresses across Canada. By entering a street name and
location the white pages directory retrieves and displays a large number of
residential properties located on the selected street. Figure 17 illustrates the
details returned by entering the name of the street that UOIT is located on –
Simcoe Street North, Oshawa, Ontario. Names have been obscured on this
image.

Figure 17: Canada Whitepages address & neighbours
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By selecting a particular returned individual address the website displays the entire,
accurate address for properties located on the chosen street; as illustrated in Figure
18. Part of the name and telephone number have been obscured in this image,
however such privacy provisions do not normally apply when using this publically
available tool. Survey packages were prepared and despatched ‘To The Resident’ at
the addresses obtained from the white pages website.

Figure 18: Accurate residential address

Thus it was possible for the researcher located in Wollongong, Australia to construct
accurate mailing lists for use in this study. Every Province across Canada – except
the French speaking Province of Quebec, had a sample population included in the
final survey.
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Australia
Surveys were despatched to every State and Territory in Australia. The survey
sampling strategy made use of the Australian Institute of Health and Welfare
recommended Australian Standard Geographic Classification (ASGC) Remoteness
Areas (RA) to target diverse populations (Australian Institute of Health and Welfare
2012). The ASGC RA uses five categories: major cities, inner regional, outer
regional, remote and very remote. Figure 19 illustrates the locations included in the
Australian survey.

Figure 19: Sample populations in Australia

Canada
In Canada surveys were despatched to diverse populations in every English speaking
Province, except Nunavut. Figure 20 illustrates the sample sites included in the
Canadian survey.

Figure 20: Sample populations in Canada
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3.6

Managing and Analysing the Survey Data

The ordinal data (quantitative) gathered via the public opinion survey was collected
at the same time as the collection of the open ended (qualitative) question responses,
thus being concurrent. The respondent responses to the statements were, as
previously described, captured on a Likert scale. These ordinal measurements were
represented using numerical values to denote the ordering information. These only
reflect the ranking order and no inference is made regarding the distances between
adjacent values as emphasised by Svensson (2001), Powers and Xie (2000). In total
1,573 pilot and final surveys were returned, Table 13 presents a summary of the
surveys.
Table 13: Pilot and final survey summary
Number of
Number
Number of
surveys that
returned
surveys
could not be
surveys
despatched
delivered

Survey

Response Rate
%

Pilot – Australia

168

482

0

34.8

Pilot – Canada

44

250

46

17.6

Final – Australia

1158

5173

267

23.6

Final - Canada

203

1640

63

12.8

1573

7545

376

TOTAL

The quantitative and qualitative pilot study survey data was captured using a
custom-built MSAccess database with data entered manually. There were four
datasets in total that were stored in four separate databases: (1) Australian pilot (2)
Australian final (3) Canadian pilot (4) Canadian final. The structure of the databases
was identical for each dataset. Validation at the point of data entry was applied to
the fields in the tables to ensure only valid, clean data was captured. Figure 21
depicts the table structure for the table within the database that held the survey data.
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The primary key was a sequential
number allocated to the survey at the
time of receipt. The survey number
was written on the envelope and every
page of the returned survey and used
in the database.

The

responses

to

open

ended

questions were stored as memo which
allowed the capture of entire comments
made by respondents.

Where possible default values and
validation were added to the fields. No
default values were used for the Likert
scale responses, however validation was
used. This example illustrates the default
of sex to “F” and validation to only “F” or
“M”

Figure 21: Structure of Survey table in custom database

Statistical analysis was undertaken using SPSS 17.0 and all the data, apart from
qualitative comments, were exported from the MSAccess database to SPSS. The
SPSS Package supported the analysis of the survey data as the demographics of
respondents were available with the Likert scale responses to enable statistical
evaluation. The non-parametric Chi-Square, Mann Whitney U-test and Cronbach
Alpha tests were heavily relied upon for this study and Chapters 4, 5 and 6 present the
results of these tests with many statistically significant results emerging.
The Pearson Chi-Square (X2) test was used to evaluate relationships between two
categorical variables. The Pearson Chi-Square test is widely used when analysing
non numeric variables such as the Likert scale attitudinal responses gathered through
the consumer surveys used in this study. This non parametric test was used to
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investigate statistically significant relationships between two categorical variables to
address the null hypothesis stated at the start of this chapter. The statistically
significant results are included in the next section. The test results included in this
section are those where results fall below the commonly used significance level of
0.05. The larger the value the more likely the variables are related. There can be
small or large differences between the number of times a Likert response is expected
and the actual number of times the respondents chose the Likert response. The matrix
type layout of test results in this chapter is intended to clearly show both the expected
number of Likert responses and the actual number of responses in each category. The
cells in the matrix that contribute the most to the Chi-Square result are those where
the expected and actual counts are very different. The df parameter is the degrees-offreedom which is calculated for each matrix as:
df = (number of rows -1 ) x (number of columns -1)
The Chi-Square values and the df value are used together to determine the
significance level of the test result. The observed versus expected counts have been
included to provide insight into the nature of the relationship, however the Pearson
Chi-Square test does not allow any conclusions beyond identifying where a
relationship exists between the consumers’ demographics and the response to survey
statements.
The custom-built MSAccess database continued to provide support for the qualitative
analysis. Hardcopy coding sheets were used by the qualitative researchers as
described more fully below. Once the coding sheet sets had been completed the
encoding data was added to the MSAccess database as a separate table for each
qualitative researchers coding. The survey number and thematic code were recorded
and a concatenated key created from the joining of these data items, as illustrated in
Figure 22.

Figure 22: Creation of concatenated key

117

Once all researchers coding had been identified by the concatenated key an SQL
query was created to capture differences between the researcher’s encoding, as
illustrated in Figure 23.

Figure 23: MSAccess database supporting qualitative analysis

The results of this query were combined with the full text of the consumer’s
response. This report formed the basis of discussions between the qualitative
encoders regarding differences in encoding and assisted the process towards
building consensus. This data management mechanism assisted in developing the
systematic approach to qualitative analysis (Spencer, Ritchie et al. 2003) and
reduced ‘data overload’ (Miles and Huberman 1994). The demographics of
consumer respondents were withheld from qualitative researchers in an attempt to
keep them from being influenced by factors beyond the consumer comments.
The design, capture and analysis of the qualitative aspects of this study were
influenced by the earlier work of Miles and Huberman (1994). The qualitative data
was stored in the same custom-built relational database that held the Likert scale
data. Themes identified in the literature review, and relevant to the research
questions driving this study, were organised into a hierarchical structure within the
tripartite privacy model. Miles and Huberman’s earlier work on deductive data
analysis using a priori themes based on the literature review findings influenced this
aspect of the research design. Table 14 presents the thematic classification scheme
that was used in a deductive manner during the analysis of the qualitative data.
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Table 14: Deductive themes used for qualitative analysis
Code

Sub

Theme

Related Source

A

Expressing anxiety

(Nehf 2003), (Nissenbaum 2010)

B

Not anxious about secondary use of data

(Barrett, Cassell et al. 2006)

C

Consumer TRUST - Don’t know who has information – Lack of transparency

(Woodward 1995; Fraser 2003; Nehf 2003; Croll and Morarji 2006;

Code
1

Concept

Sutcliffe 2006; Schneider, Kerwin et al. 2009; Tarini, Goldenberg
et al. 2010)

2

Justification

D

Not everyone who has access has patients’ best interests at heart

(Magnusson 2004; Fernando 2009; Clarke 2010)

E

Surveillance

(Magnusson 2004; Clarke 2010)

A

‘Right’ to privacy

(Warren and Brandeis 1890)

B

Responsibility of citizens to participate in secondary use. Individual rights

(Melton 1997; Walton, Doll et al. 1999; Lowrance 2003; Whiddett,

versus ‘common good’

Hunter et al. 2007; Zeps, Iacopetta et al. 2007; Willison, Emerson
et al. 2008; Dyer 2009; Rodwin 2009; Townend 2010; Buckley,
Murphy et al. 2011)

C

Personal data as a commercial commodity; Commercial aspects of data use

(Rindfleish 1997; Rodwin 2009; Rosenbaum 2010; Townend
2010)

3

Management

D

Ownership of data

(Magnusson and Opie 1998; Rodwin 2009)

A

Good data stewardship required and consumers need confidence in

(Fraser 2003; Rosenbaum 2010)

arrangements underpinning secondary use
B

Consumers as research partners not research subjects

(Whiddett, Hunter et al. 2007; Ruyter, Louk et al. 2010; Townend
2010; Trinidad, Fullerton et al. 2011)

C

Consumer control of data issues

(Tavani and Moor 2001)

D

Restricted access to consumer data issues

(Tavani and Moor 2001)

E

De-identification of data

(Lowrance 1997; Lowrance 2002; Lowrance 2003; O'Keefe 2008;
Willison, Steeves et al. 2009; O'Keefe and Connolly 2010)
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F

Consent

(Woolf, Rothemich et al. 2000; Willison, Keshavjee et al. 2003;
Singleton and Wadsworth 2006; Willison, Schwartz et al. 2007;
Beskow and Dean 2008; Willison, Steeves et al. 2009; Elger,
Lavindrasana et al. 2010)

G

Payment for use of data

(PricewaterhouseCoopers 2009; Rosenbaum 2010)

H

Legal system to protect consumers

(Warren and Brandeis 1890; Magnusson 2002; Magnusson 2004;
Australian Law Reform Commission 2008)

I

Consumers to provide input on data stewardship – including being able to

(Sadan 2000; Trinidad, Fullerton et al. 2011)

decline to participate
J

Role of Government

(Magnusson 2004)

K

Secondary use mechanisms: Human Research Ethics Committees; computer

(Croll and Croll 2006)

technology
L

Comments in support of secondary use

M

Comments about sensitivity of different types of information eg. Sexual health,

(Tavani and Moor 2001; Willison, Steeves et al. 2009;

mental health

Nissenbaum 2010)

Comments about the purpose of data use e.g. OK for research but not OK for

(Nissenbaum 2010)

N

commercial secondary use
4
5

Survey design
Recounting

A

Positive

B

Negative

A

Positive

B

Negative

health industry
experiences
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Where appropriate, Table 14 also includes the literature sources informing the
themes. Any emergent themes were noted and further discussed amongst the
qualitative researchers. They are presented in Chapter 4 and in Chapter 6.
Analysis of the larger final surveys was undertaken by two Australian researchers.
As outlined with the pilot study, this study has relied on process and triangulation
for establishment of validity of the qualitative data as suggested by Byrne (2002, p.
152). Miles and Huberman’s (1994) work on intercoder agreement in qualitative
research informed the design of qualitative aspects of this study. The suggested
measure is depicted in Figure 24.

Number of agreements
Reliability =
Total number of agreements + disagreements

Figure 24: Reliability calculation

This reliability measure was used iteratively during the evaluation of each
qualitative researchers coding of the consumers responses. Miles and Huberman’s
estimate of intercoder agreement in the 90% range was the target for reliability
adopted in this study.
The interwoven processes of data reduction, data display and conclusion
drawing/verification formed the basis of qualitative ‘analysis’ in this study (Miles
and Huberman 1994). The main focus and aims of the qualitative data analysis
revolved around content analysis of the two open ended questions included in the
public opinion survey. Themes were identified with a focus on the way the theme
was treated and the frequency of occurrence. The analysis was then linked to
demographic variables such as gender, level of education and self reported
experience working in healthcare sector.
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The focus of analysis here is not on the language itself. Narrative analysis was
considered as a suitable approach for this research but was rejected as the majority
of respondents did not write in a manner that developed narrative structures as
described by Kohler Riessman (2002).
The focus of analysis is on content where attempts are made to capture and interpret
the substantive meanings in the data as described by Spencer, Ritchie and O’Connor
(2003). A common system of categories has been applied largely informed by
existing knowledge. As Spencer, Ritchie et al. suggest:

This approach is felt to offer a systematic overview of the
scope of the data; to aid finding themes or examples that do
not appear in an orderly way in the data; to aid locating
conceptual, analytical categories in the data; and to help
getting a handle on the data for making comparisons or
connections connections (Spencer, Ritchie et al. 2003).
As Miles and Huberman (1994) indicate ‘naming and classifying’ is insufficient and
this study attempts to understand the patterns within the qualitative data within the
tripartite privacy framework proposed by Moor and Tanavi (Tavani and Moor
2001). These results and further analysis are presented in Chapters 4, 5 and 6.
No in vivo coding was conducted – the coding template came from the informing
theory and literature. Each of the qualitative researchers received two sets of
hardcopy encoding sheets – one set including consumer responses to the question
’Do you have any concerns regarding data re-use’ and the other encoding sheets for
responses to the prompt ‘Other Comments’. A sample encoding sheet is included in
Appendix D. The layout of the encoding sheets was intended to support the
qualitative researchers in the evaluation of consumer comments. The full text of the
consumer response, preformatted boxes for recording thematic codes and space to
allow further brief comments were combined on the form. The concise presentation
of the qualitative codes on a single A4 page enabled quick look-up without the need
to flick through multiple pages (Miles and Huberman 1994, p. 52).
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By presenting the entire text of the consumer comment it was possible to gain
insight into the consumer’s response without causing fragmentation of the text
which can lead to poor analysis results. As Miles and Huberman caution “Words are
fatter than numbers and usually have multiple meanings” (1994, p. 52), therefore the
surrounding text is important in understanding consumers meaning. Multiple themes
can be found in each consumer comment. The next three pages present the
qualitative components provided by consumers on Australian surveys numbered
889, 602 and 423. These have been included to illustrate the effort that consumers
directed towards their qualitative responses. The majority of consumers left survey
Component 2 open ended questions blank. Some wrote brief comments, and as the
examples here illustrate in Figure 25, Figure 26 and Figure 27, some respondents
took full advantage of the opportunity to express their opinion.
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Figure 25: Survey 889, Component 2 open ended questions
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Figure 26: Survey 423, Component 2 open ended questions
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Figure 27: Survey 602, Component 2 open ended questions

126

3.6.1

Integrated Analysis

Fusing Quantitative and Qualitative Data
The concerns raised by Bryman (2007) regarding the lack of genuine integration of
qualitative and quantitative data in mixed methods studies is acknowledged. This
study addresses these concerns by: (1) deliberately fusing the quantitative and
qualitative data and (2) through the organisation and structure of thesis chapters.
The quantitative and qualitative data is presented in Chapters 4, 5 and 6 in an
integrated manner similar to that proposed by Creswell (2009; Creswell and Plano
Clark 2011). In keeping with the recommendations of Creswell:

In a concurrent study, the quantitative and qualitative
data collection may be presented in separate sections, but
the analysis and interpretation combines the two forms of
data to seek convergence or similarities amongst the
results. (Creswell 2009, p. 220)
The fusing of quantitative and qualitative data in this study is assisted by the fact that
the quantitative and qualitative aspects address the same research questions. This
aspect of the research design goes someway to answering Bryman’s (2006) concerns
about many mixed methods studies having multiple sets of questions where some are
addressed by quantitative and other questions are addressed by qualitative
components. This thesis describes a genuinely fused mixed methods design.
Interpretation of the qualitative and quantitative public opinion survey data
considered the extent to which the datasets triangulate and converge. As Hanson et
al. (2005) and Bryman (2006) suggest this mixed method design is useful in
confirming, cross-validating and corroborating earlier public opinion survey
findings. Inclusion of multiple data sources and methods contributes data
triangulation and method triangulation.
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3.7

Australian and Canadian Consumer Survey Comparison

The same questions and formatting were used for the larger Australian and Canadian
surveys that followed the pilot surveys. Validity of inter-survey comparisons was
aided by keeping the questions and formatting the same for both countries.
A null hypothesis was formulated to guide the comparison between the two
independent groups i.e. Canada and Australia:
H0: There is no significant difference between Canadian and Australian
consumer opinion as expressed through responses to the public opinion survey
used in this study where p<=0.05.
The non parametric Mann-Whitney U test was used to investigate the differences
between the Canadian and Australian survey results. This test was chosen as it is
suitable for the ordinal data gathered with the Likert scale where no assumptions are
made about normal distribution. Canada was coded as country ‘1’ and Australia
country ‘2’ within SPSS 17.0 as illustrated in Figure 28.

Figure 28: Mann-Whitney U test SPSS 17.0
dialogue box

This test is also suitable because it is not necessary to have the same number of
samples in each independent group. The results of the comparison are presented in
Chapter 6.
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3.8

Conclusion

This Chapter described the overall exploratory research design and articulated the
research questions and assumptions from the literature. Epistemology and
methodology were considered with justification for the approaches used in this study.
The influence of Bryman (2006; 2007), Creswell (2009) and Plano Clark (Plano
Clark and Creswell 2008; Creswell and Plano Clark 2011) in choice of mixed
methods and Miles and Huberman (1994) on qualitative methods is apparent in the
research design. The public opinion survey instrument was introduced and the design
decisions taken regarding the instrument were considered against the framework
provided by Bourque and Fielder (2003).
The pilot and final surveys were described. In total, 1,573 consumers contributed
their opinion regarding secondary use of medical data, particularly pertaining to
privacy matters, through the surveys. These survey responses were organised around
‘concept’, ‘justification’ and ‘management’ of privacy (Tavani and Moor 2001). The
understanding of consumer views is an integral part of the early stages of the system
development life cycle where the problem definition and requirements are specified.
Usually it is the proponents of information systems who dictate the problem to be
solved and system requirements. The use of the consumer surveys has enabled this
study to capture public opinion for use in developing a conceptual model, including
consumer

expectations

of

privacy,

which

may

inform

future

physical

implementations of information systems in the healthcare sector and beyond.
As foreshadowed, the results of deployment and fusing of mixed method findings
and conclusions are presented in following Chapters.
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4 AUSTRALIAN CONSUMER PUBLIC OPINION SURVEY RESULTS
4.1

Introduction

The Research Methodology Chapter described the journey from literature review to
pilot survey development, focus group testing, deployment, analysis of results and
improvement of the instrument, leading to the final survey instrument which was also
described.
A null hypothesis was formulated to investigate the diversity of opinion expressed by
different groups of consumers:
H0: There is no significant difference between groups of consumers as
expressed through responses to the public opinion survey used in this study
where p<=0.05.
This chapter presents the survey respondent demographics and descriptive statistics,
consideration of instrument internal reliability, frequency response statistics for
every opinion statement and non-parametric quantitative test results, and qualitative
results.
The next chapter includes more detailed discussion and analysis of the results.
4.2

Background

The survey was deployed into the Australian community as the national EHR is
under development and perhaps coming to the attention of consumers through media
reports. The secondary use of medical data context is rife with contradictions and
vexing questions that arise from the pace of technological development and adoption
by many stakeholders.
4.2.1

Descriptive Statistics

A total of 1,158 of the final Australian surveys were returned. The majority of
respondents were female. This was not unexpected as Aora and McHorney (2000)
previously reported that women want to participate in medical related decision
making.
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Frequency

% of

(n)

Total

Female

759

66

Male

369

32

Unknown

30

2

TOTAL

1158

Gender
70
60

% of Total

Gender

50
40
30
20
10
0
Female

Male

Unknown

Figure 29: Australian respondent demographics, gender

Women also are more active in seeking healthcare and questioning of clinicians
during visits (Nathanson 1977; Mechanic 1978). Figure 29 illustrates the percentage
of respondents by gender.

Age

Frequency

% of

(n)

Total

40
35

18 – 25

32

3

26 – 39

149

13

40 – 50

259

23

51 – 65

424

37

66 – 80

214

19

Over 80

45

4

Unknown

35

3

TOTAL

1158

30

% of Total

Age

25
20
15
10
5
0
18 ‐ 25

26 ‐ 39

40 ‐ 50

51 ‐ 65

66 ‐ 80

Over 80 Unknown

Figure 30: Australian respondent demographics, age

The majority of respondents provided the optional demographics and the largest age
group to respond were respondents aged 51-65 years. It was pleasing to have 45
octogenarians respond to the survey; however, the number of responses from the
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youngest age group, 18-25, was disappointing. It is possible that social media and
online surveys may be a better method to engage with this age group.

Highest Level
of Education

Frequency

% of

(n)

Total

< Year 10

59

5

25

Year 10

119

10

20

Year 12

111

10

Trade

88

8

Prof. Qual.

271

23

Bachelor
Degree

238

21

% of Total

Highest level of Education

15
10
5
0

233

Postgraduate

< Year 10 Year 10

20

Year 12

Trade

Prof.
Qual.

Bachelor Postgrad
Degree

1158

TOTAL

Figure 31: Australian respondent demographics, highest level of education

The majority (64%) of respondents self–reported as holding professional or higher
levels of education. In addition to dominating the quantitative survey responses this
well educated group also provided the majority of qualitative comments (see Table
15). It was, however, pleasing to have 135 comments from respondents with trade and
high school level education as the ‘voice’ of these respondents is that of the majority
of the Australian community. This Chapter and the next two Chapters reveal
statistically significant results across the highest level of respondent education which
has implications for the management of privacy in the secondary use of medical data
context.
Table 15: Frequency of open-ended comments by highest level of education
Highest Level of
Education

Frequency of
Comment 1

% of Total Number
of Comment 1

Frequency of
Comment 2

% of Total
Number of
Comment 2

Post Grad

84

25

47

24

Bachelor

73

22

41

21

Professional

77

23

57

29

Trade

16

5

9

5

Year 12

34

10

17

9

Year 10

28

8

11

6

<Year 10

13

4

7

4

TOTAL

338

197
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Respondents were invited to self-report if they had ever worked in the healthcare
sector including the allied health sector. This is an important demographic as it
provides an opportunity to look at a segment of the population who are often
responsible for consumer (patient) privacy in both the delivery of healthcare and the
secondary use of data. There are statistically significant differences in opinion
between this group of respondents and the non- healthcare workers in terms of the
‘concept’ of privacy and the ‘management’ of privacy as described in this and
following chapters.

Frequency

% of Total

Yes

268

23

No

860

74

Unknown

30

3

TOTAL

1158

100

Healthcare Worker
80
70
60

% of Total

Healthcare
Worker

50
40
30
20
10
0
Yes

No

Unknown

Figure 32: Australian respondent demographics, health sector worker

The Research Methodology chapter discussed the importance of determining internal
reliability for the final surveys and Table 16 presents the results of internal reliability
evaluations. All but one of the constructs falls above the threshold for this study i.e.
>0.60. The Justification – balance construct, does not meet the expected threshold
hence caution is required when analysing this construct. The comments made by
citizens in response to the two open ended questions may provide some insight on
this ‘getting the balance right’ issue.
Table 16: Reliability of scales
Tripartite

Construct

Code

Component
Concept
Justification
Management

Cronbach Alpha

Number

(α)

items

Anxiety

C-A

0.691

6

Limited Access

C-LA

0.602

2

Rights based

J-RB

0.644

3

Balance

J-B

0.159

3

Control

M-C

0.715

11

Data Stewardship

M-DS

0.617

5
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4.2.1.1 Response Frequency
This section presents the survey response frequencies in tabular and graphical
format. The survey results are not presented in the order of appearance on the survey
instrument but are rather grouped by the tripartite component to which they belong
i.e. the ‘concept’ of privacy, ‘justification’ of privacy or ‘management’ of privacy.
The table includes the statement number, text of the statement used in the survey,
tabular presentation of response frequency, and percentage of valid responses.
Missing responses are included in the tabular results but are not represented in the
bar charts. ‘Don’t know’ was a response category on the Likert scale and such
responses are presented on the bar charts. Table 17 presents the survey data that
related to the concept of privacy with a focus on consumer anxiety and the medical
community concept of privacy as being limited access as described in the literature
review.
Analysis and discussion of these response frequencies is presented in the next
Chapter.
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Table 17: Privacy tripartite component – concept of privacy, survey response frequency.
5. If an unauthorised person gained access to my medical information then I would feel that my privacy had been violated.
Response

Frequency

Valid %

900
800

Don’t know

0

Strongly agree

7

.6

Disagree

12

1.0

Neutral

39

3.4

Agree

236

20.6

200

Strongly agree

849

74.3

100

TOTAL

1143

Missing

15

TOTAL

1158

Frequency

700
600
500
400
300

0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

6. I am concerned that my medical information may be stolen.
Response

Frequency

Valid %

500
450

Don’t know

12

1.0

Strongly agree

37

3.2

Disagree

242

21.2

Neutral

441

38.5

Agree

273

23.9

100

Strongly agree

139

12.2

50

TOTAL

1144

Missing

14

TOTAL

1158

400
Frequency

350
300
250
200
150

0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

135

Agree

Strongly
Agree

8. I worry about medical receptionists reading my medical information.
Frequency

Valid %

Don’t know

3

0.3

Strongly agree

49

4.3

Disagree

276

24.1

Neutral

468

40.8

Agree

240

20.9

Strongly agree

111

9.7

TOTAL

1147

Missing

11

TOTAL

1158

Frequency

Response

500
450
400
350
300
250
200
150
100
50
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

9. I worry about computer staff being able to read my medical information when they are looking after medical systems.
Response

Frequency

Valid %

450

4

0.3

400

Strongly agree

39

3.4

350

Disagree

244

21.3

Neutral

404

35.2

Agree

306

26.7

Strongly agree

151

13.2

TOTAL

1148

50

Missing

10

0

TOTAL

1158

Frequency

Don’t know

300
250
200
150
100

Don't know

Strongly
Disagree

Disagree

Neutral

Response

136

Agree

Strongly
Agree

25. I would never agree to donate my medical information to anyone because I worry about potential misuse of the information.
Response

Frequency

Valid %

600

23

2.0

500

Strongly agree

123

10.9

400

Disagree

539

47.8

Neutral

275

24.2

Agree

103

9.1

Strongly agree

64

5.7

TOTAL

1128

Missing

30

TOTAL

1158

Frequency

Don’t know

300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

27. I worry about insurance companies getting access to medical information because they may not use information in a way that benefits
society.
Response

Frequency

Valid %

500

Don’t know

14

1.2

450

Strongly agree

15

1.3

350

Disagree

70

6.1

Neutral

225

19.8

Agree

462

40.7

Strongly agree

348

30.7

TOTAL

1134

Missing

24

TOTAL

1158

Frequency

400
300
250
200
150
100
50
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

137

Agree

Strongly
Agree

10. In Australia my healthcare providers try to protect my privacy by restricting access to my medical information.
Response

Frequency

Valid %

600

225

19.8

500

Strongly agree

8

0.7

400

Disagree

33

2.9

Neutral

231

20.3

Agree

518

45.5

Strongly agree

124

10.9

TOTAL

1139

Missing

19

TOTAL

1158

Frequency

Don’t know

300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

11. It seems that my healthcare providers feel that the fewer people who see my medical information the higher the level of privacy they
have provided for me.
Response

Frequency

Valid %

500
450

Don’t know

223

19.7

Strongly agree

4

0.3

Disagree

45

3.9

Neutral

289

25.6

Agree

463

41

Strongly agree

103

9.1

TOTAL

1127

50

Missing

31

0

TOTAL

1158

400
Frequency

350
300
250
200
150
100

Don't know

Strongly
Disagree

Disagree

Neutral

Response

138

Agree

Strongly
Agree

Table 18 presents response frequencies for statements that contribute to the second tripartite component, justification of privacy. These
statements explore the consumers opinion regarding ‘rights’ based justifications for privacy and the balancing ‘common good’ against
individual rights.

Table 18: Privacy tripartite component - justification of privacy, survey response frequency
1. I believe that I have a ‘right’ to personal privacy.
Frequency

Valid %

Don’t know

1

0.1

Strongly agree

3

0.3

Disagree

7

0.6

Neutral

25

2.2

Agree

326

28.3

Strongly agree

791

68.6

TOTAL

1153

Missing

5

TOTAL

1158

900
800
700
Frequency

Response

600
500
400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

139

Agree

Strongly
Agree

3. I have the ‘right’ to share my medical information with others.
Frequency

Valid %

Don’t know

6

0.5

Strongly agree

16

1.4

Disagree

15

1.3

Neutral

39

3.4

Agree

509

44.5

Strongly agree

558

48.8

TOTAL

1143

Missing

15

TOTAL

1158

600
500

Frequency

Response

400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

4. I expect Australian laws and healthcare guidelines to protect my personal privacy.
Frequency

Valid %

Don’t know

2

0.2

Strongly agree

3

0.3

Disagree

3

0.3

Neutral

17

1.5

Agree

310

26.9

Strongly agree

815

70.9

TOTAL

1150

Missing

8

TOTAL

1158

900
800
700
Frequency

Response

600
500
400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

140

Agree

Strongly
Agree

12. If information about my health can be used to help others who are suffering ill-health then I believe my information should be used to
help those people.
Response

Frequency

Valid %

700

18

1.6

600

Strongly agree

27

2.4

500

Disagree

71

6.2

Neutral

160

14.0

Agree

598

52.5

Strongly agree

266

23.3

TOTAL

1140

Missing

18

TOTAL

1158

Frequency

Don’t know

400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

26. I support the idea of medical information donation when the information is used in a way that benefits society.
Response

Frequency

Valid %

700

Don’t know

10

0.9

Strongly agree

14

1.2

Disagree

19

1.7

Neutral

82

7.2

Agree

648

57.2

Strongly agree

360

31.8

TOTAL

1133

100

Missing

25

0

TOTAL

1158

600

Frequency

500
400
300
200

Don't know

Strongly
Disagree

Disagree

Neutral

Response

141

Agree

Strongly
Agree

28. Using medical information for the ‘common good’ is OK but I worry about the risk to a person’s privacy.
Response

Frequency

Valid %

600

12

1.1

500

Strongly agree

15

1.3

400

Disagree

82

7.2

Neutral

255

22.5

Agree

564

49.8

Strongly agree

204

18.0

TOTAL

1132

Missing

26

TOTAL

1158

Frequency

Don’t know

300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

The final privacy tripartite component - Privacy Management, consumer survey response frequencies - are presented in Table 19.
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Table 19: Privacy tripartite component – privacy management, survey response frequency
2. I think my records belong to me – they don’t just belong to my healthcare providers.
Response

Frequency

Valid %

700
600

0

Strongly agree

10

0.9

Disagree

33

2.9

Neutral

86

7.5

Agree

362

31.5

100

Strongly agree

658

57.3

0

TOTAL

1149

Missing

9

TOTAL

1158

Frequency

Don’t know

500
400
300
200

Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

7. When my medical information is stored on a computer owned by a healthcare provider they should not assume that they ‘own’ the
information.
Response

Frequency

Valid %

700

5

0.4

600

Strongly agree

8

0.7

500

Disagree

20

1.7

Neutral

52

4.5

Agree

442

38.7

Strongly agree

617

53.9

TOTAL

1144

Missing

14

TOTAL

1158

Frequency

Don’t know

400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

143

Agree

Strongly
Agree

18. Any medical research groups who want to use ‘donated’ data must comply with the wishes of the person who has ‘donated’ the data.
Response

Frequency

Valid %

700

4

0.3

600

Strongly agree

6

0.5

500

Disagree

25

2.2

Neutral

66

5.8

Agree

425

37.2

Strongly agree

617

54.0

TOTAL

1143

Missing

15

TOTAL

1158

Frequency

Don’t know

400
300
200
100
0

Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

24. I would be happy to let the Australian Government decide who can use my medical information.
Frequency

Valid %

Don’t know

12

1.1

Strongly agree

457

40.3

Disagree

422

37.2

Neutral

120

10.6

Agree

83

7.3

Strongly agree

40

3.5

TOTAL

1134

Missing

24

TOTAL

1158

Frequency

Response

500
450
400
350
300
250
200
150
100
50
0

Don't
know

Strongly
Disagree

Disagree

Neutral

Response

144

Agree

Strongly
Agree

30. A legal judge in Australia decided that the notes written about a patient, by a Doctor, are owned by the Doctor not the patient. This
decision seems reasonable to me.
Frequency

Valid %

Don’t know

22

1.9

Strongly agree

365

32.2

Disagree

387

34.1

Neutral

123

10.8

Agree

164

14.4

Strongly agree

74

6.5

TOTAL

1135

Missing

23

TOTAL

1158

Frequency

Response

450
400
350
300
250
200
150
100
50
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

13. If my health information could be made anonymous by removing things like my name, address, phone number and Medicare number I
would be more likely to agree for the information to be used for medical research.
Response

Frequency

Valid %

3

0.3

600

Strongly agree

8

0.7

500

Disagree

25

2.2

400

Neutral

68

5.9

Agree

542

47.5

Strongly agree

495

43.4

TOTAL

1141

Missing

17

TOTAL

1158

Frequency

Don’t know

300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

145

Agree

Strongly
Agree

14. I feel that I continue to have privacy even when other people have access to my personal information if I am the one who has granted
the other people access.
Response

Frequency

Valid %
700

Don’t know

23

2.0

Strongly agree

13

1.1

Disagree

96

8.5

Neutral

169

14.9

Agree

607

53.4

200

Strongly agree

228

20.1

100

TOTAL

1136

Missing

22

TOTAL

1158

600

Frequency

500
400
300

0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

15. I support the idea of people being given a personal choice about ‘donating’ their medical information for research.
Response

Frequency

Valid %

700

3

0.3

600

Strongly agree

8

0.7

500

Disagree

21

1.8

Neutral

63

5.5

Agree

595

52.1

Strongly agree

453

39.6

TOTAL

1143

Missing

15

TOTAL

1158

Frequency

Don’t know

400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

146

Agree

Strongly
Agree

16. If I donated my medical information for research I would want to choose the level of privacy I required. For example I may choose (1)
‘always anonymous’ or (2) ‘name and Medicare number can always be used’.
Frequency

Valid %

Don’t know

13

1.1

Strongly agree

25

2.2

Disagree

20

1.8

Neutral

55

4.8

Agree

523

46.1

Strongly agree

499

44.0

TOTAL

1135

Missing

23

TOTAL

1158

600
500
Frequency

Response

400
300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

17. If I give consent for my health information to be used for research I want to be able to say who can use my information like ‘medical
researchers’, ‘drug companies’, ‘university researchers’ or ‘insurance companies’.
Response

Frequency

Valid %

600

Don’t know

6

0.5

Strongly agree

11

1.0

Disagree

44

3.9

Neutral

116

10.1

Agree

461

40.3

100

Strongly agree

505

44.2

0

TOTAL

1143

Missing

15

TOTAL

1158

Frequency

500
400
300
200

Don't know

Strongly
Disagree

Disagree

Neutral

Response

147

Agree

Strongly
Agree

19. A person must be able to choose to keep their medical information private and never consent to release their medical information for
any purpose.
Response

Frequency

Valid %

600

9

0.8

500

Strongly agree

24

2.1

400

Disagree

117

10.3

Neutral

126

11.1

Agree

376

33.0

Strongly agree

486

42.7

TOTAL

1138

Missing

20

TOTAL

1158

Frequency

Don’t know

300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

20. If I donated my medical information for research I would like to give my consent once - at the time of ‘signing up’ as a data donor.
Frequency

Valid %

Don’t know

24

2.1

Strongly agree

57

5.0

Disagree

164

14.4

Neutral

160

14.1

Agree

521

45.9

Strongly agree

210

18.5

TOTAL

1136

Missing

22

TOTAL

1158

600
500
400
Frequency

Response

300
200
100
0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

148

Agree

Strongly
Agree

21. If people agree to donate their data for medical research there must be a way for them to stop the donation agreement at any time.
Response

Frequency

Valid %

600

Don’t know

6

0.5

Strongly agree

9

0.7

Disagree

44

3.9

Neutral

67

5.9

Agree

493

43.2

200

Strongly agree

522

45.7

100

TOTAL

1141

Missing

17

TOTAL

1158

500

Frequency

400
300

0
Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

22. If people agree to donate their data for medical research from time to time they must be asked if they want to continue to donate.
Response

Frequency

Valid %

600

9

0.8

500

Strongly agree

17

1.5

400

Disagree

81

7.1

Neutral

135

11.9

Agree

506

44.5

Strongly agree

390

34.3

TOTAL

1138

Missing

20

TOTAL

1158

Frequency

Don’t know

300
200
100
0

Don't know

Strongly
Disagree

Disagree

Neutral

Response

149

Agree

Strongly
Agree

23. If I choose to donate my medical information then healthcare providers should release the information according to my instructions.
Response

Frequency

Valid %

600

Don’t know

8

0.7

Strongly agree

4

0.4

Disagree

18

1.6

Neutral

74

6.5

Agree

554

48.9

100

Strongly agree

475

41.9

0

TOTAL

1133

Missing

25

TOTAL

1158

Frequency

500
400

300

200

Don't know

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Response

29. I should be able to see my medical information and it should be easy to correct any mistakes in the information.
Response

Frequency

Valid %

600

Don’t know

7

0.6

Strongly agree

2

0.2

Disagree

19

1.7

Neutral

69

6.1

Agree

477

42.1

200

Strongly agree

560

49.4

100

TOTAL

1134

Missing

24

TOTAL

1158

500

Frequency

400
300

0
Don't know

Strongly
Disagree

Disagree

Neutral

Response

150

Agree

Strongly
Agree

4.2.2

Mixed Method Analysis

This section reports the results of both quantitative and qualitative analysis.
QuantitativeChi-Square tests were performed on the gender, age, education level and
self-reported healthcare worker demographics across all of the survey questions.
Demographic characteristics containing null values have been removed prior to ChiSquare analysis. The 5 point Likert scale has been reduced to disagree, neutral and
agree by combining ‘strongly disagree’ and ‘disagree’ into ‘disagree’ and ‘strongly
agree’ and ‘agree’ into ‘agree’. The ‘Don’t know’ response was omitted from this
aspect of analysis. The results presented in this section include only those Chi-Square
tests where no more than 20% of the expected counts were less than five (Yates,
Moore et al. 1999).
Qualitative
The qualitative comments provided by survey respondents were encoded, as
described in the Research Method Chapter, within Moor and Tavani’s tripartite
privacy framework (2001). The results have been organised around the tripartite
privacy framework to aid analysis of the consumer views regarding concept,
justification and management of privacy. Wherever possible, divergent views as
expressed through qualitative comments have been selected to illustrate the
differences of opinion amongst respondents. Where only a segment of the qualitative
response relates to the particular tripartite component a notation of three dots (...) has
been adopted to indicate that part of the text is omitted.
A structured notation has been adopted to convey in a concise manner the
demographics of the source respondent. The notation begins and ends with a square
bracket [] followed by, survey number, gender (M or F), home State or Territory, age
bracket (e.g. 18-25), highest education level ( e.g. <Yr 10), and a code to indicate if
the respondent has worked in the healthcare sector (HW for healthcare worker and
NHW for non healthcare worker). If partial demographics are available the known
components are presented. Table 20 presents summary details of Australian States
and Territories that may assist in interpreting the home geographic component of the
structured notation attached to each qualitative comment.
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Table 20: Australian State and Territory Codes
Code

State or Territory

Postcode initial digits

ACT

Australian Capital Territory

26

NSW

New South Wales

2

NT

Northern Territory

08

QLD

Queensland

4

SA

South Australia

5

TAS

Tasmania

7

VIC

Victoria

3

WA

Western Australia

6

The survey results indicate that the consumers used the qualitative page to respond in
a variety of ways – only sometimes containing themselves to the stimuli questions.

4.2.3

Tripartite Component: Privacy Concept – Quantitative Analysis

There are seven survey statements (6,8,9,10,11,25,27) pertaining to the tripartite
‘concept’ component. Statistically significant differences were found regarding
highest education level, age and self reported healthcare worker. Table 21 presents a
matrix of the statements and demographics investigated via Pearson’s Chi-Square
with an X indicating where the statistically significant results were found.
Table 21: Privacy Concept Chi-Square statistically significant results.
Construct

Gender

Age

Highest Education
Level

Statement 5

Anxiety

Statement 6

Anxiety

X

X

Statement 8

Anxiety

X

X

Statement 9

Anxiety

X

X

Statement 25

Anxiety

X

X

Statement 27

Anxiety

Statement 10

Limited
Access

Statement 11

Healthcare Worker

X
X

Limited

X

Access

In terms of the concept of privacy, no statistically significant difference was found
between gender of respondents. The age of the respondent is statistically significant
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in 62.5% of the constructs used to investigate the privacy concept. Highest level of
education was significant in 50% of the anxiety constructs; however, level of
education did not have significance in terms of limited access. Healthcare workers
versus non healthcare workers emerged as significant in two statements and all of the
statistically significant results are presented in more detail and discussed in the next
sections.
4.2.3.1 Anxiety
Ch-Square tests on respondent age for Statement 5 – If an unauthorised person
gained access to my medical information then I would feel that my privacy had been
violated, resulted in statistically significant differences between various age groups
with p value 0.051, however 7 cells had expected count less than 5 indicating a poor
situation for testing with Chi-Square, hence results are not reported here.
Chi-Square tests on Statement 6 – I am concerned that my medical information may
be stolen revealed citizens’ opinions differed by age (df=10, p<0.001).
Citizens (<51years) tended to be less concerned about stolen medical information
than expected and older citizens were more concerned as illustrated in Table 22.
Table 22: Statement 6 Pearsons Chi-Square statistically significant - Age
AGE
18-25
26-39
40-50
51-65
66-80
Over 80
TOTAL

Frequency
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count

Disagree

Neutral

14
8.1
53
36.8
74
65.2
87
103.5
41
52.4
8
11.1
277

9
12.4
63
56.7
106
100.5
167
159.5
72
80.7
10
17.1
427

Agree
9
11.5
30
52.6
79
93.2
157
148.0
95
74.9
26
15.8
396

TOTAL
32
146
259
411
208
44
1100

Statistically significant results also resulted from Pearson’s Chi-Square test of
education level with Statement 6 (df=12, p<.001). As Table 23 illustrates,
tertiary educated citizens tended to be less concerned with theft of medical
information.
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Table 23: Statement 6 Pearsons Chi-Square statistically significant – Highest Level of Education
Highest
Frequency
Disagree
Neutral
Agree
Total
Education
<Yr10
7
Yr12
Trade
Prof
Bachelor
PostGrad
TOTAL

Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count

7
15.0
22
29.1
24
27.6
16
21.8
58
66.9
73
59.8
78
57.8
278

23
22.8
40
44.3
46
42.0
36
33.2
104
101.8
96
91.0
78
87.9
423

29
21.3
53
41.5
39
39.3
34
31.0
102
95.3
67
85.2
72
82.3
396

59
115
109
86
264
236
228
1097

Chi-Square tests on Statement 8 – I worry about medical receptionists reading my
medical information revealed citizens opinion differing by age (df=10,
p=0.002) and highest education level (df=12, p<0.001). Citizens aged
between 18 and 50 disagreed with Statement 8 more frequently than expected and
citizens older than 50 agreed with the statement more frequently than expected (see
Table 24).

Age
18-25
26-39
40-50
51-65
66-80
Over 80
TOTAL

Table 24: Statement 8 Pearsons Chi-Square statistically significant - Age
Frequency
Disagree
Neutral
Agree
Total
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count

17
9.2
52
42.1
88
73.3
108
120.3
44
60.4
9
12.6
318

9
13.1
56
60.1
91
104.7
183
171.8
95
86.3
20
18.0
454

6
9.7
39
44.8
77
78.0
129
127.9
72
64.3
15
13.4
338

32
147
256
420
211
44
1110

Highest Education Level emerged as a statistically significant demographic. As
illustrated in Table 25 tertiary educated Australians responded ‘disagree’ or ‘strongly
disagree’ far more frequently than expected and all other groups responded more
frequently than expected to ‘strongly agree’ or ‘agree’.
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Table 25: Statement 8 Pearsons Chi-Square statistically significant – Highest Level of Education
Highest
Frequency
Disagree
Neutral
Agree
Total
Education
<Yr10
7
Yr12
Trade
Prof
Bachelor
PostGrad
TOTAL

Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count

9
16.8
27
33.7
33
31.1
19
24.8
61
75.6
81
67.4
86
66.5
316

32
24.0
44
48.1
47
44.4
32
35.4
111
108.0
97
96.1
88
94.9
451

18
18.1
47
36.2
29
33.5
36
26.7
93
81.4
58
72.5
59
71.6
340

59
118
109
87
265
236
233
1107

The Chi-Square testing on Statement 9 – I worry about computer staff being able to
read my medical information when they are looking after medical systems, revealed
citizens’ opinion differing by age (df=10, p=0.008) and highest level of
education (df=12, p<0.001). The 18-50 years age group disagreed with this
statement more frequently than expected and the respondents over 50 years of age
‘strongly agree’/ ‘agree’ in larger numbers than expected. The number of ‘neutral’
responses from those over 50 years of age also exceeded expectations.
Postgraduate and Bachelor level educated citizens responded negatively to this
statement more frequently than expected. Trades and Professionally qualified
citizens ‘strongly agree’/ ‘’agree’ with the statement more frequently than expected
and there is no discernable trend amongst respondents with Year 12 or less
education.
Statement 25 - I would never agree to donate my medical information to anyone
because I worry about potential misuse of the information. Chi-Square testing
revealed one of the strongest results of the survey across education levels
(df=12, p<0.001). Table 26 illustrates. Age was also important with strong
results (df=10, p<0.001).
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Table 26: Statement 25 Pearsons Chi-Square statistically significant – Highest Level of Education
Highest
Frequency
Disagree
Neutral
Agree
Total
Education
<Yr10
Yr10
Yr12
Trade
Prof
Bachelor
PostGrad
TOTAL

Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count

25
33.7
49
66.8
56
63.2
37
51.7
163
157.6
159
140.8
162
137.2
651

15
13.8
41
27.4
34
25.9
26
21.2
59
64.7
55
57.7
37
56.3
267

16
8.5
21
16.8
15
15.9
23
13.0
40
39.7
20
35.5
29
34.6
164

56
111
105
86
262
234
228
1082

Postgraduate educated respondents exceeded expected counts with ‘strongly
disagree’/ ‘disagree’ responses. Their ‘neutral’ responses are well below expected
counts indicating little equivocation in relation to this statement by postgraduates.
Those with Bachelor level education are following a similar, though less extreme,
pattern of responses. High School and Trades qualified citizens are more ‘neutral’ to
positive in their responses. Professionally qualified citizens hold space between the
high school and tertiary citizens.
Age is, once again statistically significant with responses to this statement with
citizens older than 66 years responding positively to the statement more frequently
than expected and those younger than 66 years not meeting expected counts for
‘strongly agree’/ ‘agree’.
The Chi-Square test results for Statement 27 – I worry about insurance companies
getting access to medical information because they may not use information in a way
that benefits society, revealed statistically significant results for self-reported
healthcare workers (df=2, p=0.032), as presented in Table 27.

156

Table 27: Statement 27 Pearson’s Chi-Square - Statistically Significant - healthcare worker.
Healthcare
Frequency
Disagree
Neutral
Agree
Total
worker
No
Yes
TOTAL

Count
Expected Count
Count
Expected Count
Count

65
64.8
20
20.2
85

184
169.3
38
52.7
222

593
607.9
204
189.1
797

842
262
1104

Self reported healthcare workers ‘strongly agree’/ ‘agree’ with the statement more
frequently than expected and non healthcare workers are more ‘neutral’ in their
response than expected.

4.2.3.2 Restricted Access
Chi-Square tests on Statement 10 – In Australia my healthcare providers try to
protect my privacy by restricting access to my medical information, revealed
citizens’ opinion’s differing by age (df=10, p=0.029). Citizens aged less
than 66 years did not ‘strongly agree’/ ‘agree’ at expected frequencies and their
‘neutral’ frequency exceeded expected frequency. Positive responses from citizens
aged 66 years and older exceeded expected frequencies.
Chi-Square tests on Statement 11 – It seems that my healthcare providers feel that
the fewer people who see my medical information the higher the level of privacy they
provide for me, revealed citizens’ opinion’s differing between those who self
reported as healthcare workers and others (df=2, p=0.012). Healthcare
workers responses were polarised with greater than expected frequency on both
’agree’ and ‘disagree’ and less than expected on the central ‘neutral’ response as
presented in Table 28.
Table 28: Statement 11 Pearsons Chi-Square statistically significant – Healthcare Worker
Healthcare
Frequency
Disagree
Neutral
Agree
Total
worker
No
Yes
TOTAL

Count
Expected Count
Count
Expected Count
Count

34
35.8
14
12.2
48

229
211.1
54
71.9
283

157

395
414.1
157
140.9
555

661
225
886

Non-healthcare workers provided ‘neutral’ responses more frequently than expected
‘strongly agree’/’agree’ responses less frequently than expected.

4.2.4

Tripartite Component: Privacy Concept – Qualitative Analysis

Table 29 presents the qualitative codes adopted and the frequency with which a
theme was included in respondents comments to the two qualitative survey questions
for deductive themes related to the tripartite Privacy Concept as described in the
Research Method Chapter.

Code
1

Privacy
Concept

Table 29: Privacy Concept Deductive Encoding Summary
Sub Theme
Comment 1
Comment 2
Code
Frequency
Frequency
A
Expressing anxiety
83
31
B

Total
114
31

Not anxious about secondary
use of data
Consumer TRUST - Don’t know
who has information – Lack of
transparency
Not everyone who has access
has patients’ best interests at
heart
Surveillance

16

15

25

8

66

13

7

1

8

Total number of consumer comments regarding privacy concept

197

68

265

C
D
E

33
79

Examples of the qualitative comments and demographics of the respondents are
presented in Table 30 arranged under the deductive themes.
Table 30: Tripartite – Privacy Concept deductive themes
Theme
1A – Expressing anxiety
... I am very worried about the potential for misuse and privacy breaches...
[Survey595,F,NSW,18-25,Bach,NHW]

... companies or organisations may gain access with intentions that are not
consistent with human rights and misuse data according to more profit making
mandates. [Survey725,M,NSW18-25,Yr12,HW]
Who uses it and why. Privacy. I would worry about me losing control of my info.
[Survey187,F,NT,26-39,Yr10,NHW]

I was in a situation where I personally knew a medical clerk working at my
doctors surgery. I also knew she was a heroin addict. Her accessing my medical
records was a concern for me... [Survey476,F,VIC,26-39,Postgrad,NHW]
Yes ... even if companies are ethical, not all employees would be.
[Survey602,F,NSW,51-65,Postgrad,NHW]
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Would be exceedingly concerned about release of data that included things like
name, address, date of birth, medicare no. etc that might be potentially used for
identity theft [Survey377,M,NSW,51-65,Bach,HW]
General concerns regarding who has access to the information, purposes and
possible negative impact on the patient eg. discrimination. [Survey561,F,NSW,5165,Trade,NHW]

1B – Not anxious about secondary use of data
Provided it has no detrimental impact on the individual, I don’t have any
objections.[Survey476,F,VIC,26-39,Postgrad,NHW]
I am not overly concerned regarding my personal records but understand the
concerns of others where sensitive information is contained...I would be only to
happy to support data donation... [Survey448,F,VIC,40-50,Bach,HW]
No. I feel confident that my doctor will respect my privacy and that records are
kept confidential. [Survey249,F,NSW,40-50,Postgrad,NHW]
1C - Consumer TRUST - Don’t know who has information – Lack of transparency
Yes if it is anything like the phone numbers given out by Telstra there’s no way of
knowing who will get your information, their purpose and their redistribution and
to whom. [Survey488,F,VIC,40-50,Prof,HW]
... I must admit I don’t even know who has access to my information from my
medical visits. [Survey94,F,NSW,26-39,Bach,NHW]
... in theory it sounds a good idea but once information is given out anything can
happen to it... [Survey718,M,NSW,66-80,Prof,NHW]
I do not trust my insurance company having access to medical records, but I trust
Doctors, nurses, healthcare staff and workers. [Survey190,M,NSW,51-65,Prof,NHW]
Trusting a system is important... [Survey700,F,NSr10,NHW]
1D - Not everyone who has access has patients’ best interests at heart
...Unscrupulous employers may seek to misuse private medical information...
[Survey539,M,NSW,66-80,Postgrad,NHW]

Concern re: recent offer of DNA testing and its possible effect on health
insurance premium charges and employment opportunities. [Survey191,F,NSW,6680,Postgrad,NHW]

I wouldn’t like my data to get into the hands of those outside the medical
profession. [Survey358,F,Unknown,>80,Yr10,NHW]
No only that the information is collected respectfully and only distributed to
appropriate companies that will use the information in a way that does not just
benefit themselves. [Survey239,F,NSW,18-25,HSC,Unknown]
If it gets into the hands of the wrong people. [Survey459,F,VIC,26-39,Postgrad,NHW]
Unscrupulous healthcare workers/companies eg. pharmaceutical are only in the
minority ... [Survey79,M,NSW,51-65,Prof,NHW]
1E – Surveillance
As long as Iam consulted, Iam prepared to release most of my data/records to
most researchers-companies to assist them and even for ‘status quo’ figures but
definitely not for ‘snooping’ or spying by anyone. [Survey318,M,NSW,66-80,Prof,NHW]

4.2.5

Tripartite Component: Privacy Justification – Quantitative Analysis

There are six survey statements (1,3,4,12,26,28) pertaining to the tripartite
‘justification’. Statistically significant differences were found regarding gender, age,
and highest education level. Table 31 presents a summary of statistically significant
results.
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Table 31: Tripartite Privacy Justification Statistically Significant Results
Highest Education
Construct
Gender
Age
Healthcare Worker
Level
Statement 1

Rights Based

X

Statement 3

Rights Based

X

Statement 4

Rights Based

Statement 12

Balance

Statement 26

Balance

Statement 28

Balance

X

X

X

X

Gender, age and education level are statistically significant for the rights based
construct and gender, age and education level for the statements on using data for
‘common good’. Each of these is discussed in more detail below.
4.2.5.1 ‘Rights’ based
Chi-Square tests on Statement 1 – I believe that I have a ‘right’ to personal privacy,
revealed citizens opinion differing by gender (df=2, p=0.012). Females
responded positively more frequently than expected and males were more ‘neutral’ in
their responses than expected.
Statement 3 – I have the ‘right’ to share my medical information with others, also
found gender and age to be statistically significant through Pearson Chi-Square
testing with results for gender of (df=2, p=0.019) and age of
(df=2, p<0.001).
Males were less supportive than expected of this statement and females were more
supportive than expected. In terms of age, the older citizens (>66 years) were
agreeing at lower rates than expected and those aged 26-50 were again expressing
stronger support than expected. Citizens aged 66-80 disagreed with the statement at
more than 2.5 times the expected frequency.
The Chi-Square test results for Statement 12 - If information about my health can be
used to help others who are suffering ill-health then I believe my information should
be used to help those people, revealed statistically significant results across age
(df=10, p=0.005) and highest education level (df=12, p=0.031).
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Respondents older than 66 years responded more positively than expected and the
majority of younger consumers (aged 26-65 years) did not meet the expected number
of ‘agree’ responses , as illustrated in Table 32.

Age

Table 32: Statement 12 Pearsons Chi-Square Statistically Significant - Age
Frequency
Disagree
Neutral
Agree
Total

18-25
26-39
40-50
51-65
66-80
Over 80
TOTAL

Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count

0
2.9
12
13.2
25
22.5
46
37.0
12
18.6
3
3.9
98

6
4.4
25
20.3
43
34.7
60
57.0
14
28.6
3
5.9
151

26
24.7
110
113.5
183
193.8
306
318.1
181
159.8
37
33.2
843

32
147
251
412
207
43
1092

Tertiary educated respondents did not meet ‘strongly agree’/’agree’ expected counts
for Statement 12 with counts exceeded for both ‘neutral’ and negative responses as
presented in Table 33.
Table 33: Statement 12 Pearson Chi-Square Statistically Significant – Education Level
Highest
Frequency
Disagree
Neutral
Agree
Total
Education
<Yr10
Yr10
Yr12
Trade
Prof
Bachelor
PostGrad
TOTAL

Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count

3
5.1
11
10.5
5
9.7
5
7.8
25
23.5
25
20.9
24
20.4
98

3
7.9
21
16.1
10
14.9
12
12.0
26
36.0
40
32.0
38
31.2
150

51
44.0
85
90.3
93
83.4
70
67.2
210
201.5
167
179.1
164
174.5
840

57
117
108
87
261
232
226
1088

Respondents with less than Year 10 education level responded in higher frequency
than expected. It is possible that the older (>66 years), less formally educated
respondents are influencing these results. As the demographics presented in Figure
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33 below illustrate, many older respondents have less than 10 years of formal
education.

Figure 33: Respondents age group by Education Level

Statement 28 - Using medical information for the ‘common good’ is OK but I worry
about the risk to a person’s privacy. Chi-Square tests indicate statistically significant
results across gender (df=2, p=0.035). Women chose ‘strongly agree’/
‘agree’ as their response more frequently than expected while men responded with
‘disagree’ or ‘neutral’ more frequently than expected as illustrated in Table 34.
Table 34:Statement 28 Pearsons Chi-Square Statistically Significant - Gender
Gender
Frequency
Disagree
Neutral
Agree
Total
Female
Male
TOTAL

Count
Expected Count
Count
Expected Count
Count

55
64.4
41
31.6
96

162
169.1
90
82.9
252

523
506.5
232
248.5
755

740
363
1103

The next section presents consumers qualitative comments regarding the two Privacy
Justification issues explored through the survey – that is the ‘right’ to privacy and
balancing the needs of society in terms of secondary use of medical data.

4.2.6 Tripartite Component: Privacy Justification – Qualitative Analysis
Table 35 presents the summary of qualitative analysis.
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Code
2

Justification

Sub
Code
A
B

C
D

Table 35: Justification Qualitative Summary
Theme
Comment 1
Frequency
‘Right’ to privacy
8
Responsibility of citizens to
participate in secondary use.
Individual rights versus ‘common
good’
Personal data as a commercial
commodity; Commercial aspects
of data use
Ownership of data

Total number of consumer comments regarding privacy justification

Comment 2
Frequency
6

Total

43

26

69

48

16

64

29

33

62

128

81

209

14

Examples of the qualitative comments and demographics of the respondents are
presented in Table 36 arranged under the deductive themes.
Table 36: Tripartite model – Justification of Privacy - Deductive themes
Theme
2A – ‘Right’ to Privacy
So called privacy in Australia is over the top. Information should be available to
improve society in this case health. [Survey36,M,NSW,66-80,Yr10,NHW]
... seeing a GP does not mean that I have handed over my right to privacy or my
choice to disclose or not! [Survey405,F,SA,51-65,Postgrad,HW]
2B – Responsibility of citizens to participate in secondary use. Individual rights versus
‘common good’

With appropriate protocols and audit trails in place, I believe de-personalised
medical data can be used for worthwhile research purposes. [Survey1152,F,VIC,5165,Postgrad,HW]

I understand the use of medical data is of utmost importance for research and
progress, but always have that fear of not being able to trust the powers that be.
But risks aside how will there ever be progress in research?... [Survey617,F,NSW,6680,HSC,NHW]

As tax payers we all contribute to everyone’s healthcare – medicare, subsidies
(pensioners, unemployed etc), research, hospitals – as such, all info that can be
collected and used anonymously to improve treatments, diagnosis etc should be
available to all in the medical/research fields... [Survey493,F,NSW,66-80,Bach,NHW]
... As a former federal bureaucrat (including in health department) I know
accidents can happen that result in breach of patient privacy – but I think the
“public good” resulting from medical research has to be seen as important enough
to outweigh the risk of privacy breach. [Survey988,F,ACT,51-65,Postgrad,NHW]
2C - Personal data as a commercial commodity - Commercial aspects of data use
Yes,

intermediaries

gather

data

and

aggregate

and

sell

this

data.

[Survey375,M,NSW,51-65,Postgrad,NHW]

My greatest concern is insurance companies accessing information that will then
‘allow’ them to refuse certain people or increased premiums to an unreasonable
level. [Survey423,F,ACT,51-65,Bach,NHW]
Yes. I am concerned particularly about insurance companies and also the
extrapolation of that data towards my offspring. [Survey780,F,NT,51-65,Postgrad,HW]
... Medical data used as a tool for research by non-profit organisations is fine. I
don’t want to be giving big pharmaceutical companies the ability to make bigger
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profits ... [Survey604,F,NSW,40-50,Bach,NHW]
... Drug companies want this information as do research organisations. Healthcare
providers may see this as an opportunity to compile and sell their data on their
health files. Regulation of this activity is probably required at Federal Govt level.
[Survey1039,F,NSW,51-65,Bach,NHW]

Concerns over theft of data for use for commercial purposes as was experienced
last year in India with British medical records Also concerned that employers and
others will discriminate if they have access to this info. [Survey489,F,ACT,40-50,Prof,NHW]
I do have concerns that health practitioners may ‘sell’ aggregated data from
patients of their practice [Survey1153,F,VIC,40-50,Prof,NHW]
Life insurance companies and genetic testing – both sides of this argument have
merit and I’m not clear on how to resolve it. [Survey539,M,NSW,66-80,Postgrad,NHW]
2D – Ownership of Data
... I think that both Doctor and myself should ‘own’ the information.
[Survey969,F,NSW,26-39,Postgrad,NHW]

The notes made by the doctor are for the doctors records, but the patient should
be able to access copies if requested. Why should the patient be denied notes
about their own health? [Survey262,M,SA,66-80,Prof,NHW]
It’s a disgrace that a doctor own ‘notes’ they write up on a person. [Survey4,F,NSW,2639,Prof,NHW]

... I would like to think that a wide range of medical data can be collected for the
benefit of all ie. medical research – they should not be the property of GPs.
[Survey23,F,NSW,51-65,Prof,HW]

Re Q30 my opinion is that records should be ‘jointly owned’ by the Dr and patient
– after all the patient “pays” for the service – whether thru bulk bill or ‘cash’ doesn’t
matter! [Survey91,F,NSW,40-50,HSC,NHW]
...As a school teacher, I make notes/observations and record results constantly
about my pupils. They are NOT for publication in anyway and I never show them
to parents. However there is a constant system of reporting to parents using
bonafide channels of communication, including written reports and face-to-face
interviews. In the same way, I would expect that my Doctor makes notes to himself
regarding my treatment. They are HIS alone ... again not for publication in any
way. [Survey116,F,NSW,51-65,Bach,NHW]
...“Ownership” and health records is debatable issue and as a healthcare provider
myself it is a dilemma as to who ‘owns’ the records – this is partly due to
differences in interpreting the purpose of the records. [Survey24,F,NSW,51-65,Postgrad,HW]

4.2.7

Tripartite Component: Privacy Management – Quantitative Analysis

There are sixteen survey statements (2,7,13,14,15,16,17,18,19,20,21,22,23,24,29,30)
pertaining to the tripartite ‘privacy management’ component. Statistically significant
differences were found regarding gender, age, highest education level and healthcare
workers and further details are provided in this section.
Table 37: Privacy Management statistically significant results.
Highest Education
Construct
Gender
Age
Healthcare Worker
Level
Statement 2

Data Stewardship

Statement 7

Data Stewardship

Statement 18

Data Stewardship

Statement 24

Data Stewardship

X

X
X

X
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Statement 30

Data Stewardship

X

Statement 13

Control

Statement 14

Control

Statement 15

Control

Statement 16

Control

X

Statement 17

Control

X

Statement 19

Control

X

Statement 20

Control

Statement 21

Control

X

Statement 22

Control

X

Statement 23

Control

X

Statement 29

Control

X

X
X
X
X

X

X

X

X

X

4.2.7.1 Data Stewardship
Chi-Square test results for Statement 2 – I think my medical records belong to me –
they don’t just belong to my healthcare providers, indicate significant difference for
gender (df=2, p=0.054 ) and healthcare workers (df=2, p=0.004).
Females agreed or strongly agreed in higher frequencies than expected which
contrasts with males who responded positively less frequently than expected. Males
disagreed with the statement more frequently than expected.
Healthcare workers disagreed with Statement 2 at almost twice the expected
frequency and did not meet expected frequency in supporting the statement. In
contrast, non-medical workers exceeded expected frequency in ‘agree’ and ‘strongly
agree’ responses (see Table 38).
Table 38: Statement 2 statistically significant – Healthcare worker
Healthcare
worker
No
Yes
TOTAL

Frequency
Count
Expected Count
Count
Expected Count
Count

Disagree

Neutral

24
33.0
19
10.0
43

62
63.6
21
19.4
83

Agree
773
762.4
222
232.6
995

Total
859
262
1121

The only statistically significant difference between citizens responses to Statement 7
– When my medical information is stored on a computer owned by a healthcare
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provider they should not assume that they ‘own’ the information, emerged for
healthcare workers and non-healthcare workers (df=2, p<0.001). Self
reported healthcare workers responded ‘strongly disagree’/ ‘disagree’ more than
twice as often as expected and the frequency of their positive response was less than
expected. In contrast non-healthcare workers responded ‘strongly agree’/ ‘agree’
more frequently than expected as illustrated in Table 39.
Table 39: Statement 7 statistically significant – Healthcare Worker
Healthcare
worker
No
Yes
TOTAL

Frequency
Count
Expected Count
Count
Expected Count
Count

Disagree

Neutral

12
20.7
15
6.3
27

34
38.3
16
11.7
50

Agree

Total

806
793.0
229
242.0
1035

852
260
1112

Chi-Square test results for Statement 30 – A legal judge in Australia decided that the
notes written about a patient, by a Doctor, are owned by the Doctor not the patient.
This decision seems reasonable to me, indicate significant difference for age
(df=10, p<0.001) and healthcare worker status (df=2,
p=0.009). Citizens younger than 25 years and citizens older than 66 years ‘strongly
agree’/ ‘agree’ response frequency exceeded the expected counts (see Table 40).
Healthcare workers responses were more polarised than expected with the ‘neutral’
response frequency lower than expected. Healthcare workers’ positive response was
more frequent than expected and their negative response frequency was less than
expected.

Age
18-25
26-39
40-50
51-65
66-80
Over 80
TOTAL

Table 40: Statement 30 Pearson Chi-Square statistically significant - Age
Frequency
Disagree
Neutral
Agree
Total
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count

18
20.9
100
100.4
182
169.1
293
278.9
123
138.8
21
29.0
737

4
3.5
26
16.8
33
28.2
36
46.5
18
23.2
6
4.8
123
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9
6.6
23
31.9
36
53.7
85
88.6
65
44.1
16
9.2
234

31
149
251
414
206
43
1094

4.2.7.2 Control
Pearson Chi-Square testing on Statements 13, 14 and 15 did not yield statistically
significant differences. Chi-Square test results for Statement 16 – If I donated my
medical information for research I would want to choose the level of privacy I
required. For example I may choose (1) ‘always anonymous’ or (2) ‘name and
Medicare number can always be used’ indicate significant difference for gender
(df=2, p<0.001) and age (df=10, p<0.001). The frequency of
females responding ‘strongly agree’/’agree’ exceeded expected frequency and, in
contrast, frequency of males responding positively was less than expected. Citizens
younger than 66 years responded ‘strongly agree’/’agree’ more frequently than
expected. In contrast, citizens 66 years and older responded positively less frequently
than expected as presented in Table 41.

Age
18-25
26-39
40-50
51-65
66-80
Over 80
TOTAL

Table 41: Statement 16 Pearson Chi-Square statistically significant - Age
Frequency
Disagree
Neutral
Agree
Total
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count

0
1.2
4
5.7
0
10.2
15
16.3
19
8.0
5
1.5
43

2
1.5
3
6.9
8
12.3
12
19.7
21
9.7
6
1.9
52

29
28.3
139
133.3
251
236.5
388
378.9
163
185.4
28
35.6
998

31
146
259
415
203
39
1093

Statement 17 – If I give consent for my health information to be used for research I
want to be able to say who can use my information like ‘medical researchers’, ‘drug
companies’, ‘university researchers’ or ‘insurance companies’. Pearsons Chi-Square
testing resulted in statistically significant differences by gender (df=2,
p=0.005) and healthcare worker (df=2, p=0.011). In terms of positive
response of ‘strongly agree’/ ‘agree’, females responded more frequently than
expected and males less frequently than expected. Interestingly, self reported
healthcare workers responded ‘strongly agree’/ ‘agree’ more frequently than
expected and non-medical workers responded positively less frequently than
expected. Table 42 presents these results and it is clear that medical workers are less
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frequently ‘neutral’ or negative regarding this statement whereas non-medical
workers responded more frequently to ‘neutral’ or ‘strongly disagree’/’disagree’ than
expected.
Table 42: Statement 17 Pearsons Chi-Square statistically significant – Healthcare Worker
Healthcare
Frequency
Disagree
Neutral
Agree
Total
worker
No
Yes
TOTAL

Count
Expected Count
Count
Expected Count
Count

47
42.1
8
12.9
55

96
85.7
16
23.3
112

707
722.2
237
221.8
944

850
261
1111

Chi-Square test results for Statement 19 – A person must be able to choose to keep
their medical information private and never consent to release their medical
information for any purpose, yielded statistically significant results for gender
(df=2, p=0.001) and highest education level (df=12,
p=0.006). Males responded negatively to this statement more frequently than
expected. Females responded negatively to this statement less frequently than
expected. ‘Neutral’ responses from both genders were as expected. Tertiary educated
citizens (Bachelor or Post Graduate) and citizens with less than 10 years of education
did not respond positively at the expected frequency.
Chi-Square test results for Statement 20 – If I donated my medical information for
research I would like to give my consent once – at the time of ‘signing up’ as a data
donor, yielded statistically significant results for age (df=10, p=0.001),
highest education level (df=12, p=0.004) and healthcare worker
(df=2, p=0.047). Citizens aged 40-65 years responded ‘strongly
disagree’/’disagree’ more frequently than expected. Citizens with professional and
tertiary education expressed negative responses to this statement more frequently
than expected. Healthcare workers responded ‘strongly disagree’/’disagree’ more
frequently than expected.
Chi-Square test results for Statement 21 – If people agree to donate their data for
medical research there must be a way for them to stop the donation agreement at any
time, yielded statistically significant results for gender (df=2, p=0.022). In
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terms of positive responses of ‘strongly agree’/’agree’, females frequency exceeded
expectations and male frequency of response was less than expected.
Chi-Square test results for Statement 22 – If people agree to donate their data for
medical research from time to time they must be asked if they want to continue to
donate,

yielded statistically significant results for gender (df=2,

p<0.001), education level (df=12, p=0.019) and healthcare worker
(df=2, p=0.037). In terms of positive responses of ‘strongly agree’/’agree’
female frequency exceeded expectations and male frequency of response was less
than expected. Citizens without tertiary education responded ‘strongly agree’/’agree’
greater than or equal to the expected level. Citizens holding tertiary education
qualifications did not respond ‘strongly agree’/’agree’ at expected frequency and
their level of negative response exceeded the expected values (see Table 43).
Healthcare workers responded ‘strongly disagree’/’disagree’ more frequently than
expected.

Age
18-25
26-39
40-50
51-65
66-80
Over 80
TOTAL

Table 43: Statement 22 Pearsons Chi-Square statistically significant - Age
Frequency
Disagree
Neutral
Agree
Total
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count
Expected Count
Count

4
5.0
5
10.4
9
9.7
5
7.6
23
23.4
29
20.6
97

8
7.0
8
14.3
16
13.5
5
10.5
26
32.3
32
28.4
134

45
45.0
104
92.3
85
86.8
76
67.9
215
208.3
171
183.1
864

57
117
110
86
264
232
1095

Chi-Square testing on Statement 23 – If I choose to donate my medical information
then healthcare providers should release the information according to my
instructions, revealed that respondents gender was significant (df=2,
p=0.037). In terms of positive responses of ‘strongly agree’/ ‘agree’, female
frequency exceeded expectations and male frequency of response was less than
expected.
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Chi-Square testing on Statement 29 – I should be able to see my medical information
and it should be easy to correct any mistakes in the information, revealed that
healthcare worker was significant (df=2, p=0.024). Healthcare workers did
not reflect a positive response. They had lower than expected ‘strongly agree’/’agree’
response frequencies and higher ‘neutral’ and negative responses.

4.2.8

Tripartite Component: Privacy Management – Qualitative Analysis

The qualitative analysis for Privacy Management are presented in Table 44.

Code
3

Management

Table 44: Management Qualitative Summary
Sub Theme
Comment 1
Code
Frequency
31
A
Good data stewardship required
and consumers need confidence
in arrangements underpinning
secondary use
10
B
Consumers as research partners
not research subjects
C
Consumer control of data issues
57
11
D
Restricted access to consumer
data issues
53
E
De-identification of data

Comment 2
Frequency
14

Total

1

11

21
17

78
28

13

66

45

F

Consent

49

12

61

G

Payment for use of data

6

1

7

H

Legal
system
to
protect
consumers
Consumers to provide input on
data stewardship – including
being able to decline to participate
Role of Government

12

8

20

23

7

30

19

6

25

Secondary use mechanisms:
Human
Research
Ethics
Committees; computer technology
L
Comments in support of
secondary use
M
Comments about sensitivity of
different types of information eg.
Sexual health, mental health
N
Comments about the purpose of
data use e.g. OK for research but
not OK for commercial secondary
use
Total number of consumer comments regarding privacy management

8

2

10

78

26

104

18

15

33

89

19

108

464

162

626

I
J
K

Examples of the qualitative comments and demographics of the respondents are
presented in Table 45 arranged under the deductive themes.
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Table 45: Tripartite – Management of Privacy – deductive themes
Theme
3A – Good data stewardship required and consumers need confidence in
arrangements underpinning secondary use
3B -Consumers as research partners not research subjects
I was once approached to participate in medical research. I did want to participate
but eventually declined when the personal data was going to be passed on to
organisations other than the research team. [Survey399,F,NSW,51-65,Postgrad,NHW]
3C - Consumer control of data issues
... I do believe it is a personal matter and the person (patient) involved should
have the right to offer their information if they see fit. [Survey644,F,NSW,51-65,Bach,HW]
I would not want anyone to have access to my medical information without my
permission. [Survey230,M,NSW,66-80,Prof,NHW]
... It would have to be my personal okay about what I want to share How I would
want to share it. Who would share it. And how long it was shared...
[Survey189,F,unknown,66-80,Prof,NHW]

3D - Restricted access to consumer data issues
I think once we agree to share our details we cannot expect to put limitations or
restrictions on its use – we co-operate or we don’t!! [Survey885,M,NSW,66-80,HSC,NHW]
... How do I restrict use of my medical data that is held by a specialist that I may
never need to see again? [Survey559,M,NSW,51-65,Postgrad,NHW]
3E - De-identification of data
Medical data should be deidentified for research purposes. I am concerned that
healthcare providers travel to and from communities with med data on laptops
(NT remote Aboriginal communities) [Survey703,F,NT,40-50,Postgrad,HW]
As the amount of data collected gets more specific, anonymising records is
unlikely to remain a sufficient condition to keep people from being identified...
[Survey473,M,VIC,51-65,Bach,NHW]

Names and addresses should be withheld if used for research – non debatable.
[Survey181,F,NSW,51-65,Prof,HW]

... Any research requiring personal details is corrupt and should not be supported.
Don’t treat the public with contempt – leave personal details out of research.
[Survey570,M,NSW,66-80,Prof,NHW]

3F - Consent
... if consent given must not lose sight medical records are about an actual
person and not just details on a piece of paper. [Survey562,F,NSW,40-50,Trade,NHW]
... I am happy to allow medical researchers access to my records on a case by
case basis. [Survey582,M,NSW,40-50,Bach,NHW]
3G - Payment for use of data
All insurance or drug companies are primarily responsible to their shareholders
and NOT the general public and therefore should not be given/sold a person’s
private medical records without that persons explicit permission.
[Survey385,M,NSW,40-50,Prof,NHW]

If money is involved then I would not agree to my records being “bought” by
companies or organisations either... [Survey437,M,NSW,51-65,Postgrad,NHW]
3H - Legal system to protect consumers
Working in medical records informs my view ... the issue of patient records
intellectual property needs to be challenged in the courts. [Survey183,F,NSW,5165,Prof,HW]

In general I find the pedantic use of privacy laws relating to dealing with private
companies and government departments is often ridiculous, irrelevant and
frustrating, making simple inquiries about trivial matters long winded and monty
pythonish! [Survey326,M,NSW,51-65,Trade,NHW]
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Do not want lay people ie. the State, making decisions regarding my records –
not even the justice system who are not qualified to determine the issue.
[Survey189,F,unknown,66-80,Prof,NHW]

3I - Consumers to provide input on data stewardship – including being able to
decline to participate
Should never be made available without prior discussion and approval.
[Survey1019,F,NSW,51-65,Prof,NHW]

No. I would have no issue sharing me medical data as long as it was used
correctly to benefit society, it was anonymous and I gave permission.
[Survey491,F,NSW,26-39,Prof,NHW]

3J - Role of Government
I would worry about what government officials may do with the medical data –
could the data be used against people in an individual sense. [Survey250,F,NSW,5165,Bach,NHW]

3K - Secondary use mechanisms: Human Research Ethics Committees; computer
technology
... It raises other questions – what about information about children, the elderly,
mentally ill? We need to know their privacy is protected. Who speaks for them?
[Survey,F,NSW,40-50,Postgrad,HW]

3L - Comments in support of secondary use
I think the idea of donating medical information is a great idea – it gives people
who may not want to donate a part of themselves to research the opportunity to
still give something to medicine. ... hopefully in the near future I’ll be signing up
for a medical information donation plan! [Survey239,F,NSW,18-25,HSC,unknown]
3M - Comments about sensitivity of different types of information eg. Sexual health,
mental health
... I feel I should (and others should) have the right to keep their medical
information private unless (i) it is used statistically (but anonymously) (ii) there is
a condition present that could negatively affect other eg. AIDS, genetic problem.
Through my desire for privacy I should not be allowed to give negative
consequences to others. [51-65, reuse concern]
... some misgivings regarding mental health issues getting (scary) info into the
wrong hands. Information travels so quickly and is so potable with digital
systems... [Survey189,F,unknown,66-80,Prof,NHW]
Privacy is essential for sensitive information but for lower level info there is a lot
of red tape and admin to maintain privacy which hinders getting the job done.
[Survey29,F,NSW,51-65,Postgrad,HW]

3N - Comments about the purpose of data use eg. OK for research but not OK for
commercial secondary use
I would be happy for information to be used for research that would help the
community. I would not feel comfortable on this information being used by
commercial entities such as drug companies where the results built corporate
profits rather than social, health etc outcomes. [Survey825,F,SA,40-50,Postgrad,NHW]
Don’t like the idea of insurance/drug/advertising companies getting it, but I have
no problem with it being used for legitimate medical purposes. [Survey467,M,VIC,4050,Bach,NHW]

Yes – once information is available for re-use it will be virtually impossible to stop
access by insurance companies + commercial medical researchers/drug
companies and others. Having said that, I support the THEORY that information
should be available, with permission, for not for profit medical research to assist
with identifying treatment and cures. [Survey667,F,NSW,40-50,Postgrad,NHW]
It all depends on the use of the data and who has collected the data.

172

[Survey99,F,NSW,66-80,Yr10,NHW]

A prime concern would be the release of medical info to companies possibly
related to the research bodies but not actively involved in research.
[Survey6,M,NSW,51-65,Bach,NHW]

Not if it is to be used for research; the only problem I have is if it is to be used by
insurance companies against people. [Survey1013,F,NSW,51-65,Bach,HW]
I am much more interested in medical research and university research in the
area of medicine. I am not interested in research for insurance companies etc
[Survey101,M,NSW,66-80,Bach,NHW]

4.3

Emergent Qualitative Themes

A deductive approach was taken to the encoding of qualitative comments with
existing literature providing the areas of focus. Issues arose through the survey
qualitative material that were not anticipated through the deductive process. These
are listed here as themes that emerged through inductive process of analysis:


Organ donation comments



Primary care delivery recommendations for improvements



Broad data management issues



Accessing medical data for purposes of solving crime

The Australian pilot survey included public opinion statements regarding altruism
and explored this theme with quantitative opinion statements regarding financial
donations to support medical research and blood donation. The qualitative comments
on the pilot survey included comments regarding organ donation. The altruism
statements were not included in the final survey and hence the feedback on organ
donations was less expected in the larger survey. These are important themes and the
qualitative comments gathered by the Australian survey may inform future research
into these matters.
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4.4

Further Consideration of Results

Section 4.1 of this Chapter presented quantitative and qualitative results for the
tripartite components of Privacy Concept, Privacy Justification and Privacy
Management.
Table 46 presents further details of results from Pearsons Chi-Square testing. The
summary tables in Section 4.1 used an X to indicate statistically significant results.
Where Chi-Square testing results fall within the normal statistically significant range
but expected counts fewer than 5 exceeded the 20% threshold, these are included
with appropriate annotations in Table 46.
Some of the Privacy Management results are at 22.2% of expected cell counts with
fewer than five counts which puts them just outside the threshold. Future research
with larger sample sizes may provide the number of responses required to bring these
into the acceptable range. They are provided here for interest and no claims are made
regarding statistical significance. In addition, three tests have been included where p
values are just outside the significant range, these are tagged ‘Special inclusions’ and
results will be discussed below without claiming any statistical significance.
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Table 46: Further consideration of quantitative results
Construct

Gender

Age

Highest Education Level

Healthcare Worker

PRIVACY CONCEPT
Statement 5

Anxiety

Statement 6

Anxiety

(df=10, p<0.001)

(df=12, p=0.001)

Statement 8

Anxiety

(df=10, p=0.002)

(df=12, p<0.001)

Statement 9

Anxiety

(df=10, p=0.008)

(df=12,p<0.001)

Statement 25

Anxiety

(df=10, p<0.001)

(df=12, p<0.001)

Statement 27

Anxiety

Statement 10

Limited

(df=2, p=0.03)
(df=10, p=0.03)

Access
Statement 11

Limited

(df=2, p=0.012)

Access
PRIVACY JUSTIFICATION
Statement 1

Rights Based

(df=2, p=0.012)

(df=10, p<0.001)
5 cells (55.6%) expected
count fewer than 5

Statement 3

(df=12, p=0.007)

Rights Based
(df=2, p=0.019)

(df=10, p=0.008)

8 cells (38.1%) expected
count fewer than 5

Statement 4

Rights Based



( df=2, p=0.001)
2 cells (33.3%) expected
count fewer than 5

Statement 12

Balance

(df=10,
p=0.005)

175

(df=12, p=0.031)

Construct
Statement 26

Balance

Statement 28

Balance

Gender

Age

Highest Education Level

Healthcare Worker

(df=2, p=0.035)
PRIVACY MANAGEMENT

Statement 2

Data
Stewardship

Statement 7

(df=10, p=0.004)
(df=2, p=0.05)

(df=2, p=0.004)

4 cells (22.2%) expected
count fewer than 5

Data

(df=2, p<0.001)

Stewardship
Statement 18

(df=12, p=0.031)

Data

6 cells (28.6%) expected

Stewardship
Statement 24

Statement 30

count fewer than 5

Data

(df=2, p=0.056)

Stewardship

Special inclusion

4 cells (22.2%) expected
count fewer than 5
( df=10, p<0.001)

Stewardship
Statement 13

Control

Statement 14

Control

Statement 15

Control

Statement 16

Control

Special inclusion

(df=10, p<0.001)



Data

(df=2, p=0.056)

(df=12, p=0.055)

(df=2, p=0.009)

Special inclusion

(df=2, p<0.001)

(df=10, p<0.001)

(df=12, p=0.001)

4 cells (22.2%) expected

6 cells (28.6%) expected

count fewer than 5

count fewer than 5



Statement 17

Control

( df=2, p=0.005)

Statement 19

Control

(df=2, p=0.001)

Statement 20

Control

(df=2, p=0.011)
(df=12, p=0.006)
(df=10, p=0.001)

176

(df=12, p=0.004)

(df=2, p=0.047)

Construct

Gender

Statement 21

Control

(df=2, p=0.022)

Statement 22

Control

(df=2, p<0.001)

Statement 23

Control

(df=2, p=0.037)

Statement 29

Control

Age

(df=10, p=0.021)
7 cells (38.9%) expected
count fewer than 5

177

Highest Education Level

Healthcare Worker

(df=12, p=0.019)

(df=2, p=0.037)

(df=2, p=0.024)

Given the narrow margin of the ‘special inclusions’ from the acceptable threshold
established for this research, they do provide some insight that could be further
explored in subsequent research.
Statement 30 - A legal judge in Australia decided that the notes written about a
patient, by a Doctor, are owned by the Doctor not the patient. This decision seems
reasonable to me, Chi-Square testing returned a result concerning highest education
level that was just outside the threshold for significance (df=12, p=0.055).
Opinion was diverse across education levels in response to this statement. Table 47
provides details regarding expected and actual counts.

Table 47:Statement 30 Chi-Square test results by highest education level
Highest
Education
<Yr10
Yr10
Yr12
Trade
Prof
Bachelor
PostGrad
TOTAL

Frequency
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count
Expected
Count

Disagree
33
39.1
84
78.8
68
71.4
61
57.9
184
178.4
152
154.9
152
153.5
734

Neutral
5
6.5
8
13.1
10
11.9
9
9.6
31
29.7
38
25.7
21
25.5
122

Agree
20
12.5
25
25.1
28
22.8
16
18.5
50
56.9
40
49.4
55
48.9
234

Total
58
117
106
86
265
230
228
1090

Statement 24 - I would be happy to let the Australian Government decide who can
use my medical information, Chi-Square testing returned a result concerning highest
education level that was just outside the threshold for significance (df=2,
p=0.056). Females did not respond as positively as expected and males ‘strongly
agree/’agree’ more frequently than expected.
Statement 18 - Any medical research groups who want to use ‘donated’ data must
comply with the wishes of the person who has ‘donated’ the data, Chi-Square testing
returned a result concerning healthcare workers that was just outside the threshold
for significance (df=2, p=0.056). Healthcare workers responded more
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positively than expected and were less ‘neutral’ in their opinion as illustrated in
Table 48.
Table 48:Statement 18 Chi-Square test results by healthcare worker.
Healthcare
worker
No
Yes
TOTAL

Frequency
Count
Expected Count
Count
Expected Count
Count

Disagree

Neutral

22
23.8
9
7.2
31

55
47.5
7
14.5
62

Agree
776
781.7
244
238.3
1020

Total
853
260
1113

The ‘Special inclusion’ Chi-Square test results are further discussed in the next
Chapter.
Statement 16 - If I donated my medical information for research I would want to
choose the level of privacy I required. For example I may choose (1) ‘always
anonymous’ or (2) ‘name and Medicare number can always be used’, Chi-Square
testing returned the strongest  result of all tests at (df=10, p<0.001) across
respondent age. The problem with this result is that 4 cells (22.2%), have expected
counts fewer than 5.
4.5

Chapter Summary

This chapter reported the results of the Australian consumer survey. Demographic
details and response rates were reported. Responses were received from every State
and Territory across Australia and from urban, regional and remote locations.
Response frequencies for each statement were presented in tabular and graphical
format with each 5 point Likert scale response frequency included.
Results of empirical tests for instrument reliability were presented with all but one
construct resulting in Cronbach Alpha > 0.6 which falls within the exploratory
research satisfactory range as suggested by Nunnally (1978) and is similar to those
used on satisfaction surveys deployed by the National Health Service in Britain
(McKinley, Manku-Scott et al. 1997). Instrument face and content validity were also
reported.
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Pearsons Chi-Square tests were conducted across the categorical demographics data
and ordinal responses to statements resulting in 38 statistically significant results
allowing rejection of the null hypothesis:
H0: There is no significant difference between groups of consumers as
expressed through responses to the public opinion survey used in this study
where p<=0.05.
Frequency and expected count tables were presented for those results showing
strongest results. The rejection of the null hypothesis makes it clear that there is a
statistically significant variation in consumer opinion on matters investigated through
the consumer survey. This has implications for any proposal that attempts to satisfy
consumers’ expectations in the secondary use of medical data.
Qualitative comments were classified and reported based on assessment by two
coders following Miles and Huberman recommended approach (1994). The summary
counts for theme occurrence in survey responses were presented along with sample
comments from a diverse set of survey respondents. These qualitative results
complemented the quantitative results and were co-presented within the tripartite
framework.
The results of this survey have provided the starting point to documenting Australian
consumer expectations regarding secondary use of their medical data. This is the first
study that has attempted to elicit this information from Australian consumers and, as
described in the Introduction chapter, the consumers are important stakeholders
whose requirements should be included in conceptualising the secondary use of the
data contained in their EHRs. The next chapter provides analysis of the survey
results presented in this chapter.
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5 AUSTRALIAN CONSUMER PUBLIC OPINION SURVEY
ANALYSIS AND INTERPRETATION OF RESULTS
5.1

Introduction

The overall aim of this research study is “To better understand consumer’s views of
secondary uses of medical data with a particular focus on privacy matters”. The
specific research questions are:
Research Question 1
What are consumer’s expectations and concerns regarding secondary uses of their
medical data, particularly with respect to privacy matters?
Research Question 2
Does the RALC theory (Tavani and Moor 2001) and the framework for contextual
integrity (Nissenbaum 2010) offer privacy concepts that can: (1) be applied in the
secondary use of medical data context and (2) gain support from interested
consumers?
The Australian survey results presented in the previous chapter will be arranged and
analysed in this chapter in a manner that helps answer the above research questions.
Chapter 7 will use the outcomes of the consumer focussed research questions to aid
in the design of a flexible secondary use of medical data framework.
The survey results pertaining to the tripartite components Privacy Concept and
Privacy Justification provide data to address Research Question 1. The tripartite
Privacy Management component, also explored through the consumer survey,
contributes towards addressing Research Question 2.
Key findings include:


11, 6 and 21 statistically significant Chi-Square results across demographics
related to the concept, justification and management of privacy respectively
181



5, 4 and 14 dominant qualitative themes resulted from responses to openended questions for the concept, justification and management of privacy
respectively



No statistically significant gender differences emerged concerning the
concept of privacy



No statistically significant differences emerged between healthcare workers
and non-healthcare workers regarding the justification of privacy



Regarding privacy management women expect more control over re-use of
their data



Healthcare workers attitudes towards medical data stewardship and consumer
correction of data differ from the broader community



Australian consumers do not support the Australian Government taking a data
stewardship role over consumers medical data



The RALC and Contextual Integrity privacy theories could be applied to
secondary use of medical data context

This chapter includes Figures that provide multiple bar charts condensed for
comparison and discussion purposes. The y-axis in the bar charts represents the
number of consumer responses and the x-axis is the dichotomised opinion results.
The green bars represent the actual counts of respondents and the grey bars represent
the expected counts from the Chi-Square calculations. This data was initially
presented in tabular format in the previous Chapter and a selection of results is
provided here in graphical format to facilitate discussions.
5.2

Research Question 1

The results of the public opinion survey provide some insight into consumers’
‘expectations’ and ‘concerns’ regarding secondary uses of their medical data,
particularly pertaining to privacy matters. The focus of this section will be on
analysing the quantitative and qualitative results of the Privacy Concept and Privacy
Justification aspects of the survey. When statistically significant results are
introduced these will be clearly identified. Where appropriate the Australian public
opinion survey results will be supplemented by results of prior research to provide
the most comprehensive descriptions possible to address the Research Questions.
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5.2.1

Tripartite Privacy Concept and Justification of Privacy

The concept of privacy is a large topic and it was only possible to explore two key
aspects via the survey – consumer anxiety and consumer understanding of the
frequently considered ‘limited access’ concept. The first qualitative question - Do
you have any concerns regarding the collection and re-use of medical data, took a
very direct approach to investigating Research Question 1; specifically the matter of
consumer concern. The deductive themes apparent in both the literature review and
the comments expressed by Australians were predominantly general anxiety, trust
and lack of transparency issues, questionable intent of some parties with access to
medical data, and the concept of surveillance. The quantitative survey responses
received from the Australian public indicate attitudes and opinions varying in
statistically significant ways according to the age and education level of the
respondent. On the whole, citizens aged over 50 tend to express more concern or
anxiety regarding privacy. Citizens with higher levels of education tend to express
less anxiety regarding privacy issues with high school and trades educated consumers
more concerned.
Considering the quantitative survey results there were no statistically significant
differences across gender related to consumer expectations and anxiety or concern.
This contrasts with the age and education level demographic with strong test
results ranging from 20.1 to 59.7 as displayed in Table 21 in the previous Chapter.
Healthcare workers opinions were also statistically significant on two statements.
These are key survey results because they allow an improved understanding of the
similarity between male and female opinions on the concept of privacy. In contrast
the improved understanding gained through these survey results suggest that age and
education level result in different opinions. Rather than generalising Australian
consumers as a broad group when referring to privacy matters we can stratify the
consumer group and refer to the different opinions held by different parts of the
community. The next section provides further analysis of these matters.
5.2.1.1 Consumer Concerns and Expectations
The quantitative responses to Statements 5,6,8,9,25 and 27 relate to consumer
anxiety or concern regarding privacy in the secondary use context as reported in the
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previous Chapter. The quantitative responses indicate concerns amongst consumers
with many statistically significant results.
S5. If an unauthorised person gained access to my
medical information then I would feel that my privacy
had been violated.

1000

stolen.
.
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S6. I am concerned that my medical information may be
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know disagree
agree
agree

S9. I worry about computer staff being able to read my
medical information when they are looking after medical
systems.
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S8. I worry about medical receptionists reading my
medical information.
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S25. I would never agree to donate my medical
information to anyone because I worry about
potential misuse of the information.
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S27. I worry about insurance companies getting access
to medical information because they may not use
information in a way that benefits society.
.
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S10. In Australia my healthcare providers try to
protect my privacy by restricting access to my
medical information.
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S11. It seems that my healthcare providers feel that the
fewer people who see my medical information the higher
the level of privacy they have provided for me.
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Figure 34: Consumer Concern and Expectations Part 1
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5.2.1.2

Consumer Concern and Expectations Part 1

Survey results regarding the respondents feeling of violation resulting from
unauthorised access are homogenous with consumers overwhelmingly concerned, as
apparent in the Statement 5 results in Figure 34. With the vast majority of
respondents selecting the ‘Strongly agree’ response there is little room for doubt
regarding the strength of the sample populations’ opinion on the issue of
unauthorised access being a violation of privacy. This has implications for the
primary care health domain as well as the secondary use context. The consumer’s
voices here are clear and in accord.
The survey results for the next four statements (6,8,9,25) are not as homogenous as
those for Statement 5. Attitudes are diverse across age groups and highest education
level of respondents. These are further considered below.
The investigation of consumers’ expectations of limited access as part of the concept
of privacy provides surprising results. A large number of respondents selected ‘don’t
know’ as their Likert scale response. The healthcare community perceives the
concept of privacy to be one of limiting access, as documented in the Literature
Review. Yet it is clear from the survey responses to statements 10 and 11 that the
general public are not necessarily thinking about healthcare privacy in this manner.
This is also surprising given the focus on privacy matters in front-line healthcare
delivery over recent years and with publication of privacy policies and guidelines for
consumer consumption. According to the survey results, the general public are not
overwhelmingly recognising/understanding the healthcare sector attempts to explain
privacy matters about restricted access to information to them. This outcome
warrants further research into the effectiveness of current health sector privacy
campaigns.
The pattern emerging from the statistically significant results of statements regarding
concern about privacy is that older Australians express concern at higher rates than
do younger Australians. The results presented in Chapter 4 for statements 6, 8, 9 and
25 show that older respondents are more concerned than expected regarding theft of
medical information, medical receptionists and IT professionals accessing
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information, and misuse of donated information. Younger Australians did not
respond with the same frequency of concern as did older citizens. The threshold for
concern shifts between 51 years and 66 years depending on the privacy issue being
considered as described in thesis Section 4.2.3.
The data gathered with the survey instrument does not allow investigation of the
causes of more concern over the privacy concept amongst older Australians. This is
an open research area that could benefit from further more targeted research
investigating the causal factors. It is interesting to note that even though the younger
respondents are not strident regarding the concept of privacy the results of the
tripartite Privacy Management component of the survey indicate younger Australians
are open to participating in decisions regarding secondary use of their medical data.
These contrasting outcomes are intriguing.

5.2.1.3 Influence of Highest Level of Education on Concern for Privacy
It is clear that the higher the level of formal education the less concerned citizens are
regarding the theft of medical information (see Figure 35). Respondents with Year 10
or less than Year 10 level of education expressed agreement with the statement more
frequently than expected while Postgraduate and Bachelor education level
respondents disagreed more frequently than expected.
The real world implications of these differences arise when considering the majority
of healthcare professionals who make decisions regarding privacy of medical
information are tertiary educated. The results of this survey suggest that these
individuals may hold more relaxed views regarding medical information theft than
do the majority of the population who have not undertaken tertiary education. These
more relaxed views may influence the formulation of policy and guidelines
surrounding management of medical information matters and inadequately deal with
the broader consumer base fears in regard to the impact of perceived anxiety about
medical information theft. The work of Croll and Morarji (2006) emphasised the
importance of managing consumer perception as much as reality and the results of
this survey Statement 6 provide support for Croll’s work on management of
perception – in this case perceived concern over theft.
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Figure 35: Statement 6 - I am concerned that my medical information may be stolen, selected education level
responses.

Higher levels of education also led to less concern regarding access to information,
Statement 8 - I worry about medical receptionists reading my medical information,
(see Figure 35), with the Trades and Year 10 educated citizens more concerned than
tertiary educated citizens about medical receptionists reading information. These
results support and refine an earlier study (Willison, Keshavjee et al. 2003) where
Canadian respondents also indicated concern about medical receptionists access to
medical records. The study results presented in this thesis have refined the Willison
et al. approach by adding the dimension of education level to the analysis. The
statistically significant impact of education level (df=12, p<0.001), is
clearly illustrated in Figure 36.

Figure 36: Statement 8 – I worry about medical receptionists reading my medical information, selected

The earlier Canadian research alsoeducation
explored
consumers
level
responses. attitude towards computer

The earlier Canadian research also explored consumer attitudes towards computer
professionals accessing personal medical information and Statement 9 - I worry
about computer staff being able to read my medical information when they are
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looking after medical systems, was included in the Australian survey to give an
opportunity to build on the prior research. Canadian research (EKOS Research
Associates 2007) found that consumers were concerned about information
technology professionals having access to medical information and as Figure 37
illustrates Australians are also concerned however there is stratification across levels
of education (df=12, p<0.001) as previously described.
On the whole Australian consumers may not be aware of the number of information
technology (IT) professionals who have access to medical information in the day-today execution of their system support roles. The respondents to this survey showed
more concern about IT professional access than medical receptionist access, as
illustrated in Figure 37. The implications of this into the future must be considered as
the shift to electronic health records across Australia necessarily will require an
increase in the number of IT staff with access to sensitive information. The long held
healthcare profession principle of patient confidentiality may not be as widely
appreciated by the IT staff who are not located on the ‘front-line’ of delivering patient
care. The well established tradition of patient confidentiality that stretches back
hundreds of years in the nursing and medicine professions, as discussed in the
literature review, is under pressure in the information age and the IT professionals are
the agents of change the Australian general public are concerned about.

Frequency

Frequency of responses to statements 8 & 9
500
400
300
200
100
0

Receptionist
Info Tech
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

Figure 37: Frequency of responses for statements regarding concern over medical receptionist
(n=1,147) and IT professional (n=1,148) access to consumer medical information.

The ‘behind-the-scenes’ nature of the IT professional prevents the consumers from
adequately conceptualising the role they play and may contribute to the disquiet
regarding their role. In contrast, medical receptionist roles are better understood by
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consumers and the qualitative comments provided in response to the survey provide
more insight into consumer experiences and concerns about the role of medical
receptionists and privacy and confidentiality. Consumers expressed concern
specifically about medical receptionists in the qualitative comments including:


“I worry about receptionists etc. (not nursing or medical personnel) and
whether they totally understand confidentiality and the importance of it.”
[Survey 941,F,NSW,40-50,Prof,HW]



“Lack of privacy when medical receptionists give results over the phone
which is heard by those in waiting room.” [Survey 211,F,NSW,40-50,Prof,NHW]



“I was in a situation where I personally knew a medical clerk working at my
doctor's surgery. I also knew she was a heroin addict. Her accessing my
medical records was a concern for me...” [Survey476,F,VIC,26-39,Postgrad,NHW]

5.2.1.4 Consumer Concern Regarding Insurance Sector Secondary Use
Statement 27 sought to engage consumers in the controversial area of secondary use
of data by the insurance sector. A provocative statement was provided that, based on
concerns in the literature, suggested that the insurance sector secondary use of
medical data may not benefit society. The majority of respondents selected the
‘strongly agree’/’agree’ response with 225 opting for a ‘neutral’ response. There was
no statistically significant difference between gender, age or education level in these
results indicating a reasonably homogenous response from respondents. The
responses of consumers who self identified as healthcare workers were statistically
significant.
The insurance sector was particularly targeted in the consumer comments. It should
be noted that no background information was provided to the survey respondents
about secondary uses of data within the insurance industry. Respondents drew on
their own knowledge and experience in commenting on these matters. Thoughtful
consumer comments of concern regarding the insurance sector included:


“My main concern about the collection and re-use of medical data is that the
data may be wrongly used against the interests of the patient eg. by various
insurance companies who may deny cover and/or benefits.” [Survey
250,F,NSW,51-65,Bach,NHW]
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“Only concern is that insurance companies could take advantage of
information for their own benefit.” [Survey 392,F,WA,51-65,<Yr10,NHW]



“My greatest concern is Insurance Companies accessing information that
will then 'allow' them to refuse certain people or increase premiums to an
unreasonable level.” [Survey 423,F,NSW,51-65,Bach,NHW]



“Instances where insurance companies or the Government can access data to
manipulate health policies or levels of insurance does concern me yet if the
information was to be used to assist research into medicine I would be only
too happy to support data donation.” [Survey448,F,VIC,40-50,Bach,HW]

The comment from this female, a healthcare worker who resides in Victoria,
highlights the capacity for consumers to make the distinction between secondary use
for research into medicine versus secondary use by insurance sector and different
levels of concern in each instance.


“Yes. I am concerned particularly about Insurance Companies and also the
extrapolation of that data towards my offspring.” [Survey780,F,NT,5165,Postgrad,HW]

This female healthcare worker from the Northern Territory indicated how alarming
the secondary use by the insurance sector is to consumers with her concern for future
generations. This consumer is looking beyond ‘the-here-and-now’ and is imagining
disadvantages that may arise in the future due to secondary use of medical data.


“Would have some concerns about studies etc would want them to be ethical
(rather than insurance companies or similar trying to use the information for
their own purposes rather than to improve the healthcare of others).” [Survey
969,F,NSW,26-39,Postgrad,NHW]

This postgraduate educated female from New South Wales is getting to the core issue
mentioned by many respondents where altruistic use of medical information is
viewed far more favourably than is commercial use.


“Yes- particularly if used by drug companies who sometimes behave
unethically and more so if used by insurance co’s. to raise premiums for
some or exclude some from insurance, or not pay out etc.”
[Survey1100,F,NSW,51-65,Postgrad,NHW]

This female consumer from New South Wales is raising the issue of insurance
organisations choosing to exclude future policy holders or to raise premiums for
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higher risk customers based on business intelligence acquired through secondary data
use.
The results regarding wariness, anxiety or concern amongst consumers when it
comes to insurance industry involvement echoes results of earlier research that
investigated sources of research funding (Willison, Keshavjee et al. 2003). As
reported by Willison et al. the consumers were specifically concerned due to possible
attempts by insurance companies to deny coverage for consumers. The patients
participating in this earlier Canadian study were reported as being generally opposed
to selling personal data to another researcher for profit. The consumers in Willison’s
study had given little thought about the use of their medical information for
secondary purposes however the consumers had conceptualised secondary use by the
insurance industry.
The results this Australian consumer survey are consistent with the findings of
Perera, Holbrook et al. (2011) where it was found that 67% of patients and 70% of
physicians did not want private insurance companies to access medical data.
The Australian survey developed and deployed for this study explored these anxieties
further and a statistically significant result was found for healthcare workers’
responses to Statement 27 - I worry about insurance companies getting access to
medical information because they may not use information in a way that benefits
society, (df=2, p=0.032). Healthcare workers’ responses indicated concern
regarding insurance industry secondary use of consumers’ medical information. The
healthcare workers concept of privacy was challenged by the idea of use of their
patient’s medical records to meet profit driven insurance industry goals. The content
of the 2010 Healthcare Identifiers Act supports the view held by the surveyed
healthcare workers and contains specific provisions to exclude the passing of medical
data to insurance industry organisations. This contrasts with the approach adopted in
the United States and Canada, as described in the Literature Review.
The role of Australian health insurance providers is somewhat grey as they gather
vast volumes of detailed medical information about individuals through transaction
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processing systems supporting payments for health services. This data becomes ‘fuel
for the engine’ of business intelligence and data mining tools identifying patterns and
predictions for likely health outcomes. There are many qualitative responses to the
Australian survey that indicate consumer disquiet with this practice – yet by
purchasing private health insurance Australians are contributing their personal
information for such secondary purposes.
The qualitative comments provided by some survey respondents are unambiguous
and emphatic in terms of insurance industry secondary uses – these uses are not
supported by the Australian respondents. Broadly speaking, many of the qualitative
comments indicated that if de-identified data was used the consumers would be less
concerned about secondary use. This concession was not extended to the insurance
industry. Some consumer comments indicated they were not prepared to support
anonymised release of data to the insurance industry as they were cognisant of the
potential impact of refused insurance policies or raised premiums based on
intelligence garnered from the secondary use of medical data. In this matter a number
of consumers indicated some depth of understanding of these matters and their
concern was apparent, for example:


“... organisations such as insurance companies or even drug companies are
often less than above reproach and are notorious for employing tactics and
policies which are immoral beyond expression. I would be most distressed to
learn that my own data had contributed to the formation of such policies. On
a larger scale such disreputable organisations obtaining vast quantities of
information or databases, especially when the information was not originally
given for their use is far more troubling given the power of information when
collected enmass in this way.” [Survey 135,F,NHW]

The issues that this female, non-healthcare worker raised included lack of trust in
insurance companies and desire to ensure that her medical information makes no
contribution to such secondary use. She highlights that the information was
originally collected for another, more primary purpose and she reflects on the
computational potential of such large datasets. In this way she is reflecting the
published literature.
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“Yes, insurance companies are already using medical information to
‘genetisize’ potential future applicants for health insurance. Someday they
will 'cluster' them and come up with the argument that since all applicants
will die, there are some that will die sooner in certain clusters and ultimately
everyone will either have exclusion clauses in their policy or premium
loadings, not because they are necessarily a higher risk, but because they
belong to a certain genetic or illness cluster.” [Survey520,M,NSW,5165,Postgrad,HW]

This postgraduate educated male from New South Wales, has a well elucidated view
of future health industry secondary use of medical information and his concern is
apparent. He also raised the issue of genetic data.
Genetic data was not specifically raised in this survey however some consumers
highlighted specific concerns regarding this very special type of data. These have
been identified as emergent themes and there is potential for future research
regarding the implication of genetic data. Other consumer comments regarding
genetic data include:


“Life insurance companies and genetic testing - both sides of this argument
have merit and I'm not clear on how to resolve it.” [Survey539,M,NSW,6680,Postgrad,NHW]



“Genetic testing and potential use by insurance companies to deny cover is a
concern. For this reason I would not be tested as by my understanding of the
law I would be obliged to share any results with insurance providers.”
[Survey681,F,NT,40-50,Postgrad,NHW]

5.2.1.5 Consumer Concerns and Expectations Part 2
The next section continues to explore consumers’ expectations and concerns with a
focus on the ‘rights’ based justifications of privacy. The consumer concerns and
expectations regarding the healthcare sector justification of data re-use as finding a
‘balance’ between the needs of society versus individual expectations of privacy is
also investigated. Figure 38 presents the frequency response charts for statements
associated with these issues. The opening statement in the survey investigated
consumer attitudes about privacy as a ‘right’. Qualitative comments provided by two
respondents indicated that the introduction of the ‘rights’ based approach to privacy
did not rest well with them. Both of the citizens were aged 51-65 years and reside on
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opposite sides of Australia with a postgraduate educated female from WA and a
professional male from NSW. Apart from these two consumers the remainder of the
respondents wrote frequently of their perceived ‘rights’ regarding their privacy. The
quantitative results show the majority of consumers ‘strongly agree’/’agree’ they
have a ‘right’ to personal privacy with statistically significant differences between
gender (df=2, p=0.012). Females responded positively more frequently than
expected and males were more ‘neutral’ in their responses than expected. One female
respondent from South Australia provided a very concise comment, “... seeing a GP
does not mean that I have handed over my right to privacy or my choice to disclose
or not!”
S1. I believe that I have a ‘right’ to personal
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Figure 38: Consumer Concerns and Expectations Part 2
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Gender differences continued (df=2, p=0.019) with responses to Statement 3
– I have a ‘right’ to share my medical information with others. Again women
responded more positively than expected and men did not meet positive expectations
and selected ‘neutral’ and negative responses more frequently than expected. These
gender differences regarding expectations and ‘rights’ based views are a precursor to
the far more statistically significant differences between gender that are described
below. This emergent gender difference grows in importance throughout the
remainder of this Chapter.
The older Australian respondents, aged 66-80 years disagreed with Statement 3, with
2.5 times the expected frequency of disagreement whereas the 26-50 year olds
expressed stronger support for this statement than expected. The Chi-Square test
results reflected these differences (df=10, p=0.008). The statement is very
broad and was an initial step to exploring the notion of empowered consumers who
have some ‘right’ over the movement of their medical information. Older
respondents are likely to be more compliant with the notion that sharing medical
information belongs in the doctors’ domain rather than with the patients. There is
insufficient data available through this survey to confirm this proposition and future
research could explore this generational shift in attitude further.
The younger respondents are overwhelmingly positive in their responses to
Statement 3 indicating an expectation that sharing medical data is their ‘right’. This
will likely have implications on secondary use of medical data in the future. For
example, in a future scenario where a research group called XYZ may call for
contributions of medical data to investigate disease ABC – possibly using social
networking tools or the like to ‘get-the-word-out’ – young Australians may see it as
their ‘right’ to decide if their data will be used to contribute towards the study. If the
data is housed on a health service providers IT infrastructure the young Australian
consumer may send a ‘share my data with XYZ’ instruction to the health service
provider and actually expect the provision of their data to the XYZ research group to
support research into disease ABC. Who ‘owns’ this data – the consumer or the
health service provider? Is it reasonable for consumers to expect to be able to
respond to ‘calls for data donations’ from research group XYZ? Are there suitable
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ethics approvals in place? Should the doctor decide who the consumer can ‘share’
their medical data with? The survey used in this study explores many of these
questions.
The results from Statement 3 – I have the ‘right’ to share my medical information
with others, are perhaps the first from an investigation into this type of issue. Further
research where consumers are presented with forward thinking scenarios, similar to
the one above, can assist in anticipating and planning for boundary pushing
secondary use scenarios. The generational shift apparent in responses to this
statement could sound a warning that the established ‘doctor decides’ paradigm may
come under future pressure in the secondary context.
Statement 4 gauged the expectation of consumers regarding how Australian law
combined with healthcare guidelines, which interpret the law, protects their privacy.
There were no statistically significant differences between consumers on this matter.
The consumers do overwhelmingly expect legal protection. The 2008 Australian Law
Reform Commission’s (ALRC) recommendations described in the literature review
would enhance consumer privacy protection. At the time of finalising this thesis the
Australian Government had yet to act on the ALRC Privacy recommendations
regarding medical information privacy.
Statements 12, 26 and 28 explored consumer attitudes regarding the often used
healthcare sector justification for secondary data use as seeking a ‘balance’ between
broad societal good and privacy needs of individuals. When viewed through the
medical researchers’ lens, as discussed in the literature review, the medical data
gathered during the delivery of healthcare is an increasingly valuable resource for
retrospective observational studies. Statements 12 and 26 explore the consumers’
responses to suggestions that their data should be used to help other humans
suffering ill-health and tests attitudes with a statement about medical information
donation being useful when some benefit to society is the outcome. The consumer
response, refer S12 and S26 in Figure 38, is positive however not to the same extent
as the statements regarding ‘rights’ to privacy.
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Chi-Square testing on statement 12 – If information about my health can be used to
help others who are suffering ill-health then I believe my information should be used
to help those people, revealed statistically significant results across age
(df=10, p=0.005) and highest level of education (df=12, p=0.031).
Citizens 66 years and older were responding positively to this statement more
frequently than expected and those younger than 66 years did not meet expected
counts for positive responses, thus resulting in the result.
Respondents with tertiary education responded less positively to this statement than
expected and the negative responses were more frequent than expected. There is no
clear trend amongst the other education levels. This is probably not the sort of
response that the healthcare community would have hoped for from tertiary educated
consumers. Future research could investigate this area further and the use of
background materials and a vignette to garner responses may enhance the
understanding of consumer attitudes on this issue.
There were no statistically significant difference amongst respondents to statement
26 – I support the idea of medical information donation when the information is used
in a way that benefits society, and there were fewer ‘neutral’ responses to this
statement than to S12. Qualitative responses provided more insight into consumer
views which were largely supportive, for example:


“... I’m very healthy so far. Don’t think I’d worry anyway, if it would help
others.” [Survey 1143,F,VIC,66-80,Prof,NHW]



“I think there should be some balance sought between the rights of patients
and doctors and the broader societal good...” [Survey 1137, F,VIC,4050,Postgrad,NHW]



“... I believe the health benefits of access to patient records potentially
outweigh the cost associated with less personal privacy...” [Survey 1118,
F,VIC,51-65,Postgrad,HW]



“I believe the sharing of data if used for the common good is totally
reasonable...” [Survey1005,M,NSW,51-65,Prof,NHW]
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“... there should be some form of monitoring or policing the release of data.
Self-regulation is insufficient for an issue as sensitive as this.”
[Survey972,M,NSW,51-65,Yr12,HW]



“I would be happy for information to be used for research that would help
the community. I would not feel comfortable on this information being used
by commercial entities such as drug companies where the results built
corporate profits rather than social health etc. outcomes.” [Survey825,F,SA,4050,Postgrad,NHW]

The last statement above from the South Australian female leads back to the
concerns previously described regarding insurance industry access for purposes that
consumers may not perceive as necessarily of benefit to society. There are numerous
similar consumer comments focussing on pharmaceutical organisations. During the
conduct of this study interested members of the healthcare sector, including medical
specialists, informally argued the case regarding the contribution made by
pharmaceutical organisations to the overall welfare of society through the
development of new drugs; a process which may involve secondary use of medical
data. None of the 1,158 Australians who responded to this survey made the same
argument in the qualitative feedback. Examples of comments include:


“I think most people have some concern. I certainly do. Drug companies
want this sort of information as do research organisations. Healthcare
providers may see this as an opportunity to compile and sell data on their
health files. Regulation of this activity is probably required at Federal Govt.
level.” [Survey1039,F,51-65,Bachelor,NHW]

There was no reference to on-selling of medical data in the survey material, yet this
consumer is informed and aware of the practice.


“We have concerns re the holders of information i.e. our medical records
selling for profit, especially to drug companies, marketers and potential
employers.” [Survey173]



“Once information is available for re-use it will be virtually impossible to
stop access by insurance companies + commercial medical researchers/drug
companies and others. Having said that, I support the THEORY that
information should be available, with permission, for not for profit medical
research to assist with identifying treatment and cures.” [Survey667,F,NSW,4050,Postgrad,HW]
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“My age, life experiences, education and employment in the health industry
cause me to be very cautious about sharing personal health information. I
would be concerned also about the agendas of drug companies being
provided with such information...” [Survey889,F,NSW,40-50,Postgrad,HW]



“All insurance or drug companies are primarily responsible to their
shareholders and NOT the general public and therefore should not be
given/sold a person's private medical records without that person's explicit
permission.” [Survey385,M,NSW,40-50,Prof,NHW]

The final statement exploring consumer concerns and expectations is Statement 28 –
Using medical information for the ‘common good’ is OK but I worry about the risk
to a person’s privacy, resulted in Chi-Square statistically significant results across
gender (df=2, p=0.035). In a manner consistent with many of the other
expectations and concerns, female respondents ‘strongly agree’/’agree’ responses
exceeded expected counts and males positive responses failed to meet expected
counts. This is another outcome that emphasises the gender differences in attitude.
The research reported by Parkin and Paul (2011) indicated that consumers supported
the secondary use of medical data, including identifiable (rather than anonymous)
data, for utilitarian purposes. The consumer responses to Statements 12, 26 and 28 in
this survey are similarly generally supportive of secondary use for utilitarian
purposes. An important point of difference however is this surveys statements did not
explore the specific use of identifiable data.

5.3

Summary of Research Question 1 Findings

The first research question driving this study is “What are consumer’s expectations
and concerns regarding secondary uses of their medical data, particularly pertaining
to privacy matters?” In summary, the findings of Research Question 1 relate to the
attitudes of the adult Australians who responded to this survey with findings
including:
1. Consumers are expressing concern regarding secondary use of medical
data and associated privacy issues; particularly regarding potential data
use by insurance and pharmaceutical sectors.
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2. There are statistically significant differences across age groups, education
levels of respondents and self-reported healthcare workers regarding these
privacy concerns.
3. There are statistically significant gender and age differences regarding
consumer’s expectations of a ‘right’ to privacy.
4. There are many consumers who are not aware of the healthcare sector
concept of privacy related to ‘limited access’.
5. There are statistically significant differences across education level and
age regarding the privacy concept of ‘Getting-the-balance-right’ to
deliver benefit to society through secondary use of data.
5.4

Research Question 2

The second research question asks Does the RALC theory (Tavani and Moor 2001)
and the framework for contextual integrity (Nissenbaum 2010) offer privacy concepts
that can: (1) be applied in the secondary use of medical data context and (2) gain
support from interested consumers?” This part of the Chapter looks more closely at
consumers’ attitudes towards the ‘management’ of privacy which is the third
component of the tripartite model.
Specific recommendations discussed by Moor and Tavani were investigated through
opinion statements in the consumer survey. These included individual control for the
management of privacy in possibly three ways: choice, consent and correction. The
survey focussed more on consent because “Consent is a means of control that
manages privacy and justifies what without it would be an invasion of privacy”
(Tavani and Moor 2001, p. 8). The notion of consent also has great import in the
medical community and this convergence influenced the number of survey
statements that focussed on ‘real world’ aspects of operationalising consent for
secondary use of medical data.
Beyond the quantitative aspects of the survey instrument many respondents
expanded their description of attitude through the two optional open ended questions.
The frequency counts associated with each tripartite Privacy Management construct
in the survey provide insight into the level of support that may be offered by
consumers. Never before have Australian consumers been asked to respond to such
detailed queries regarding their expectation of privacy management of the secondary
200

use of medical data. The normative zones of privacy surrounding vast volumes of
stored medical data are under pressure with the shift to electronic health records.
Stewardship of this data, with more interest and participation by consumers,
challenges the restricted access account of privacy. Therefore some of the questions
in the Privacy Management section of the survey engaged consumers in stewardship
matters. Table 49 recaps and summarises the consumer responses to stewardship
statements. The wording of Statements 2 and 7 was quite provocative to respondents
with experience with the existing healthcare sector data stewardship paradigm where
healthcare providers have provided unchallenged stewardship of consumers’ medical
information.
Table 49: Consumer Data Stewardship
S2. I think that my medical records belong to me– S7. When my medical information is stored on a computer
they don’t just belong to my healthcare providers.
owned by a healthcare provider they should not assume
that they ‘own’ the information.

S7

1000
500
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagre
agree
agree

S18. Any medical research groups who want to
use ‘donated’ data must comply with the wishes of
the person who has ‘donated’ the data.

Frequency

Frequency

S2
1000
500
0

Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

S24. I would be happy to let the Australian

Government decide who can use my medical
information.

Frequency

S18
1000
500

Frequency

S24

0

600
400
200
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

S30. A legal judge in Australia decided that the
notes written about a patient, by a Doctor, are
owned by the Doctor not the patient. This decision
seems reasonable to me.

Frequency

S30

Intentionally blank

600
400
200
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree
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As described above the restricted access approach to privacy is challenged because
this privacy theory alone is inadequate in dealing with secondary use of medical data
in the Information Age. As the Literature Review presented, the medical community
have, and continue to rely heavily on, the restricted access approach to patient
privacy. Therefore it is not surprising that three of the five survey statements related
to data stewardship reveal statistically significant differences for self-reported
healthcare workers and S18 Chi-Square results just outside the statistically
significant threshold at p=0.056.
This is the first time that metrics have been available to quantify healthcare worker
attitudes and allow contrast to the attitudes held by the broader community. The
different attitudes have implications for the future as a shift away from tight
healthcare sector sole stewardship of data with more engagement with consumers is
apparent in the survey results on both data stewardship and consumer choice and
consent as shown in Table 50.
The Australian responses to Statement 7 link to the research published by Buckley,
Murphy et al. (2011) regarding a survey of the Irish public. The Irish survey found
that 68% of patients were unwilling to allow General Practitioners to decide which
researchers could access patient identifiable data. The strong response from Irish
respondents could be interpreted as an unwillingness to delegate ‘ownership’ of data
to their General Practitioner.
Introduction of the 2010 Healthcare Identifiers in Australia, to be administered by a
Government agency, is the preliminary step to having integrated medical information
available for the Australian Government to adopt a stewardship role over, as
foreshadowed by Magnusson (2002).
This is the background to Statement 24 and it is apparent that Australian consumers
do not endorse Government data stewardship. On this issue healthcare workers and
the broader community are in accord with no significant differences in the
overwhelmingly negative response to Statement 24 – I would be happy to let the
Australian Government decide who can use my medical information. This is an
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interesting result when compared to the research of Perera et al. (2011) where only
40% of patients indicated they did not support government access to medical data.
Statement 30 explored consumer views to the Breen Vs. Williams case, described in
the Literature Review, and qualitative consumer feedback was diverse ranging from
criticism such as:


“It's a disgrace that a doctor own ‘notes’ they write up on a
person”.[Survey4,F,NSW,26-39,Prof,NHW]



“Regarding Q30, the judges determination does not seem reasonable to me
because a doctors notes are written in collaboration with the patient ie. They
are partly based on information supplied by the patient, therefore the patient
has claim to these notes.” [Survey465,M,NSW,51-65,Bach,NHW]

to support from professionals outside the healthcare sector who could find parallels
between the teaching profession and that of medical doctors in terms of note taking:


“My overriding belief is that my medical record is mine but is distinct from
doctors notes eg. Like a teacher's notes compiled before writing a student's
report. I should have complete access to these and be the sole person who
decides who has access to these.” [Survey48,F,NSW,26-39,Postgrad,NHW]



“As a school teacher, I make notes/observations and record results
constantly about my pupils. They are NOT for publication in any way and I
never show them to parents. However, there is a constant system of reporting
to parents using bonafide chanels of communication, including written
reports and face-to-face interviews. In the same way, I would expect that my
Doctor makes notes to himself regarding my treatment. They are HIS alone ...
Again, not for publication in anyway. The actual record of my medical
history treatments are mine upon request (or should be).” [Survey116,F,NSW,5165,Prof,NHW].

Similar to many of the other survey responses the Statement 30 results were
statistically significant across age with the over 66 years of age citizens again
supporting S30 in larger numbers than expected. This older age group is again
indicating attitudes that the doctor should have stewardship of patient medical
information. The 51-65 year olds are the transition age where expected positive
counts are narrowly missed but ‘strongly disagree’/’disagree’ responses exceed the
expected count. The consumers younger than 51 years are not responding positively
to the legal decision re-enforcing stewardship by the healthcare provider. This
outcome is similar to the findings of Mulligan (2001) where statistically significant
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differences were found across age groups regarding confidence in health sector data
storage.
These initial data stewardship research findings add to the emerging picture of
consistently different attitudes to the concept, justification and management of
privacy across generations of Australian survey respondents. The data stewardship
findings reported here are an early warning of changing expectations amongst the
Australian community and planning will be required to effectively manage the
transition to ensure that the nation has an agreed strategy on stewardship of health
data as it is rapidly accumulated in many health information systems around the
country.
Relying on the traditional compliance of consumers regarding health data
stewardship will be inadequate in the future. If the Australian Government expected
to fill the void by becoming the national data steward consumers’ responses to
Statement 24 indicate this would not be an acceptable strategy from citizens’ points
of view. A forward looking secondary data stewardship strategy is required for
Australian consumers’ medical information.
The next section moves to considering the tripartite Privacy Management issues of
choice, consent and correction. Table 50 includes a recap of the consumer responses
to Privacy Management statements that revealed statistically significant results
across gender.

204

Table 50: Consumer Privacy Management Part 1
S16. If I donated my medical information for S17. If I give consent for my health information to be used
research I would want to choose the level of privacy I for research I want to be able to say who can use my
required. For example I may choose (1) ‘always information like ‘medical researchers’, ‘drug companies’,
anonymous’ or (2) ‘name and Medicare number can ‘university researchers’ or ‘insurance companies’.
always be used’.
.

S17
Frequency

Frequency

S16
600
400
200
0

600
400
200
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

S19. A person must be able to choose to keep their
medical information private and never consent to
release their medical information for any purpose.

S21. If people agree to donate their data for medical
research there must be a way for them to stop the donation
agreement at any time.

S21
Frequency

Frequency

S19
600
400
200
0

600
400
200
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

S22. If people agree to donate their data for medical
research from time to time they must be asked if they
want to continue to donate.

S23. If I choose to donate my medical information then
healthcare providers should release the information
according to my instructions.

S23
Frequency

Frequency

S22
600
400
200
0

600
400
200
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

Don’t Strongly Disagree Neutral Agree Strongly
know agree
agree
disagree

Statistically significant results between genders are clear on the issue of consumer
control within the management of privacy domain. The frequency of women
expressing a desire for various aspects of control over secondary use of their medical
data is consistent through the Chi-Square expected count frequencies for survey
Statements 16, 17, 19, 21, 22, and 23. In contrast, men did not meet expected counts
(See Table 51) and with respect to the control of use of their data, men hence do not
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express the same level of expectation as do women. This reflects the gender
differences findings of Research Question 1.

Statement

Table 51: Gender Differences Regarding Management of Privacy – Control.
Strongly Agree/Agree

16. If I donated my medical information for research I would want to
choose the level of privacy I required. For example I may choose
(1) ‘always anonymous’ or (2) ‘name and Medicare number can
always be used’.
17. If I give consent for my health information to be used for
research I want to be able to say who can use my information like
‘medical researchers’, ‘drug companies’, ‘university researchers’ or
‘insurance companies’.
19. A person must be able to choose to keep their medical
information private and never consent to release their medical
information for any purpose.
21. If people agree to donate their data for medical research there
must be a way for them to stop the donation agreement at any
time.
22. If people agree to donate their data for medical research from
time to time they must be asked if they want to continue to donate.

23. If I choose to donate my medical information then healthcare
providers should release the information according to my
instructions.

Female

Male

Count

694

310

Expected Count

675.1

328.9

Female

Male

Count

655

289

Expected Count

636.7

307.3

Female

Male

Count

589

255

Expected Count

569.5

274.5

Female

Male

Count

680

312

Expected Count

666.7

325.3

Female

Male

Count

615

259

Expected Count

586.6

287.4

Female

Male

Count

689

324

Expected Count

679.3

333.7

As noted at the end of the previous Chapter, Statement 24 Chi-Square test results
return p=0.056, just outside the statistically significant range, and responses to this
statement regarding the Australian Government controlling access to medical data
for secondary uses attracts support from males and greater than expected opposition
from females.
This finding supports those of recent Australian studies that indicated women were
more engaged in healthcare matters. A 2010 report from CSC (Pettigrew, Roman et
al. 2010) found Australian women are generally more engaged than men when it
comes to in their personal healthcare management. In particular, the CSC report (p.
23) states that: more women (83%) keep test results and x-ray images than men
(72%), more women (60%) keep educational documentation than men (47%), and
more women (46%) than men (39%) shared personally held medical information
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with healthcare providers. In addition, it supports an early Canadian study into
secondary uses of medical information for research found that women required more
detail than men regarding research that used their data (Willison, Keshavjee et al.
2003).
A reasonable conclusion to draw is that women would be more responsive to
requests to join as research partners in research using medical information provided
they were offered a genuine opportunity to partner. It is also reasonable to conclude
that women would demand more control than men would over the nature of the
secondary use. This has implications for future systematic approaches to tackling the
secondary use of medical data and may provide some insight for human research
ethics committees in deliberations regarding medical data usage. If a consumer is
prepared to be fully engaged and give instruction regarding secondary use of their
medical data perhaps ethics committee’s no longer need to make judgements
regarding the use of consumer data for secondary purposes - the consumer
instructions could be followed.
It is interesting to note that based on the results from the part of this survey that
investigated the ‘concept’ of privacy there was no statistically significant difference
between women and men in terms of anxiety regarding privacy. Women are no more
concerned about privacy than are men so it is not likely that the anxiety over privacy
is driving the desire for more control over secondary use of their data. The reason
behind the women’s desire for more control over secondary uses is an interesting
open research area.
Tertiary educated respondents did not meet expected positive counts for Statement
19 - A person must be able to choose to keep their medical information private and
never consent to release their medical information for any purpose. Consumers with
less than Yr10 education also failed to meet expected counts for ‘strongly
agree’/’agree’ while the remainder exceeded expected counts for positive responses.
This is an important survey question as it attempts to draw out the views on
maximising personal privacy through withdrawal from secondary use initiatives.
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Why are tertiary educated consumers, in particular, not more agreeable to this
notion? This warrants further analysis and details are described below. What emerges
are diverse attitudes that reflect some of the perspectives described in the Literature
Review. It is outstanding to have such examples illustrating the various competing
points of view regarding secondary use from our own citizens.
The qualitative comments for respondents with <Year 10 or with Bachelor or
Postgrad education who selected ‘strongly disagree’/’disagree’ responses for
Statement 19 were reviewed to find some elaboration of the attitudes behind
responses to this statement. There were no relevant elaborating comments from the
<Year 10 educated respondents so no further insight into their attitudes could be
gained.
Of the tertiary educated respondents who selected ‘strongly disagree’/’disagree’ for
S19, the following are comments that elaborate their attitudes in a useful way:


“I think it is important that medical data is available for ethical and valid
research which could be beneficial to all Australians.”[Survey677,F,ACT,5165,Bach,HW]

This is a response from a healthcare worker who is not endorsing the opportunity for
a consumer to withdraw from having their medical data used for secondary purposes.
What we read in the above comment is an endorsement of the ‘common good’
argument often used by the healthcare sector as justification for using an individual’s
medical data. The next elaborating comment is from a female resident of the ACT
who debunks concerns regarding society surveillance and argues for compulsory
consumer participation for the ‘common good’. She also raises the spectre of deidentified data and the next section of the Chapter discusses anonymity matters.


“Medical break throughs could be made with better access to nonidentifiable data. Any system will be criticized by those who fear a "bigbrother" campaign by Govt. so voluntary data input might not be
comprehensive. A legislated compulsory system would be better for the
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common good, as it would enable a more complete picture of health issues in
the community.”[Survey776,F,ACT,26-39,Bach,NHW]
An intriguing comment came from a male, non-healthcare worker in Victoria who
commented:


“Brin has written about privacy issues in the "Transparent Society" Any
legal or administrative systems put in place should be designed to cope with
the challenges of the Moore's law like decrease in security costs, both as an
opportunity and a further pressure.” [Survey473,M,VIC,51-65,NHW]

This respondent is referring to a non-fiction book “The Transparent Society” written
by David Brin (1998) who considers a world with social transparency and far less
privacy. Another comment took a very economic rationalist approach to addressing
why an individual should not be allowed to ‘opt-out’:


“As tax payers we all contribute to everyone's healthcare - Medicare,
subsidies(pensioners, unemployed etc.), research, hospitals - as such, all info
that can be collected and used anonymously to improve treatments,
diagnosis etc. should be available to all in the medical/research fields. It is
through the sharing of information that improvements occur and prevents
duplication of research and gives larger data base thereby hastening
developments.”[Survey493,F,NSW,66-80,NHW]

The analysis of the negative responses to Statement 19 did not elicit any points of
view that have not been acknowledged in the Literature Review component of this
study. Having the response to this statement held within a relational database with
the demographics was ideal as the development of SQL queries to drill-down into the
responses and comments to quickly develop a profile of attitudes was speedy and
straight forward.
Statements 21, 22 and 23 explored the level of control and frequency of consent
renewal expected by consumers when their medical information is being used for a
secondary purpose. Healthcare workers responded positively to the idea of
consumers having an opportunity to re-affirm consent for secondary use of their data.
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There were mixed responses from the sample population with tertiary educated
citizens responding in the negative more frequently than expected. Analysis of these
responses indicates a diversity of views with no clear pattern apart from the gender
differences already considered.
Analysis of S20 responses, as illustrated in Table 52 below, indicates that consumers
also have mixed attitudes towards the provision of one consent for data donation.
The Irish consumer survey (Buckley, Murphy et al. 2011) found that 89.5 % of
respondents would agree to an ongoing consent without the need for consent for
individual studies. Considering the impact of age (10 year increments) the Irish
survey found a significant association between age and increased likelihood of
agreeing to ongoing consent.
This Australian survey also found statistically significant differences across age
(df=10, p=0.001) with citizens aged 40-65 responding ‘strongly
disagree/disagree’ more frequently than expected. Buckley, Murphy et al (2011)
suggest that employment security influences citizens willingness to share their
medical information.
Combining the results of S22 and S20 delivers a range of views on the issue of
timing and frequency of consent. The implications of this for future implementations
of consent associated with any secondary use of medical data is that flexible
arrangements will be required to accommodate diverse consumer expectations.
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Table 52: Consumer Privacy Management Part 2
S13. If my health information could be made anonymous S14. I feel that I continue to have privacy even when other people
by removing things like my name, address, phone number have access to my personal information if I am the one who has
and Medicare number I would be more likely to agree for granted the other people access.
the information to be used for medical research.

S14
Frequency

Frequency

S13
600
400
200
0

1000
500
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

S15. I support the idea of people being given a personal
choice about ‘donating’ their medical information for
research.

S20. If I donated my medical information for research I would like to
give my consent once - at the time of ‘signing up’ as a data donor.

S20

1000

Frequency

Frequency

S15

500
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

600
400
200
0
Don’t Strongly Disagree Neutral Agree Strongly
know disagree
agree
agree

S29. I should be able to see my medical information and it
should be easy to correct any mistakes in the information.

Frequency

S29

Intentionally blank

600
400
200
0
Don’t
know

Strongly Disagree Neutral
agree
disagree

Agree Strongly
agree

The results of Statement 13 indicate positive consumer attitudes towards the use of
anonymous medical data for research purposes. There are no statistically significant
differences across respondents on this statement. This positive response to the use of
anonymised data is similar to that reported by an earlier Canadian study (EKOS
Research Associates 2007) where 84% of respondents indicated agreement with use
of data for research if names and addresses were first removed.
It is acknowledged that deciding on a suitable approach to de-identifying data is a
complex matter however the issue of best approach to de-identification, or
anonymising, medical data is beyond the scope of this study. Too often information
technology studies have tackled de-identification as if it alone was the answer to all
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things privacy related. The point of this study is to investigate matters well beyond
de-identification challenges. The consumer response to this question cannot be
interpreted as carte blanche agreement with any third party use of de-identified data.
The consumer responses to this entire survey indicated that a nuanced, sophisticated
understanding of secondary use that requires a less blunt instrument than simply deidentifying data prior to secondary use.
Statement 29 explores the ‘correction’ component of Privacy Management suggested
by Tavani and Moor. Statistically significant results were revealed across Healthcare
Workers attitudes with these consumers responding negatively or ‘neutral’ more
frequently than expected which contrasts with the rest of the respondents who are
‘positive’ more frequently than expected.
Further analysis, similar to that described above for S19, was conducted to gain
insight into consumers who did not support consumers seeing and correcting
information, the following comment was informative:


“…Drs comments on file are not written to be viewed ie. Situations of
patients with mental illness - personal comments on patient’s condition
should remain with Dr - NOT AVAILABLE FOR VIEWING…”
[Survey392,F,WA,51-65,<Yr10,NHW]

Unfortunately the healthcare workers who selected ‘strongly disagree’/’disagree’ did
not elaborate on the issue of consumers viewing and correcting information in
qualitative comments hence no further insight could be gained. Perhaps as the long
held practice has been for patients to not necessarily view their medical information
the negative healthcare worker responses were ‘status quo’ without needing
elaboration. The majority of respondents are supportive of the view and correction
notion hence endorsing this aspect of RALC theory. The comment from the West
Australian consumer above gives an illustrative example of difficulties with some
consumers. The scope of this study is specifically about health service provider held
medical information hence looking towards applying this aspect of RALC is
challenging.
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Statement 14 aims at the core of the restricted access/limited control (RALC) hybrid
privacy theory. The response from consumers indicates that they understood the
statement i.e. few ‘don’t know’ responses. This is a good start because composing a
statement to pose this core RALC concept of Privacy Management was an iterative
task due to the intangible and slippery privacy concepts at play. This statement
combines the notion of ‘restricted access’ in that normative privacy would ordinarily
exclude some people from having access to personal information. However, if the
subject of the information (in this case consumer/patient) is the authority who has
granted access, then through this exercise of some control by the subject a sense of
privacy is maintained. The consumer response to this statement is affirmation of a
foundation construct of RALC privacy theory and bodes well for translation into real
world operations, such as secondary use contexts.
Summary of Privacy Management findings:


Statistically significant results indicate that women expect more control over
re-use of their data.



Healthcare Workers attitudes towards medical data stewardship and
consumer correction of data differ from those attitudes of the broader
community.



The advantages of using anonymised data are universally acknowledged by
all consumers.



Initial investigations suggest that Australian consumers do not support the
Australian Government taking on a data stewardship role over consumers’
medical information.



The diverse ‘lens’ approach taken to developing the literature review of this
study is reflected in consumer comments, particularly responses to Statement
19.
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5.5

Summary of Research Question 2 Findings

The second research question driving this study is:

“Do the RALC and contextual integrity privacy theory offer privacy concepts that
can: (1) be applied in the secondary use of medical data context and (2) gain support
from interested consumers?”
In summary, the findings of Research Question 2 are:


The outcomes from the investigation into Privacy Concept, Privacy
Justification and Privacy Management components through the Australian
Public Opinion Survey Regarding Secondary Use of Medical Data indicates
that the RALC and contextual integrity privacy theory could be applied in
the secondary use of medical data context.
As consumers completed the surveys there was no expectation that
respondents would conceptualise the tripartite components of the privacy
theory. Each of the carefully selected attitudinal statements, many first
trialled in the pilot surveys, sought to engage consumers on one particular
tripartite component. The tripartite component classification was transparent
to the respondents and relied upon the researcher to compile constructs
appropriately as discussed for the pilot survey in thesis section 3.5.3.2 and for
the final survey in thesis section 3.5.5. The consumers who responded to the
survey were able to engage with the attitudinal statements and the analysis of
quantitative results, classified according to privacy ‘concept’ or ‘justification’
or ‘management’, provided reliable results as discussed in thesis section
3.5.2.
Without specifically defining these theoretical constructs for survey
respondents, it was possible to identify Contextual Integrity components
within Australian and Canadian consumer survey respondent’s open-ended
comments. The survey comments identified different actors (e.g. not-forprofit medical researchers and for-profit commercial actors), different
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attributes (e.g. sexual health, mental health and family history) and
transmission principles (e.g. consumer consent requirements and consumer
feedback requirements on instances of secondary data use).


Given the satisfactory response rate to the Australian survey and the clarity
and volume of quantitative and qualitative survey data gathered, support for
operationalising RALC (Tavani and Moor 2001) and Nissenbaum’s (2010)
contextual integrity to support secondary use of medical data would likely
gain support from interested consumers.

5.6

Conclusion

Research Questions 1 and 2 have been addressed in this Chapter. In addition to these
research questions the rejection of the null hypothesis:
H0: There is no significant difference between groups of consumers as
expressed through responses to the public opinion survey used in this study
where p<=0.05.
indicates that a one-size-fits all approach to representing Australian consumer
opinions and expectations regarding secondary use of their medical data would be
inadequate. Any further work needs to acknowledge and accommodate the diversity
of consumer opinion. There is an opportunity to further explore the application of the
RALC and Chapter 7 focuses on the challenges of developing a privacy framework
for secondary uses of medical data. The importance of this framework is apparent
when reflecting on the generational shift that has emerged from the analysis
presented in this chapter. Other complex issues that need to be addressed by the
framework are the healthcare workers well established data stewardship practices.
The role of women in establishing the secondary use framework is important as the
results of the Australian survey indicate that they are more likely to engage
productively in this endeavour.
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6 CANADIAN CONSUMER PUBLIC OPINION SURVEY RESULTS AND
COMPARISON TO AUSTRALIAN RESULTS AND ANALYSIS
6.1

Introduction

The survey was deployed into the Canadian community where the introduction of
electronic health records is further progressed than in Australia. The survey
instrument used in Australia was used in the English speaking parts of Canada with
little change beyond that which was needed to customise to local healthcare
arrangements, as described in the Research Method Chapter. Hence the survey
constructs are not reproduced here. This Chapter presents the Canadian survey
results and discussion including comparison to the Australian survey results.
6.1.1

Descriptive Statistics

In total, 203 Canadians responded to the consumer survey. Table 53 presents the
demographics of Canadian respondents and for comparison selected Australian
demographics are also provided.
Table 53: Canadian Survey Respondents Demographics

Canadian
Respondent characteristics

Frequency
(n)

Canadian %

Australian %

of total

of Total

Gender
Female

111

54.7

65.5

Male

81

39.9

31.9

Not specified

11

5.4

2.6

18-25

2

1.0

2.8

26-39

22

10.8

12.9

40-50

50

24.6

23.1

51-65

80

39.4

36.6

66-80

30

14.8

18.5

Over 80

10

4.9

3.9

Unknown

9

4.4

3.0

Age
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Respondent characteristics

Canadian

Canadian %

Australian %

Frequency (n)

of total

of Total

Highest Level of Education
Secondary school

28

13.8

10.3

College

30

14.8

9.6

Trade Qualification

6

3.0

7.6

Professional Qualification

20

9.9

12.4

Bachelor Degree

47

23.2

20.6

Postgraduate

62

30.5

20.1

Unknown

10

4.9

3.3

Yes

38

18.7

23.1

No

156

76.8

74.3

Unknown

0

0

2.6

Worked in healthcare sector

6.1.2

Survey Psychometrics

This section investigates the validity of the Canadian consumer public opinion
survey instrument using the same approach adopted with the Australian survey.
Table 54 presents the survey constructs, organised within appropriate tripartite
privacy components, for the Canadian consumer survey scales. The Cronbach alpha
(α) calculations were conducted using SPSS 17.0 and, as with the Australian survey,
the alpha values were in the exploratory research range with the exception of
Privacy Justification – ‘finding-a-balance’.
Table 54: Canadian Survey Internal Reliability
Tripartite
Component
Concept
Justification
Management

Construct

Code

Cronbach Alpha (α)
Canada

Australia

Number of
items

Anxiety

C-A

0.748

0.691

6

Limited Access

C-LA

0.561

0.602

2

Rights based

J-RB

0.676

0.644

3

Balance

J-B

0.481

0.159

3

Control

M-C

0.690

0.715

11

Data Stewardship

M-DS

0.579

0.617

5
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Face validity was conducted by the University of Ontario Institute of Technology
(UOIT) Research Ethics Board (REB) and student members of Health Informatics
Research centre who were untrained in terms of survey instrument design or content
of the survey. Content validity was addressed by Australian researchers and reviewed
by the Canada Chair in Health Informatics at UOIT.
The survey instrument performed consistently when moved from the Australian
context to the Canadian context which aids claims of instrument validity.
6.1.3 Response Frequency and Comparison
This section presents the survey response frequencies in tabular and graphical
format. The survey results are not presented in the order of appearance on the survey
instrument but rather they are grouped by the tripartite component to which they
belong i.e. Privacy Concept, Privacy Justification or Privacy Management. Table 55
includes the statement number and text of the statement used in the survey and
tabular presentation of Canadian response frequencies and percentage of valid
responses. Australian response frequencies are provided in tabular format. The bar
charts present the percentage of Canadian and Australian responses within each
Likert scale valid response which includes the ‘don’t know’ option.
Despite the difference in sample size between Australia and Canada, there is value in
comparing the two survey results as the proportions of consumers within
demographic groups are similar, as illustrated in Table 53. The Cronbach Alpha (α)
internal reliability is higher for the Canadian survey than for the Australian survey on
issues of consumer anxiety and perception of individual ‘rights’ to privacy. The
Cronbach Alpha (α) measure on the Privacy – Justification ‘getting-the-balanceright’ construct was higher on the Canadian survey than the Australian survey,
however this continues to be outside the accepted range for exploratory research.
Any future research using this survey instrument needs to redesign the statements
pertaining to the ‘getting-the-balance-right’ between the ‘common good’ of society
perceptions of individual rights to get higher internal reliability.
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To aid in the comparison between Australian and Canadian survey results a null
hypothesis was generated:
H0: There is no significant difference between Canadian and Australian consumer
opinion as expressed through responses to the public opinion survey used in this
study where p<0.05.
The Mann-Whitney U test was used to investigate the null hypothesis. Where the test
results were statistically significant, and the null hypothesis was rejected, a note
appears in Table 55 along with the asymptotic significance (2 tailed). The MannWhitney U test results are non-parametric and hence cannot provide definitive
metrics for the differences between the Canadian and Australian samples. By
reviewing the bar charts in Table 55 it is possible to gain a broad sense of the
differences in opinion however no confidence intervals can be stated. Despite this
limitation, high level insight can be gained as presented in Table 55 below. Further
research would enable a more precise calculation of the opinion differences between
Australians and Canadians, however for the purpose of this initial study the MannWhitney U test and frequency bar charts were sufficient.
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Table 55: Canadian and Australian Survey Response Frequency and Statistically Significant Mann-Whitney U test results.

Tripartite Privacy Concept Component

Australia

6. I am concerned that my medical
information may be stolen.

Canada

Australia

8. I worry about medical
receptionists reading my medical
information.

Canada
Australia

know

Disagree

0
0.0%

Strongly

Disagree

Neutral

Agree

0

1

7

44

151

0.0%

0.5%

3.4%

21.7%

74.4%

Agree

0%

0.6%

1.0%

3.4%

20.6%

74.3%

1

7

43

73

54

23

0.5%

3.5%

21.4%

36.3%

26.9%

11.4%

1.0%

3.2%

21.2%

38.5%

23.9%

12.2%

0

18

60

73

36

14

0%

9.0%

29.9%

36.3%

17.9%

7.0%

0.3%

4.3%

24.1%

40.8%

20.9%

9.7%

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .001
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% of Respondents

Canada

Strongly

% of Respondents

5. If an unauthorised person gained
access to my medical information then
I would feel that my privacy had been
violated.

Don’t

% of Respondents

Survey Statement

80
60
40

Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

9. I worry about computer staff
being able to read my medical
information when they are looking
after medical systems.

Canada
Australia

Don’t

Strongly

know

Disagree

0

Strongly

Disagree

Neutral

Agree

14

48

68

50

22

0.0%

6.9%

23.8%

33.7%

24.8%

10.9%

0.3%

3.4%

21.3%

35.2%

26.7%

13.2%

Agree
% of Respondents

Survey Statement

40
30
20

Australia

4

27

109

33

16

11

2.0%

13.5%

54.5%

16.5%

8.0%

5.5%

2.0%

10.9%

47.8%

24.2%

9.1%

5.7%

% of Respondents

Canada

Don't
know

2

8

37

75

75

1.5%

1.0%

4.0%

18.5%

37.5%

37.5%

1.2%

1.3%

6.1%

19.8%

40.7%

30.7%

% of Respondents

Australia

3

Canada

Australia

37

3

9

41

95

18

18.2%

1.5%

4.4%

20.2%

46.8%

8.9%

19.8%

0.7%

2.9%
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20.3%

45.5%

10.9%

Agree

Strongly
Agree

40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .052
% of Respondents

10. In Canada my healthcare
providers try to protect my privacy
by restricting access to my medical
information.

Canada

Strongly Disagree Neutral
Disagree

60

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .037

27. I worry about insurance
companies getting access to
medical information because they
may not use information in a way
that benefits society.

Australia

0

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .054

25. I would never agree to donate
my medical information to anyone
because I worry about potential
misuse of the information.

Canada

10

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

11. It seems that my healthcare
providers feel that the fewer people
who see my medical information
the higher the level of privacy they
have provided for me.

Canada
Australia

Don’t

Strongly

know

Disagree

59

Strongly

Disagree

Neutral

Agree

1

8

38

81

12

29.6%

0.5%

4.0%

19.1%

40.7%

6.0%

19.7%

0.3%

3.9%

25.6%

41%

9.1%

Agree

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .014

60

% of Respondents

Survey Statement

40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

1. I believe that I have a ‘right’ to
personal privacy.

Canada
Australia

0

0

2

3

43

154

0%

0%

1.0%

1.5%

21.3%

76.2%

0.1%

0.3%

0.6%

2.2%

28.3%

68.6%

% of Respondents

Tripartite Privacy Justification Component
100
50

Australia

1

0

0

7

70

124

0.5%

0%

0%

3.5%

34.7%

61.4%

0.5%

1.4%

1.3%

3.4%

44.5%

48.8%

% of Respondents

Canada

Don't
know

Australia

0

0

1

6

41

154

0%

0%

0.5%

3.0%

20.3%

76.2%

0.2%

0.3%

0.3%

1.5%

26.9%

70.9%
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% of Respondents

Canada

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

80
60
40

Canada

20

Australia

0
Don't
know

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .001

4. I expect Canadian laws and
healthcare guidelines to protect my
personal privacy.

Australia

0

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .035

3. I have the ‘right’ to share my
medical information with others.

Canada

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

100
50

Canada
Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

26. I support the idea of medical
information donation when the
information is used in a way that
benefits society.

Canada

Australia

Canada
Australia

Strongly

know

Disagree

2

Strongly

Disagree

Neutral

Agree

2

16

31

97

50

1.0%

1.0%

8.1%

15.7%

49.0%

25.3%

1.6%

2.4%

6.2%

14%

52.5%

23.3%

4

2

5

11

100

77

2.0%

1.0%

2.5%

5.5%

50.3%

38.7%

0.9%

1.2%

1.7%

7.2%

57.2%

31.8%

Agree

% of Respondents

12. If information about my health
can be used to help others who are
suffering ill-health then I believe my
information should be used to help
those people.

Don’t

% of Respondents

Survey Statement

60
40

Australia

4

4

16

44

91

40

2.0%

2.0%

8.0%

22.1%

45.7%

20.1%

1.1%

1.3%

7.2%

22.5%

49.8%

18%

% of Respondents

Canada

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

80
60
40

Canada

20

Australia

0
Don't
know

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .038

28. Using medical information for
the ‘common good’ is OK but I
worry about the risk to a person’s
privacy.

Canada

20

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

16. If I donated my medical
information for research I would
want to choose the level of privacy I
required. For example I may
choose (1) ‘always anonymous’ or
(2) ‘name and Medicare number
can always be used’.

Canada

Australia

2

3

2

10

94

86

1.0%

1.5%

1.0%

5.1%

47.7%

43.7%

1.1%

2.2%

1.8%
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4.8%

46.1%

44%

% of Respondents

Tripartite Privacy Management Component
60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

17. If I give consent for my health
information to be used for research
I want to be able to say who can
use my information like ‘medical
researchers’, ‘drug companies’,
‘university
researchers’
or
‘insurance companies’.
19. A person must be able to
choose to keep their medical
information private and never
consent to release their medical
information for any purpose.

Canada

Australia

Canada

Australia

Canada

Australia

1
0.5%

Strongly

Disagree

Neutral

Agree

0

6

12

82

98

0%

3%

6%

41.2%

49.2%

Agree

0.3%

0.7%

2.2%

5.9%

47.5%

43.4%

3

2

16

22

106

49

1.5%

1.0%

8.1%

11.1%

53.5%

24.7%

2.0%

1.1%

8.5%

14.9%

53.4%

20.1%

0

5

9

26

75

84

0%

2.5%

4.5%

13.1%

37.7%

42.2%

0.5%

1%

3.9%

10.1%

40.3%

44.2%

4

5

28

24

54

84

2%

2.5%

14.1%

12.1%

27.1%

42.2%

0.8%

2.1%

10.3%

11.1%

33%

42.7%
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% of Respondents

Australia

Disagree

% of Respondents

Canada

Strongly

know

% of Respondents

13. If my health information could
be made anonymous by removing
things like my name, address,
phone number and Medicare
number I would be more likely to
agree for the information to be used
for medical research.
14. I feel that I continue to have
privacy even when other people
have access to my personal
information if I am the one who has
granted the other people access.

Don’t

% of Respondents

Survey Statement

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

21. If people agree to donate their
data for medical research there
must be a way for them to stop the
donation agreement at any time.

22. If people agree to donate their
data for medical research from time
to time they must be asked if they
want to continue to donate.

23. If I choose to donate my
medical information then healthcare
providers should release the
information according to my
instructions.

Canada

Australia

Canada

Australia

Canada

Australia

Disagree

7

12

3.5%

6%

Neutral

Agree

33

31

75

16.6%

15.6%

37.7%

Strongly
Agree

41
20.6%

2.1%

5%

14.4%

14.1%

45.9%

18.5%

2

4

17

19

69

87

1%

2%

8.6%

9.6%

34.8%

43.9%

0.5%

0.7%

3.9%

5.9%

43.2%

45.7%

0

6

19

28

82

63

0%

3%

9.6%

14.1%

41.4%

31.8%

0.8%

1.5%

7.1%

11.9%

44.5%

34.3%

2

3

9

22

85

79

1%

1.5%

4.5%

11%

42.5%

39.5%

0.7%

0.4%

1.6%

6.5%

48.9%

41.9%
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% of Respondents

Australia

know

Disagree

% of Respondents

Canada

Strongly

% of Respondents

20. If I donated my medical
information for research I would like
to give my consent once - at the
time of ‘signing up’ as a data donor.

Don’t

% of Respondents

Survey Statement

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

29. I should be able to see my
medical information and it should
be easy to correct any mistakes in
the information.

Canada
Australia

Don’t

Strongly

know

Disagree

0
0%
0.6%

Strongly

Disagree

Neutral

Agree

0

3

5

72

120

0%

1.5%

2.5%

36%

60%

0.2%

1.7%

6.1%

42.1%

Agree

49.4%

% of Respondents

Survey Statement

80
60
40

Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

Australia

Canada

Australia

7. When my medical information is
stored on a computer owned by a
healthcare provider they should not
assume that they ‘own’ the
information.

Canada

Australia

3

1

4

12

100

79

1.5%

0.5%

2%

6%

50.3%

39.7%

0.3%

0.7%

1.8%

5.5%

52.1%

39.6%

4

83

69

22

15

6

2%

41.7%

34.7%

11.1%

7.5%

3%

1.1%

40.3%

37.2%

10.6%

7.3%

3.5%

2

2

3

15

57

124

1%

1%

1.5%

7.4%

28.1%

61.1%

0.4%

0.7%

1.7%
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4.5%

38.7%

53.9%

% of Respondents

24. I would be happy to let the
Canadian Government decide who
can use my medical information.

Canada

% of Respondents

15. I support the idea of people
being given a personal choice
about ‘donating’ their medical
information for research.

% of Respondents

H0 rejected: Mann-Whitney U test results asymp. sig (2 tailed) = .007
60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

80
60
40

Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

2. I think that my medical records
belong to me – they don’t just
belong to my healthcare providers.

Australia

Canada

Australia

18. Any medical research groups
who want to use ‘donated’ data
must comply with the wishes of the
person who has ‘donated’ the data.

Canada

Australia

know

Disagree

6
3%

Strongly

Disagree

Neutral

Agree

77

53

16

31

16

38.7%

26.6%

8%

15.6%

8%

Agree

1.9%

32.2%

34.1%

10.8%

14.4%

6.5%

0

2

6

18

56

121

0%

1.0%

3.0%

8.9%

27.6%

59.6%

0%

0.9%

2.9%

7.5%

31.5%

57.3%

2

3

8

13

68

105

1.0%

1.5%

4.0%

6.5%

34.2%

52.8%

0.3%

0.5%

2.2%
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5.8%

37.2%

54.0%

% of Respondents

Canada

Strongly

% of Respondents

30. A legal judge in Australia
decided that the notes written about
a patient, by a Doctor, are owned
by the Doctor not the patient. This
decision seems reasonable to me.

Don’t

% of Respondents

Survey Statement

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

80
60
40

Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

60
40
Canada

20

Australia

0
Don't
know

Strongly Disagree Neutral
Disagree

Agree

Strongly
Agree

The next section discusses the results from the Canadian survey with an
emphasis on comparison with Australian results including the Mann-Whitney
U test and statistically significant Chi-Square test results.
6.1.4

Analysis

Data pre-processing was undertaken on the Canadian survey responses in
exactly the same manner as that described for the Australian surveys in the
Chapter 4. The qualitative comments have been encoded in the same manner
as the Australian survey using the same coding scheme with an adjustment to
highest level of education to include “College”. The Canadian survey is
smaller than the Australian survey with 203 and 1,158 returned surveys
respectively. The frequencies with which themes arise in the qualitative
comments have been tabulated as with the Australian survey and sample
respondents comments are provided.
In an approach similar to the analysis of the Australian quantitative data, the
Pearson Chi-Square (X2) test was used with the Canadian survey results. The
Canadian sample size is much smaller than the Australian sample size and the
results of Chi-Square tests on small samples are not as reliable as results from
larger samples. As with the Australian results, where the Canadian expected
count of Chi-Square results is less than five the result was excluded. This left
just two statistically significant Chi-Square test results; on Statement 9 and
Statement 20. These results are discussed in the appropriate tripartite material
below.
6.1.5

Tripartite Component - Privacy Concept

The eight statements considering the concept of privacy, including anxiety and
limited access approaches, revealed that amongst Canadian respondents there
was only one statistically significant difference and this related to Statement 9.
The Chi-Square tests on Statement 9 – I worry about computer staff being able
to read my medical information when they are looking after medical systems,
revealed citizens opinion differing according to highest level of education
(df=10, p=0.049) with post graduate educated citizens responding
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negatively more frequently than expected in contrast to college and
professional educated citizens who responded more positively.
This result is similar to the Australian responses to Statement 9 where ChiSquare testing also revealed opinion varying across education level
(df=12, p<0.001). The difference in the degrees of freedom is
expected as the Canadian education demographics include fewer categories
than Australia. Tertiary educated (Bachelor and Postgraduate) Australians and
Postgraduate educated Canadians are responding in a more negative way than
expected to the Statement, thus indicating less anxiety regarding the
involvement of IT professionals in managing health information systems than
are other citizens.
The null hypothesis regarding no difference between Canadian and Australian
consumers opinion was rejected for half the statements that relate to the
tripartite Concept of Privacy Component (see Table 55). These are Statements
8, 9, 25, 27 and 11 and results for each are incorporated into discussions
below.
Statement 8 explored consumers’ anxiety regarding medical receptionists
reading consumer medical information and Australians indicated that they
worry about medical receptionists more than do Canadians. This sentiment is
also apparent via the greater number of Canadians who responded ‘strongly
disagree’ or ‘disagree’ to Statement 8.
Statement 9 explored consumer concern regarding IT professional access to
medical information and the Chi-Square testing discussed above revealed
differences within national samples. In addition there were differences
between Canadian and Australian consumers. Echoing the results of Statement
8, Australians were again more anxious about IT professionals’ access than
were Canadians. Canadians selected ‘strongly disagree’ and ‘disagree’ more
frequently than Australians.
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Not donating medical information because of concern about misuse was the
focus of Statement 25. Australians were more neutral on this matter than were
Canadians. Canadians outstripped Australians in negative responses thus
indicating a stronger opinion about not wanting to withhold information due to
potential misuse.
Statement 27 gathered public opinion regarding worry about insurance
companies gaining access because their uses may not benefit society. Here
Canadians strongly agreed more at a higher percentage than did Australians.
Restricted access concepts of privacy were explored in Statement 11 and
Canadians responded ‘don’t know’ more frequently than Australians. Slightly
more Australians selected ‘strongly agree’ and ‘neutral’ than did Canadians.
The previous Chapter considered why so many survey respondents chose
‘don’t know’ and similar analysis could be applied here regarding because
many Canadians did not know that the healthcare sector relies on limited
access for privacy. The literature coming from the healthcare community is
strong in promoting the limited access approach to privacy and yet a large
percentage of Canadian and Australian citizens are unsure of this practice.
The same structured notation has been adopted for this Chapter as was used to
attach demographic characteristics to Australian qualitative comments.
Table 56 provides a summary of Canadian codes needed to interpret
demographics for qualitative comments.
Table 56: Canadian Province Codes
Code

Province

AB

Alberta

BC

British Columbia

MB

Manitoba

NB

New Brunswick

NS

Nova Scotia

ON

Ontario

SK

Saskatchewan

YT

Yukon Territory
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Table 57 presents the qualitative codes adopted and the frequency with which
a theme was included in Canadian respondents comments to the two
qualitative survey questions for deductive themes related to the tripartite
Privacy Concept (as described in the Research Method Chapter, Table 14).
Table 57: Tripartite Component - Privacy Concept, Canada- Qualitative Comment Count
Code
Sub
Theme
Comment 1
Comment 2
Code
Frequency
Frequency
1
A
Expressing anxiety
Privacy
9
9
Concept
B
Not anxious about secondary use
1
2
of data
C
Consumer TRUST - Don’t know
who has information – Lack of
2
0
transparency
D
Not everyone who has access has
12
7
patients’ best interests at heart
E
Surveillance
1
1
TOTAL

25
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Examples of the diverse qualitative comments related to the tripartite Privacy
Concept are provided below with demographic characteristics of the
respondents.

“What do people have to hide? If you want to use OHIP you must comply with
the rules that may compromise personal privacy.” [Survey31,unknown]
The Ontario Health Insurance Plan (OHIP) is a government supported program
for residents of Ontario with funding sources including taxes and Canadian
Government contributions. This consumer is expressing an opinion that is
based on an argument that if an individual wants to take advantage of the
OHIP services they are not meeting all the costs of healthcare themselves and
should be prepared to trade some of their privacy as a consequence. Some
Australian respondents expressed similar economics-based rationale for
forgoing privacy in return for heavily subsidised services.

“It must never be made available to insurance companies!”[Survey134,F,AB,5165,College,HW]
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“I don’t sit around and ‘worry’ about ‘where’ is my healthcare information.
Actually computers are not my forte but I do understand that “hackers” could
access the info – what would they do with the info? Sell to insurance
companies now that would worry me!” [Survey135,F,AB,66-80,Prof,HW]

“I am concerned about big pharma using data for their own financial benefit
and insurance companies using data to exclude some people for healthcare
coverage.” [Survey9,M,ON,40-50,Postgrad,NHW]

“I have concerns about the use of individuals medical data and potential for
abuse by employers, insurance companies and other groups we haven’t even
considered at this point. There is huge potential for discrimination – and
discrimination that is hidden is impossible to deal with. There are also other
potential harms than discrimination – who knows how this information could
be used?” [Survey4,F,ON,51-65,Postgrad,NHW]
These four comments re-enforce the Canadians Likert responses to Statement
27 expressing strong opinion regarding the insurance industry in a way
sufficiently different to Australians that the difference was identified by the
Mann-Whitney U test as described above.
“As with problems related to “3rd Party” access to daily emails and telephone
numbers, personal information is being transferred to others who may not
have the best interest of the donor. Instructions for use and storage may be
compromised as the information descends through a long process of 3rd party
collectors.” [Survey136,F,BC,51-65,Postgrad,NHW]
“During my career I was involved with a number of studies based on personal
information from surveys where the respondents had been promised
confidentiality. I have yet to meet a researcher who took this promise
seriously. I have seen confidential databases entrusted to a researcher who in
turn delegated grad students who in turn share it with research groups! The
research community does not seem to take the promise of confidentiality at all
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seriously. I basically have very little faith in promises of confidentiality.”
[Survey192,M,ON,66-80,Postgrad,NHW]

These two comments express concern about the journey of an individual’s
medical information beyond the bounds of primary care delivery. Survey 192
is particularly concerning as the respondent declared awareness of
inappropriate data management from his professional experience. This is
similar to an Australian medical researcher who was very frank in her
assessment of ‘what really goes’ on in managing consumers data and is
repeated here for comparison:
“Having worked in medical research for the past 8 years, I have been amazed
to see the difference in systems used at the different hospitals - some very strict
& completely not - patient/client and others not seeming to care at all. Given
the very sensitive nature of this data (mental health files) I was shocked to say
the least with the latter. I now work in research management and review all
ethics applications for my department. We now ensure that clients are fully
aware of the potential for data (including medical files) to be re-used/analysed
at later stages and most studies ask to recontact clients if this happens, but
also ask if they want this at the initial consulting. I believe it is vital, especially
in vulnerable populations that this area is fully and clearly explained to
clients/patients as it is often confusing and these populations should not be
taken advantage of.” [AustralianSurvey1142,F,VIC,26-39,Postgrad,HW]
The next two comments relate to an emerging theme in the Canadian survey
and relate to the storage of data outside the jurisdiction of Canada:

“Data stored outside the country of origin i.e. Canadian data stored in the
U.S. integrated database projects such as one at U of Manitoba.”
[Survey10,M,ON,66-80,Bachelor,NHW]

“My concern is that computerised records are accessed in other countries with
different or no sense of privacy protection (i.e. in US and India.)”
[Survey84,F,MB,51-65,Postgrad,HW]
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Only one Australian out of the 390 individuals who provided qualitative
comments raised the issue of offshore data storage. To have two Canadians out
of the 67 individuals who provided comments raise this issue may be an
indication this matter has more import in the Canadian community. This
requires further research to determine if this early, small indication is valid.
These cross border privacy and data management comments are very pertinent
and there is activity underway across many societies in diverse sectors
including law, healthcare and information systems struggling with these
matters. This is likely to be a growing area of both research and industry
attention in the future.

6.1.6

Tripartite Component – Privacy Justification
The Chi-Square test results for the Canadian survey statements related to
tripartite Privacy Justification component did not give rise to any statistically
significant results. The Mann-Whitney U test comparing Canadian and
Australian consumer opinions found asymptotic significant results on three
statements and enabled rejection of the null hypothesis on Statements 1, 3 and
26.
As illustrated in Table 55 Canadians’ responses to Statement 1 and Statement
3 indicate they ‘strongly agree’ more frequently than do Australians on matters
related to the ‘right’ to privacy.
The Mann-Whitney U test results indicate a difference between nations on the
issue of using medical information in a way that benefits society. As illustrated
through Statement 26 responses in Table 55. Canadians argued, through
qualitative comments, for the ‘getting-the-balance-right’ debate. Some of the
comments move from ‘getting-the-balance-right’ to issues of consent which,
for the purposes of this study, are considered in the Privacy Management
section. Rather than disjoint the consumers comments the consent matters have
been retained in those included below.
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Table 58 presents the qualitative codes adopted, and the frequency with which
a theme was included, in respondent comments to the two qualitative survey
questions for deductive themes.
Table 58: Tripartite Component – Justification of Privacy, Canada – Qualitative Comment Count
Sub
Theme
Comment 1 Comment 2
Code
Frequency
Frequency
Code
2

Justification

A

‘Right’ to privacy

B

Responsibility

of

citizens

to

2

1

4

3

10

10

7

3

23

17

participate in secondary use.
Individual rights versus ‘common
good’
C

Personal data as a commercial
commodity; Commercial aspects
of data use

D

Ownership of data
TOTAL

Examples of the qualitative comments related to the tripartite component
Privacy Justification are provided below with demographic characteristics of
the respondents.

“It is essential that researchers gain access to health records and data
conveying morbidities etc. – but they cannot use it in ways that violates a
person’s confidentiality. There is little reason a researcher should want to
focus on an individual case but information on individuals should be kept from
other organisations such as insurance companies with a vested interest in a
particular outcome”. [Survey59,M,BC,40-50,Bachelor,HW]

“I strongly believe that most people would consent to medical data use when
used for good of all people and they would be even more willing if our laws
provided and ensured accountability.” [Survey118,M,unknown,51-65,College,NHW]
“Essentially I think a balance is required. Consent to use data is a must – ALL
data needs to be voluntarily granted under conditions of informed consent.
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Data that has been anonymized does not in my opinion, belong to the subjects
anymore – and he/she has no right to direct if/how it might be used.”
[Survey190,M,NS,40-50,Postgrad,NHW]

“From a utilitarian perspective the greater good of society must trump
individual privacy. Most statistical data may remain anonymous as the name
etc of the subjects isn’t needed to come to conclusions people will benefit from
the research. People who feel free to use OHIP must make full disclosure.”
[Survey31,unknown]

It is interesting to note the importance Canadians placed on their ‘rights’ to
justify privacy yet very few of the qualitative comments elaborated on the
matter of a person’s ‘rights’. In contrast, the respondents were more likely to
elaborate on their desire to ‘get-the-balance-right’ with the case well put for
medical information to be available for health research. The Cronbach Alpha
(α) metric on constructs for ‘getting-the-balance-right’ was much better on the

Canadian (0.481) survey than the Australian (0.159) survey. Initial analysis
suggested that the wording of Statements for this construct was poor and led to
the unsatisfactory internal reliability on this construct of the survey. The
Canadian (α) is much better than the Australian and the Mann-Whitney U test
identified cross-national differences on one relevant statement and the
Canadian qualitative comments in this area are well articulated. This may be
indicators of a difference in opinion between Australia and Canada on the
veracity of these ‘getting-the-balance-right’ arguments; however the data
available via this study is unable to definitively state this is a substantial
difference. Further research could build on these early findings and explore the
future implications (if there are any) of Australians perhaps not being as
accepting of this utilitarian paradigm. The healthcare systems in Australia and
Canada have some fundamental differences that may be a factor influencing
this comparison. Australia has a mixed private-public system with cost sharing
arrangements where private insurance plays a role. In contrast Canada has a
universal public insurance plan (Blendon, Schoen et al. 2002). The delivery of
universal care for Canadian citizens may engender a more positive response to
survey Statement 26.
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6.1.7

Tripartite Component – Privacy Management

Chi-Square testing revealed statistically significant differences on only one
Statement in those related to Privacy Management. Differences across gender
were found on Statement 20 – If I donated my medical information for
research I would like to give my consent once – at the time of ‘signing up’ as a
data donor, with Chi-Square results (df=2, p=0.018) where
Canadian women were less likely to ‘strongly agree’/’agree’ with this
statement than expected and men were more likely to agree (see Table 59).
Table 59: Statement 20 Pearsons Chi-Square statistically significant - Gender
Gender
Frequency
Disagree
Neutral
Agree
Female
Male
TOTAL

Count
Expected Count
Count
Expected Count
Count

31
23.2
10
17.8

16
16.4
13
12.6

56
63.4
56
48.6

41

29

112

Total
103
79
182

This result is similar to the Australian women who were found, via ChiSquare testing, to be expressing different opinions to men across a number of
the Privacy Management statements. Given the small sample size and
challenges associated with Chi-Square with expected counts fewer than five it
is not surprising that very few Chi-Square statistically significant results could
be found in the Canadian results, however there was sufficient data to allow
this gender issue to emerge.
The Mann-Whitney U test result for Statement 29 – I should be able to see
my medical information and it should be easy to correct any mistakes in the
information found asymptotic significant differences between Australian and
Canadian consumer opinion. A review of the bar chart in Table 55 reveals that
Canadians ‘strongly agree’ with this statements more frequently than do
Australians. This statement was included to explore the ‘correction’ aspects of
Moor and Tavani’s Restricted Access Limited Control (RALC) Theory. This
theory

suggests

that

the

subject

of

information

(in

this

context

consumers/patients) should be able to see and correct any information that is
held by a health service provider. The reason for the stronger view from
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Canadians may be because they are further advanced with the implementation
of electronic health records (EHR) and Canadian consumers may be feeling
some shared angst over their lack of ability to see and correct their electronic
health record. As yet Australia has not completed the introduction of electronic
health records and hence Australian consumer may not be as informed about
the issue as are Canadians. The Australian implementation of electronic health
records has emphasised the personally controlled aspects which contrasts with
the Canadian approach to EHRs which has not emphasised consumer
controlled aspects.

Code
3

Table 60: Tripartite Component – Management of Privacy– Qualitative Comment Count
Sub Theme
Comment 1 Comment 2
Code
Frequency
Frequency
Management
A
Good data stewardship
2
0
required and consumers need
confidence in arrangements
underpinning secondary use
B
Consumers as research
0
0
partners not research subjects
C
Consumer control of data
2
9
issues
D
Restricted access to
0
0
consumer data issues
E
De-identification of data
12
4
F

Consent

6

0

G

Payment for use of data

0

0

H

Legal system to protect
consumers
Consumers to provide input
on data stewardship –
including being able to decline
to participate
Role of Government

0

3

1

0

1

0

Secondary use mechanisms:
Human Research Ethics
Committees; computer
technology
Comments in support of
secondary use
Comments about sensitivity of
different types of information
eg. Sexual health, mental
health
Comments about the purpose
of data use eg. OK for
research but not OK for
commercial secondary use

0

1

7

0

0

0

15

2

46

19

I

J
K

L
M

N

TOTAL
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Examples of the qualitative comments related to the tripartite component Privacy
Management are provided below along with demographic characteristics of the
respondents.

“Personal medical data is a private matter and would not exist if there was not a
person having that data collected. Information about a medical history is a result of
a person being diagnosed in a professional manner. Access or use of a persons
medical data, without full consent, in a context of informed use of such data is
equivalent to THEFT.” [Survey97,F,NS,51-65,Postgrad,NHW]

“My husbands medical information was stolen at an H1N1 clinic. The computer stick
was taken. Not great!!” [Survey109,F,ON,51-65,Bach,NHW]
These two Canadians are sharing opinions that indicate they are troubled by the theft
of medical information. This echoes similar qualitative concerns from Australians.

“I believe medical practitioners need to be trained (and retrained) about releasing
and discussing the details with the patient. There is a very ‘paternalistic’ attitude
that permeates the profession – and I am dealing with a mid-age female doctor and I
am mid-age female. This attitude is very common and therefore I have resigned
myself to this attitude and trying to work around it – this wastes time and doesn’t
allow me to be proactive and self-directed.” [Survey136,F,BC,51-65,Bach,NHW]
As described in the Literature Review of this thesis, struggling with perceptions and
the reality of medical paternalism is a complex issue that is apparent in both the
primary care context and spills over into the secondary use context. The recent calls
to adopt a research partnering approach with consumers/patients would overcome
some of the paternalism and empower consumers. None of the Australian or
Canadian consumers’ qualitative comments directly mentioned partnering for future
research however the sentiment expressed by the Canadian woman from British
Columbia, who made the above comment, does focus on paternalism and negative
associations.
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“Access to medical history – generally agree ASSUMING personal information is
kept ANONYMOUS.” [Survey181,M,ON,51-65,Postgrad,NHW]

“Use of data for research is OK if information, imaging studies etc. are anonymized
but this doesn’t always happen. I’ve seen cases at meetings where CT scans are
shown (case exchanges) and patient identifying info is still visible.” [Survey50,F,NS,4050,Postgrad,HW]

The anonymising, or de-identifying, of consumers data also emerged as an important
issue in the Australian consumers’ qualitative comments. There are some interesting
comments from Australians and Canadians who state that once data has been
anonymised the consumer should not have any control over the secondary use. Other
opinions indicate that even when anonymised the consumer should have some
influence over data use.
“A persons medical information is their own personal property and should never be
used without consent. A persons medical information should only be used for
purposes that the patient has specified it be used for and nothing else.”
[Survey118,M,unknown,51-65,College,NHW]

This College educated Canadian male is arguing the case for medical information to
be considered the property of the consumer with the consumer making decisions
regarding re-use.
6.2

Emergent Qualitative Themes

As with the Australian survey, the Canadian survey adopted a deductive approach to
the encoding of qualitative comments with existing literature providing the areas of
focus. There are emergent issues that arose through the survey qualitative material
that was not anticipated through the deductive process. These emergent Canadian
themes are listed here as the themes that emerged via an inductive process of
analysis:


Offshore data storage issues e.g. United States and India



Shared experiences from healthcare workers and researchers who witnessed
poor privacy management during their careers
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6.3

Summary of Comparative Findings

The comparison of results from the Canadian and Australian surveys found
statistically significant results, via Mann-Whitney U testing, regarding the Privacy
Concept, Privacy Justification and Privacy Management as summarised below:
Privacy Concept


Anxiety about medical receptionists and IT professionals
accessing personal medical information differs between
Canadian and Australian respondents.



Withholding medical information due to concern about
potential for misuse varies between the Canadian and
Australian respondents.



Canadian and Australian respondents vary on the anxiety
regarding insurance sector use of medical data.

Privacy Justification


The strength of Canadian consumers’ opinions regarding a
person’s ‘rights’ vary from Australian consumers.



Differences exist between the Canadian and Australian survey
respondents regarding the donation of medical information for
use that benefits society.

Privacy Management


Differences exist between Canadian and Australian consumers
regarding the consumers’ ability to see and correction medical
information.

6.4

Chapter Summary

This chapter reported the results of the Canadian consumer survey and provided
comparison with the Australian survey results. Responses were received from urban,
regional and remote locations including the Yukon, Ontario, Manitoba, British
Columbia, Nova Scotia, Alberta and New Brunswick. Response frequencies for each
statement were presented in tabular and graphical format with each Likert scale.
Results of empirical tests for instrument reliability were presented with all but one
construct resulting in Cronbach Alpha > 0.5, which falls within the exploratory
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research satisfactory range. Pearsons Chi-Square tests were conducted across the
categorical demographics data and ordinal responses to statements resulted in two
statistically significant results. To aid in the comparison with Australian consumer
survey results a null hypothesis was generated:
H0: There is no significant difference between Canadian and Australian
consumer opinion as expressed through responses to the public opinion survey
used in this study where p<=0.05.
The Mann-Whitney U test was employed to investigate the differences between
Australian and Canadian citizens’ attitudes and the null hypothesis was rejected on
six statements.
As with the Australian surveys, qualitative comments were classified and reported
based on assessment by two coders following Miles and Huberman recommended
approach (1994). The same two qualitative researchers who coded the Australian
survey also coded the Canadian survey. The summary counts for theme occurrence in
survey responses were presented along with sample comments from a diverse set of
survey respondents. These qualitative results complement the quantitative results and
were co-presented within the tripartite framework.
This Chapter concludes the material that relates directly to the Canadian and
Australian consumer surveys. Chapter 7 introduces a privacy framework for
secondary use of medical data and Chapter 8 presents study conclusions.
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7 A PRIVACY FRAMEWORK FOR SECONDARY USE OF MEDICAL
DATA
7.1

Introduction

In this Chapter a Privacy Framework for secondary use of medical data is proposed
which builds on existing privacy theory (Tavani and Moor 2001; Nehf 2003; Moor
2005; Tavani 2007b; Nissenbaum 2010) and is informed by the opinion of
consumers as described in Chapters 4, 5 and 6 and other consumer research
(Willison, Keshavjee et al. 2003; Willison, Schwartz et al. 2007; Willison, Emerson
et al. 2008). The results of the survey chapters indicated statistically significant
differences between groups of consumer. To accommodate the vast diversity of
consumer opinion is a primary goal in developing the Privacy Framework. A flexible
framework will be required. The expectations of the medical research community
are also acknowledged and provided for within the proposed privacy framework.
This Chapter begins by using a series of figures to illustrate the construction of the
proposed privacy framework drawing on elements of existing privacy theory and
associated concepts for the secondary use of medical data context. Once the broad
structure or ‘skeleton’ of the framework is in place the consumer views are used to
refine the details of the framework.
The proposed Privacy Framework is not a detailed attempt to anticipate every
possible permutation and combination of some consumer desires to apply restrictions
to parts of their Electronic Health Records (EHR). The proposed Privacy Framework
does not attempt to meticulously offer an ever increasing list of potential third party
data users to consumers to consider if they are in or out of their approved list of data
receivers. In the real world such a framework would rapidly become unwieldy and it
would be difficult to maintain consumer engagement with such an onerous approach.
The proposed privacy framework for secondary use of medical data is a conceptual
model which deliberately avoids introducing aspects of physical information systems
design. The importance of establishing a conceptual or logical design independent of,
and prior to, physical design is a core principle of information systems analysis and
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design as discussed in the Introduction chapter. Moving to physical system designs
with inadequate consideration of the important conceptual design matters often leads
to unsuccessful or inadequate information systems. The focus here remains on
development of a conceptual model incorporating the requirements of the often over
looked stakeholder – the consumer.
The next section introduces the ‘skeleton’ of the privacy framework, and once all
parts have been introduced, more detailed discussion regarding the framework is
provided including choices made regarding what should be included and excluded
from the privacy framework for the secondary use of medical data.
7.2

The Initial ‘Skeleton’ of the Framework

Construction of the ‘skeleton’ of the privacy framework will be described in a staged
approach with the first stage involving the incorporation of Nissenbaums’ framework
for Contextual Integrity as depicted in Figure 39. In Stage 2 (see Figure 40) Moor
and Tavani’s influence is added.
Nissenbaum’s research into privacy from the perspective of context provides very
useful insight and the abstract privacy elements she describes include Context,
Actors, Attributes and Transmission Principles as described in the Literature review
Chapter. Figure 39 illustrates the core elements of Nissenbaums’ framework for
contextual integrity and the introduction of these core elements into the privacy
framework for secondary use of medical data which is depicted in the right hand box
in Figure 39. The arrowed lines indicate the mapping and interpretation of each of
Nissenbaum’s core elements to the associated element in the privacy framework.
Each of the arrowed lines is labelled A, B, C, D for ease of reference and the
transition of each of Nissenbaums’ elements to the privacy framework for secondary
use of medical data is described here.
Component A – Context
The context for this model is Australian society where the struggle with privacy in
the digital age is on-going. Specifically, the context for the proposed Privacy
Framework is the secondary use of medical data with engagement with consumers to
deliver improved privacy.
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Component B – Actors
The actors playing a role in any context include those who are sending information,
those who are receiving information, and the subjects of the information. In the
secondary use of medical data context the ‘senders’ of information are most likely to
be healthcare providers. In this context the ‘receivers’ include medical researchers,
health service researchers, commercial data ‘harvesting’ organisations, Government
organisations, insurance sector stakeholders, and other stakeholders we cannot yet
anticipate. The ‘subjects’ of the information are patients/consumers.
Component C – Attributes (Information Types)
The Attributes (Information Types) in this context includes a diverse range of
physiological measurements, diagnoses, family histories, medication histories,
mental health attributes, diseases and conditions experienced by the consumers. The
data types are equally diverse including, but not limited to images, text, numeric,
encoded physiological data, unstructured, narrative text, data streams and multimedia entries (Kalra 2006). The sensitivity levels of each attribute vary with the most
sensitive being mental and sexual health. The attributes are represented in the privacy
framework as a matrix of consumer data attributes and default sensitivity settings.
The granularity of the contents of the data attributes and default sensitivity settings
matrix are determined by the consumers. Chapters 4, 5 and 6 of this thesis provide
insight into consumers’ expectations regarding the granularity expected and, as
already emphasised, women are likely to expect finer levels of granularity in this
matrix than are men.
Component D – Transmission Principles
Nissenbaum’s Transmission Principles describe the context specific ‘terms’ and
‘conditions’ under which information may flow between actors. The transmission
principles are a key component of the privacy framework proposed here.

The Transmission Principles in Nissenbaum’s framework are interpreted here as a
matrix of terms and conditions which will be applied to any information flows within
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the secondary use of medical data context. Consumer specific expectations regarding
these terms and conditions are derived from Chapters 4, 5 and 6 of this thesis and
material from the Literature Review. The inclusion of the consumer expectations in
defining the transmission principles is one of the most innovative aspects of the
privacy framework as previously consumers were not empowered to participate in
determining such transmission principles. Frequently human research ethics
committees and/or health sector leaders and clinicians make decisions regarding
acceptable terms and conditions surrounding flow of consumer medical information.
Inclusion of the consumers as actors determining the terms and conditions of data
flow is an important aspect of the privacy framework for secondary use of medical
data.
Consumer opinions and other stakeholders’ expectations, including human research
ethics committees, will be used to guide the contents of the matrix for Terms and
Conditions for data flow in the privacy framework. The privacy framework for
secondary use of medical data is not static; rather it is continually evolving and the
Terms and Conditions suggested in this initial privacy framework are merely a
starting point. On-going vigilance and maintenance will be required to ensure that
consumers remain engaged in defining their expectations regarding the matrix. The
granularity of the contents of the Terms and Conditions matrix is determined by the
consumers. Similar to Component C, Chapters 4, 5 and 6 of this thesis provide
insight into consumers’ expectations regarding the granularity expected.
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Nissenbaum’s Framework for Contextual Integrity

Context
Actors

Privacy Framework for Secondary Use of Medical Data

A

Secondary Use of Medical Data Context

B

Actors
Senders of Information – Healthcare providers

Senders of Information

Receivers of Information – Medical researchers, Gov’t, commercial

Receivers of Information

Subjects of Information – Consumers/patients

Subjects of Information
Attributes (Information Types)

C

Consumer Data Attributes & Default Sensitivity levels

Sensitivity levels
Transmission Principles

D

Terms & Conditions for data flow

Terms and conditions for data flow

Figure 39: Constructing the Privacy Framework Stage 1

Construction of the Privacy Framework moves to Stage 2 where the theoretical contribution made by Moor and Tavani is adapted for the
privacy framework – particularly the RALC concepts. Components E, F and G are added to the Privacy Framework in Stage 2 as
illustrated in Figure 40: Constructing the Privacy Framework Stage 2. These theoretical components are enhanced and refined for this
context by the results of the Australian and Canadian consumer surveys.
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Moor and Tavani’s RALC

Privacy Framework for Secondary Use of Medical Data

Individual Controls
Choice

Secondary Use of Medical Data Context

E

Consent

Actors
Senders of Information – Healthcare providers

Survey

Correction
Restricted Access

Consumer

Receivers of Information – Medical researchers, Gov’t, commercial

F

Subjects of Information – Consumers/patients

F

Consumer Data Attributes & Default Sensitivity levels
Financial Data
Medical Data
Mental Health
Sexual Health
Genetic

E

Terms & Conditions for data flow

External Controls
Privacy Policies
Privacy Legislation

Consumer control, purpose of data re-use

G

Privacy Legislation and Data Governance Policy

Figure 40: Constructing the Privacy Framework Stage 2
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7.3

Incorporating Consumers Expectations into the Framework

This section describes the conceptualisation of consumers engagement and moves to
the inclusion of consumers expectations in the initial skeleton of the Privacy
Framework.
7.3.1

Conceptualising Levels of Consumer Engagement

Meticulously capturing and maintaining details of consumer privacy expectations
across the numerous dimensions of their EHR is a simplistic and likely unsustainable
approach to addressing privacy concerns. The results of the consumer surveys
indicate a capacity for the general public to engage in secondary use and privacy
matters. What is required is a new approach to conceptualising these matters in a
manner that leads to a physical information systems solution that can be embedded in
revised, supportive business processes in the secondary use of medical data. The
conceptual Privacy Framework thus informs both the information system design and
a shift in the privacy paradigm operating in the secondary use context.
The consumer survey results in Chapters 4-6 indicate there are various levels of
interest amongst the community regarding matters pertaining to secondary use of
medical data. There are likely to be members of the community who have no interest
in considering secondary use matters. There are also citizens who place enormous
value on their personal privacy and their engagement in secondary use matters may
vary from removing themselves entirely to looking for opportunities for maximum
influence and authority over the secondary use of their data.
There are also varying individual capacities to engage in secondary matters. For
example, citizens living with severe mental health issues, minors and dementia
suffering or very elderly citizens, may not have the capacity to engage in secondary
use and privacy matters. This was raised by a member of the survey design focus
group and some of the consumers responding to the qualitative parts of the surveys.
There are infinite combinations of citizens with varying levels of ‘interest’ and
‘capacity’ to engage in secondary use of medical data matters. If an individual has
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low or minimal capacity to engage in decision making regarding secondary use of
their medical data it is irrelevant how much interest they may show in secondary use
matters as they are incapable of making necessary decisions.
There are other citizens who have sufficient capacity to engage in secondary matters
but low levels of interest in becoming engaged. There are comments in the
Australian and Canadian consumer surveys from citizens who would fit this group.
There are other citizens who may, over time, have increased interest in secondary use
of their data if a ‘trigger’ was involved. For example, if a member of their family
suffered from a disease, say lymphoma, and there was an opportunity for family
members’ data to be used for secondary purposes specific to lymphoma research, the
interest level in secondary use of data may rise in the family members. The ‘trigger’
in this case is the lymphoma diagnosis for their family member. Other ‘triggers’ such
as media reports of profiteering from the re-sale of medical data accrued through the
delivery of primary care may have a mitigating effect. There are numerous comments
in the Canadian and Australian survey results with consumers indicating they would
not support commercial secondary use of their medical data. The ‘trigger’ here may
have an impact on the level of consumer interest in engaging in matters about
secondary data use. Alternatively this anti-commercial ‘trigger’ may lead to further
interest as the consumer moves to protect their medical data from commercial
secondary uses by engaging more in privacy matters.
The final broad group to consider are citizens who have both the capacity and
interest in secondary use matters enabling them to fully engage in decision making
regarding the secondary uses of their medical data. Figure 41 depicts the suggested
broad groupings of citizens along the axes of capacity to engage and level of interest
in secondary use matters.
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Consumer level of interest in secondary use matters

HIGH

Level 3
Level 0
Level 2

Level 1
LOW
LOW

Consumer capacity to engage in secondary use matters

HIGH

Figure 41: Consumer engagement scenario 1

Four levels of engagement amongst consumers are depicted in Figure 41. Zones have
been blocked out in this figure however no metrics have been applied as it is not
possible, with available knowledge, to predict the end of one grouping and the
beginning of the next. White buffer zones have been included in the diagram, lying
between each of the zones or groups, to emphasise that the boundaries of each group
are ill defined. This figure assists in conceptualising the various levels of concurrent
interest and capacity to engage amongst consumers. Figure 41 presents a scenario
with arbitrary definition of the boundaries of levels of interest and capacity to
engage.
Figure 42 presents an alternative scenario depicting more citizens with the necessary
level of interest and capacity to engage fully in secondary use matters. This scenario
moves towards the privacy advocates view of maximising consumer engagement and
autonomy on secondary use of medical data matters.
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Consumer level of interest in secondary use matters

HIGH

Level 3
Level 0

Level 2

Level 1
LOW
LOW

Consumer capacity to engage in secondary use matters

HIGH

Figure 42: Consumer engagement scenario 2

In contrast Figure 43 presents an alternate scenario where the vast majority of
consumers are considered to be incapable of engaging (Level 0) and with no
autonomy for consumers. This moves closer to the scenario argued for by some
public health researchers where they suggest that benefits of secondary data use to
society far outweigh any individual privacy considerations. Each of these secondary
use scenarios has been considered in the Chapter 2 Literature Review. The scenario
figures are presented to provide a conceptualisation tool that leads into the further
discussions about the Privacy Framework for secondary use of medical data.
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HIGH
Consumer level of interest in secondary use matters

Level 3

Level 0
Level 2

Level 1
LOW
LOW

Consumer capacity to engage in secondary use matters

HIGH

Figure 43: Consumer engagement scenario 3

The consumer engagement Levels 0-3 assist in broadly grouping consumers into
segments that have differing expectations on all matters related to the secondary use
of their medical data. A capable citizen may choose to join the Level 0 group where
limited opportunities would exist for consumer engagement in secondary data use
matters. This is a choice that the Privacy Framework would provide to consumers. In
contrast, if a consumer was not capable of deciding levels of engagement – even if
they wanted to join the Level 3 group – the Privacy Framework would limit their
engagement to Level 0.
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Table 61: Elaboration of Consumer Engagement Level 0 and Level 1

Engagement

Brief description

Level

Level 0

Status Quo: Existing Human Research
Ethics Committee approvals and
protections apply without additional
direction or authority from consumers
regarding secondary uses

Level 1

Consumer provides high level direction
regarding authorised secondary uses
including:


NO to secondary use



YES to secondary use
specifics eg.:
o
o
o
o
o

o

Level of anonymity
For-profit medical
research
Not for-profit medical
research
‘data brokers’
Commercial
organisations such as
the insurance and
pharmaceutical
sectors
Identify particular
areas of focus e.g.
diabetes, cancer,
schizophrenia
research etc.

Australian Consumer Comments
Anything in my not particularly fascinating medical history that
is any use to anyone else – help yourselves.
The age and mental health of a person can affect the use of
medical data.
What about information about children, the elderly, mentally ill?
We need to know their privacy is protected. Who speaks for
them?
Common good overrides preferences if it gives a better
understanding of illness in general.
It doesn’t concern me that some people have access to my
records.
... medical privacy is not something that occupies much of my
attention. I tend to take a fairly fatalistic approach: what
happens and may happen in the future is largely beyond my
control.
I am much more interested in medical research and university
research in the area of medicine. I am not interested in
research for insurance companies etc.
The patient should have the opportunity to approve or
disapprove of the collection and re-use of data.
Individuals should have the right to decide who their medical
records are given to for medical research.
If anonymous age-sex-history then we may end up with better
health funds and insurance products as well as better hospitals
and treatment!!
Names and addresses should be withheld if used for research
–non debatable.
All insurance or drug companies are primarily responsible to
their shareholders and NOT the general public and therefore
should not be given/sold a person’s private medical records
without that person’s explicit permission.
If money is involved then I would not agree to my records
being “bought” by companies or organisations either.
There is absolutely no reason why any research requires the
name or address attached to the medical records. It is certain
that any requirement to personal details is not for research...
any research requiring personal details is corrupt and should
not be supported – leave personal details out of research.
Commercial operations should pay for data ...
I would be happy to have my medical information used at any
time – preferably on an anonymous basis.
In my opinion the patient owns his/her records and the re-use
of medical data can only be at the discretion of the patient.
I believe that I the patient should be the only person capable of
authorising the use of my records for research.

Table 61 provides an introductory description of Level 0 and Level 1 Comments
from the Australian consumer surveys that support the operation of the
corresponding Level of engagement are also provided. Table 62 provides the same
details for consumer engagement at Levels 2 and 3.
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Table 62: Elaboration of consumer engagement at Level 2 and Level 3

Engagement
Level
Level 2

Brief description

Australian Consumer Comments

Consumer provides medium level

I would not want anyone to have access to medical information
without my permission.
Happy to have medical info in database with access by
consent.
... it is my choice to disclose my personal information – it
BELONGS to me – not to anyone else – seeing a GP does not
mean that I have handed over my right to privacy or my choice
to disclose or not!
Informed consent is important but I must admit I have no real
guarantee that any information I provide will not be handed to
insurance companies and similar misanthropic organisations.
It is my decision and mine alone as to who has access of my
records.
I think a person’s consent should be sought BEFORE it is used
anywhere else.
I would like to think my medical information would help with
research to help others, but only with my express approval and
if I change my mind I would have the right to revoke the
decision.
I don’t believe any of my info should be used for research or
any other purpose without my consent. Ever. I would consider
it unethical if this occurred.
If an individual wants to share information disclosure should be
voluntary, possibly consent for an individual purpose not a
general sharing of all info with a single consent.
Do not want lay people i.e. The State, making decisions
regarding my records not even the justice system who are not
qualified to determine the issues. It would have to be my
personal okay about what I share. How I want to share it. Who
would share it. And how long they shared it.
I believe my medical data is my data and owned by me. Not
owned by doctor, hospital, Medicare, Government, insurance.
Co etc
Feedback on use of information should be followed through.
I feel my information is mine, not healthcare providers or
governments so I must make the choices about the data.
All medical information should be used or controlled by the
patient.
The approval should be sent every time the information is
requested.
Would like to be aware who is using my information at all
times. Do not like the idea of ‘once’ only authority. I should be
asked every time some organisation, including the
government, wants to use my history for any form of research.

direction regarding authorised
secondary uses including:

All Level 1 directions
PLUS

Consent type e.g. per study, per
annum



Level 3

Consent frequency of renewal
Withdraw consent

Consumer provides detailed taxonomy
of authorisations including:

All Level 1 & Level 2 directions
PLUS

Feedback/reporting requirements
on studies using consumers
personal data

Willingness to be further
contacted regarding secondary
use matters
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Level 0 is similar to the current operation of Australian Human Research Ethics
Committees (HRECs) where the committee members make decisions about the
release of consumers medical data and may or may not request that researchers
obtain informed consent from information subjects – i.e. patients/consumers. The
role of HREC would be to provide approval for the overall study and to give
instructions regarding data issues. It is possible at Level 0 engagement that HRECs
may authorise the release of a consumer’s data without any regard to the consumers
wishes about secondary use matters. This may be appropriate if the citizen has been
officially deemed incapable of making decisions e.g. citizens with diminished mental
capacity. If consumers have not provided any secondary use directives the Level of
engagement is defaulted to Level 0. This maintains the status quo with HREC
making decisions regarding the necessary approvals that consumers/patients are
required to provide prior to any third party accessing personal medical data. This
situation would not satisfy consumers with concerns regarding personal privacy and
such citizens should be encouraged to move to Level 1 engagement and record a
“No” directive on secondary use or alternatively they could move to Level 3
engagement where they achieve greater autonomy and control.
Level 1 provides consumers with an opportunity to give some high level guidance on
the availability of their data for secondary purposes. The intent is for this to not be
project specific consent but rather a broad “Yes’ or “No” to the use of an individual’s
data for any kind of secondary purpose. If a consumer registers a “No” at this Level
of engagement then their personal medical data should not be used for any secondary
purpose. If consumers want to give project specific consent they need to move to
Level 2 engagement. At Level 1 engagement consumers may, if they wish, refine the
“Yes” response by nominating if their data is to be available for commercial and /or
non-commercial uses. In addition the consumer also specifies the level of anonymity
they require. The provision of Level 1 engagement with consumers could also speed
up the pace at which data could be available for secondary use as consideration of
data access issues by HREC would not be required if capable consumers had given
informed consent through the Privacy Framework operating at Level 1. This would
be of benefit to the many researchers who report delays in approval and lack of
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consistency between HRECs. The role of HREC would be to provide approval for
the overall study but to limit the instructions regarding data issues to the secondary
directives provided by the consumers. The consumers Level 1 instructions would be
permanently stored with their electronic medical record.
Level 2 enables consumers to provide Level 1 direction plus further refinements
concerning types of consent, consent renewal frequency and mechanisms for
withdrawing consent. Consumer consent for secondary use may be provided for each
study or the consumer may provide a pre-approval for studies that meet particular
requirements. The latter approach would reduce the number of times a consumer
would be contacted to seek consent and expedite the availability of data. It is
important to reflect on the hierarchical nature of these Levels of engagement. If at
Level 1 a consumer indicated that they were not interested in having their data used
for commercial secondary uses it would not be possible, within the operation of this
Privacy Framework, for such consumers to be asked to provide Level 2 study
specific consent for a commercial secondary study. The only consumers who should
be approach for such a study would be those who, at Level 1, indicated ”yes” they
support secondary uses of a commercial nature and at Level 2 indicated a wish to
give study specific consent.
Some of the consumers responding to the public opinion survey, as presented in
Chapters 4-6, provided qualitative feedback indicating they would not be satisfied
with a single consent option and would prefer to provide consent for each study.
Other respondents were happier with the notion of a single, re-useable consent. Level
2 engagement satisfies these diverse opinions by providing a flexible framework
where consumers are able to select various consent profiles. Level 2 also provides
consumers with an opportunity to select specific areas that they would like to support
by making their data available for secondary purposes. For example they may choose
to support particular focus areas of research such as breast cancer, diabetes,
depression, schizophrenia or renal disease research.
The frequency of consent renewal is an important matter where consumers can
provide direction. Annual consent renewal may be appropriate or a consumer may be
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prepared to allow consent to require less frequent renewal, to perhaps three years or
longer.
If consumers wish to remove their consent for secondary use they must be able to do
so at any time. This issue was explored through the consumer survey and further
consideration is needed regarding the implementation of such ‘withdraw’ directives.
However, it is essential that this capability be included in the privacy framework. As
already emphasised, this is a conceptual framework that leads to physical
implementation where technical solutions will be developed in accordance with the
conceptual design. Rather than saying at this stage ‘How are we going to effectively
implement that?’ and dropping this requirement from the privacy framework this
challenge must remain and move forward towards physical implementation.
The consumers Level 1 and Level 2 secondary use instructions would be
permanently stored with their electronic medical record.
Level 3 enables consumers to provide Level 2 (which includes Level 1) direction
plus further refinement to take the engagement to the finest granularity available. At
Level 3 engagement consumers have an opportunity to state their expectations
regarding feedback on secondary use of their data. For example, consumers may
request an annual report on each study or a higher level aggregated summary of all
studies that used their data. Consumers may expect to be informed not only about the
studies that have used their data but also the ‘outcomes’ from the studies. Amongst
the qualitative comments from Australian consumers a number shared their
experience of participating in studies and were very appreciative of the efforts
researchers had put in to informing the study participants about progress and
outcomes. This information was greatly appreciated by the participants and
encouraged them to continue participation; therefore this practice has been included
in the Privacy Framework for the most engaged citizens. Level 3 engagement also
gives consumers an opportunity to ‘put their hand up’ and allow themselves to be
identified and available for further contact on secondary use matters.
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7.3.2

Consumer data attributes and default sensitivity settings

Component C in Figure 39 relates to Nissenbaum’s data attributes and sensitivity
settings. This Privacy Framework does not propose that consumers consider each and
every one of the attributes of their EHR and decide if they wish to have the data
available for secondary use and if so who can use it and for what purpose. This
would be an unmanageable approach due to the complexity involved in specification
and maintenance of consumer views regarding the ‘nitty-gritty’ of their EHR. The
Levels of consumer engagement described in the previous section are sufficient to
enable consumers to provide secondary use and privacy directives across the large
number of data attributes which comprise dynamic, always evolving EHRs.
Moor and Tavani’s Restricted Access privacy concept, represented by Component F
in Figure 40, contributes to the construct of data attributes and sensitivity settings in
the proposed Privacy Framework. These are intangible concepts that are incorporated
into the Privacy Framework as principles upon which the framework has been
designed. The following scenarios illustrate the inclusion of restricted access
concepts in the Privacy Framework. It should be noted that the consumers are
empowered through the restricted access concept rather than excluded from
involvement, in the way that restricted access has traditionally been adopted in the
provision of patient confidentiality (with healthcare professionals restricting
information access to primarily the care givers).
Generally sexual health, mental health and genetic data attributes are considered to
be very sensitive data attributes of an electronic health record. Despite the fact that
the Privacy Framework does not ask citizens to consider each of these sensitive areas
and explicitly state their privacy expectations the use of the engagement Levels 0-3
does offer citizens an opportunity to secure any part of their electronic health record
from unwanted secondary use.

259

7.3.3

Combining the Skeleton of the Privacy Framework and the Levels of Consumer Engagement

This section seeks to illustrate the manner in which the skeleton of the Privacy Framework, adapted from Nissenbaum and Tavani and
Moor, combines with the levels of consumer engagement as depicted in Figure 44.

Figure 44: Privacy Framework combined with the Consumer Engagement Concept

260

The consumer data attributes, default sensitivity settings, and terms and conditions for data flow run through all levels of engagement.
Taking a shallow vertical slice through the cube is equivalent to the Level 0 engagement. By slicing deeper into the cube more of the
data attributes, and terms and conditions for data flow are encountered. This is equivalent to a higher level of consumer engagement.
The context in which the privacy framework operates is also an essential aspect and Figure 45 illustrates the addition of the broad cap or
cover of the context.

Figure 45: Addition of the context to the Privacy Framework
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In addition to the above figures three scenarios will be used here to illustrate the
operation of the Privacy Framework incorporating the consumer level of engagement
concept. The following scenarios are based on comments made by consumers in
responding to the qualitative component of the surveys deployed in this research
study:
Scenario 1 – Consumer A is a female rape victim who does not want any part of her
EHR used for secondary use by any organisation or individual.
Privacy Framework support for Consumer A in Scenario 1:
If Consumer A leaves her engagement level at Level 0 then
there will be data receivers who can gain access to de-identified
data sets, and possibly identifiable datasets, containing
Consumer A’s EHR or part thereof. To meet the total privacy
called for by Consumer A she needs to move to Level 1 and
record “NO” against the measure for consumer agreement for
secondary use.
Scenario 2 – Consumer B is a female who has multiple family members afflicted
with diabetes and she would like to ‘donate’ data to any sort of medical research to
do with diabetes. Consumer B is prepared to release her identified data and would
like to receive feedback on any secondary use that included her medical information
and she is prepared to be contacted about secondary use of medical data matters.
Consumer B does not want to be contacted to provide consent for every study that
uses her data she is satisfied to provide an annual renewal of consent that covers
research studies approved by HRECs.
Privacy Framework support for Consumer B in Scenario 2:
This consumer needs to register at Level 1 indicating she is
prepared to have her data used for secondary purposes. She
needs to indicate that both for-profit and not-for-profit medical
research into diabetes can access her data and she needs to
indicate that use of identifiable data is acceptable. At Level 2
262

she needs to indicate that her preference is to provide an annual
consent that will cover multiple studies and she would only like
to be contacted once per year to renew this consent. At Level 3
she needs to identify herself as being interested in further
contact regarding secondary use of her medical data for diabetes
research and she needs to record her instruction about the receipt
of feedback on each of the studies her data has been included in.
Scenario 3 – Consumer C is a male recently diagnosed with a genetic disorder that in
all likelihood will shorten his life by many decades. Consumer C is concerned that
knowledge of this disorder may have a negative impact on his life insurance
arrangements. At the same time Consumer C is very concerned because two of his
children have also been diagnosed with the disorder and he would like to support any
research that addresses this disorder as this may be beneficial to him and his children.
Privacy Framework support for Consumer C in Scenario 3:
Using the Privacy Framework Consumer C needs to register
“Yes” at Level 1 to indicate his intention to permit secondary
use of his data. At Level 1 he needs to set his anonymity level to
“anonymous”. Consumer C needs to avoid selecting commercial
re-use thus precluding the insurance sector and data brokers
from access. By selecting only not-for-profit medical research
Consumer C facilitates the use of his anonymous data for the
secondary use he wants to support i.e. medical research.
7.3.4

The matrix for terms and conditions of data flows

The matrix for terms and conditions for data flow is a development based on
Nissenbaum’s Transmission Principles, represented by Component D in Figure 39,
combined with Tavani and Moors’ Individual Control concepts, represented by
Component E in Figure 40. The consumer surveys explored Moor and Tavani’s
RALC and results of the surveys indicate the purpose of the secondary use of their
data influenced consumers’ views about the terms and conditions of their agreement
to support (or not to support) a particular secondary use. Hence the ‘data re-use
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purpose’ has been included in this interpretation of Nissenbaum’s transmission
principles. In addition, the transmission principles have been organised by consumer
engagement level. As previously discussed these stratify consumers. Data subject,
sender, and receiver are as defined by Nissenbaum.
The data flow conditions are very specific to the secondary use of medical data
context – as anticipated by Nissenbaum. Data flow conditions depend on a number
of factors including clear approval to proceed with the information flow from the
‘approving authority’ and such approvals are accompanied by a ‘level of anonymity’
which is, at its most simple, a dichotomy of ‘identifiable’ or ‘anonymous’. It is
acknowledged that a substantial body of work surrounds this concept of anonymity
and de-identification however those issues are not the focus here. Healthcare
providers have made assumptions regarding consumers’ expected level of anonymity
based on their narrow interpretation of what is meant by privacy. This Privacy
Framework challenges those assumptions and empowers consumers engaged at
Levels 1-3 to self-determination of privacy. The consumer survey results revealed
some consumers were agreeable to the use of identifiable data and this can add
substantial depth and opportunity to some areas of medical research which have
previously been denied via blanket denial of identifiable datasets. The qualitative
comments in consumer surveys also revealed an expectation of feedback to
consumers when their data has been used for a secondary purpose. This has led to the
inclusion of the ‘Feedback to Consumer on Outcomes of Secondary Use’ as one of
the data flow conditions. Consumers engaged at Levels 1 and 2 do not provide
instructions regarding feedback and hence this data flow condition does not apply for
those consumers. Consumers with Level 3 engagement do provide instructions
regarding feedback and hence the flow of their data is dependent on a data receiver
meeting the Level 3 feedback condition imposed by the consumer. The next section
presents the terms and condition matrix for each of the engagement levels and
highlights the privacy advances for consumers at each engagement level. The data reuse purposes included in Table 63, Table 64, Table 65 and Table 66 represent broad
categories of secondary use purposes that emerged from the literature review
conducted for this study.
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Level 0 is the ‘status quo’ engagement level with current terms and conditions of
secondary use continuing. The data re-use purposes have been broadly summarised
and it is apparent that consumers have little opportunity to engage regarding the data
flow conditions applying to each data re-use purpose. The HREC may refer to
consumers for consent however there is no guarantee this will occur. At Level 0 there
is no opportunity for consumers to apply data flow conditions requiring them to
receive feedback on secondary uses of their data. Magnusson’s Stage 3, as described
in the Literature Review Chapter, is apparent with the inclusion of the Government
entities as both data ‘senders’ and ‘receivers’ and ‘approving authority’ for consumer
data that maybe anonymised or fully identifiable.
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Table 63: Privacy Framework Transmission Principles Engagement Level 0
Data Flow Terms
Consumer

Data Re-use
Purpose

Data
Subject

Data Flow Conditions
Data
Sender

Data
Receiver

Approving Authority

engagement

Level of

Consumer consent

Feedback to Consumer on

anonymity

type (annual/study),

Outcomes of Secondary Use

renewal frequency,
withdraw

Consumers/patients
of health service

Healthcare
providers, insurance
organisations,
pharmacy etc.

Commercial
organisation eg.
pharmaceutical or
insurance sector
organisations or
marketers

Healthcare provider,
insurer who acquired
the data through
service delivery,
pharmacy

Fully identifiable
or anonymised

Not required

Not required

Transfer/sale to
Data Broker
organisation

Consumers/patients
of health service

Healthcare
providers, insurance
organisations,
pharmacy etc.

Data Broker
organisations eg.
AusGrid, Brogan
Inc and IMS

Healthcare provider,
insurer who acquired
the data through
service delivery,
pharmacy

Should be
anonymised

Not required

Not required

Non-commercial
medical research

Patients/Consumers
in target group e.g.
asthma, diabetes,
cancer etc.

Healthcare
providers

Non-commercial
medical
researchers

HREC

HREC may stipulate

Not required

Healthcare
providers

Commercial
medical
researchers

HREC

HREC may stipulate

Not required

Healthcare
providers

Government
entities

Government

Not required

Not required

Commercial reuse
of data acquired
through health
service provision

Level 0

Commercial medical
research
Government
purposes

Patients/Consumers
in target group eg.
asthma, diabetes,
cancer,
schizophrenia etc.
Entire
consumer/patient
population

May be identified
or de-identified
depending on
nature of
research
May be identified
or de-identified
depending on
nature of
research
Fully Identifiable

Level 1 engagement includes the same data re-use purposes and data flow conditions with consumers appearing as approving authority
and empowered to make decisions regarding level of anonymity. At Level 1 consumers can provide a resounding “NO” to the use of
their medical data for secondary purposes and given the hierarchical structure of the subsequent levels there is no further input required
by the consumer. In this Privacy Framework a “NO” at Level 1 ends all secondary use of a consumer’s medical data for all of the
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proposed data re-use purposes. A “YES” at this Level offers an opportunity to engage on issues of anonymity and broad secondary use
categories including Non-commercial medical research and transfer/sale to Data Broker organisation.
Table 64: Privacy Framework Transmission Principles Engagement Level 1
Data Flow Terms
Consumer

Data Re-use
Purpose

Data
Subject

Data
Sender

Data Flow Conditions
Data
Receiver

Approving Authority

engagement

Level of

Consumer consent

Feedback to Consumer on

anonymity

type (annual/study),

Outcomes of Secondary Use

renewal frequency,
withdraw

Level 1

Reuse of
commercial
data acquired
through health
service
provision

Consumers/patients of
health service

Healthcare
providers,
insurance
organisations,
pharmacy etc.

Commercial organisation
e.g. pharmaceutical or
insurance sector
organisations or
marketers

Individual Consumer

Consumer
discretion

Not required

Not required

Transfer/sale
to Data Broker
organisation

Consumers/patients of
health service

Healthcare
providers,
insurance
organisations,
pharmacy etc.

Data Broker
organisations e.g.
Brogan Inc and IMS

Individual Consumer

Should be
anonymised

Not required

Not required

Consumer

Healthcare
Providers

Medical researchers

Individual Consumer

Consumer
discretion

Not required

Not required

Consumer

Healthcare
Provider

Commercial medical
researchers

Individual consumer

Consumer
discretion

Not required

Not required

Entire
consumer/patient
population

Healthcare
providers

Government entities

Individual consumer

Consumer
discretion

Not required

Not required

Noncommercial
medical
research
Commercial
medical
research
Government
purposes

Level 1 engagement also sees consumers appear in the data flow conditions as the approving authority for Government re-use purposes.
The inclusion of consumers as the approving authority for conditional data flows for Government purposes would be an important
advancement of privacy for consumers and would minimise the opportunity for Government surveillance through medical records.
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Level 2 engagement sees the introduction of consent types and consent frequency and consent withdrawal issues regarding secondary
uses of consumer data. Research protocols imposed by HREC at Level 0 may have introduced these consent issues to the commercial
and non-commercial medical research purposes. At Level 2 consumers further engage in privacy matters by indicating if they prefer to
provide consent for each proposed secondary use study or if they prefer an alternate solution, such as annual or once only consent. A
specific question in the consumer survey related to the frequency of consent and there was mixed response with some consumers content
with once-only consent. Others strongly opposed and expecting to provide specific consent for each study (an attitude particularly strong
among women) and others were satisfied with broader consent. There was support for the option of withdrawing consent at any time;
hence at this level of engagement the conditions of data flow have been expanded to capture the consent matters
Table 65: Privacy Framework Transmission Principles Engagement Level 2
Data Flow Terms

Consumer

Data Re-use
Purpose

Data
Subject

Data
Sender

Data Flow Conditions
Data
Receiver

Approving
Authority

Level of

Consumer

Feedback to Consumer on

anonymity

consent type

Outcomes of Secondary Use

(annual/study),

engagement

renewal
frequency,
withdraw

Level 2

Reuse of
commercial data
acquired through
health service
provision

Consumers/patients of health
service

Transfer/sale to
Data Broker
organisation

Consumers/patients of health
service

Non-commercial
medical research
Commercial medical
research
Government
purposes

Consumer
Consumer
Entire consumer/patient
population

Healthcare
providers,
insurance
organisations,
pharmacy etc.
Healthcare
providers,
insurance
organisations,
pharmacy etc.
Healthcare
Providers
Healthcare
Provider
Healthcare
providers

Commercial organisation e.g.
pharmaceutical or insurance
sector organisations or
marketers

Individual Consumer

Consumer
discretion

Consumer
discretion

Not required

Data Broker organisations
e.g. Brogan Inc and IMS

Individual Consumer

Should be
anonymised

Consumer
discretion

Not required

Medical researchers

Individual Consumer

Commercial medical
researchers

Individual consumer

Government entities

Individual consumer

Consumer
discretion
Consumer
discretion
Consumer
discretion

Consumer
discretion
Consumer
discretion
Consumer
discretion
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Not required
Not required
Not required

Level 3 engagement terms and conditions of data flow include conditions related to the feedback that a consumer expects prior to
allowing the data flow. Through the qualitative comments gathered via the consumer surveys, many consumers expressed a desire to
receive feedback on use of their data. If the consumer wishes to incorporate the provision of such feedback as a requirement of data
access they can specify this at Level 3. Not represented in this matrix is the additional feature of Level 3 which is the enabling of
consumers to self-nominate as interested in being contacted directly on secondary use matters related to their health data.
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Table 66: Privacy Framework Transmission Principles Engagement Level 3
Data Flow Terms
Consumer

Data Re-use
Purpose

Data
Subject

Data
Sender

Data Flow Conditions
Data
Receiver

Approving Authority

engagement

Level of

Consumer consent

Feedback to Consumer on

anonymity

type (annual/study),

Outcomes of Secondary Use

renewal frequency,
withdraw
Reuse of
commercial data
acquired through
health service
provision

Level 3

Transfer/sale to
Data Broker
organisation
Non-commercial
medical research
Commercial
medical research
Government
purposes

Consumers/patients of
health service

Consumers/patients of
health service
Consumer
Consumer
Entire consumer/patient
population

Healthcare
providers,
insurance
organisations,
pharmacy etc.
Healthcare
providers,
insurance
organisations,
pharmacy etc.
Healthcare
Providers
Healthcare
Provider
Healthcare
providers

Commercial
organisation e.g.
pharmaceutical or
insurance sector
organisations or
marketers

Individual Consumer

Consumer
discretion

Consumer discretion

Consumer discretion

Data Broker
organisations e.g.
Brogan Inc and IMS

Individual Consumer

Should be
anonymised

Consumer discretion

Consumer discretion

Medical researchers

Individual Consumer

Consumer discretion

Consumer discretion

Commercial medical
researchers

Individual consumer

Consumer discretion

Consumer discretion

Government entities

Individual consumer

Consumer discretion

Consumer discretion

Consumer
discretion
Consumer
discretion
Consumer
discretion

The next section considers the final component of the Privacy Framework, Component G, as suggested by Tavani and Moor (2001).
External controls in the form of privacy policy and legislation are required.
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7.4

External Controls

In Australia at the time of completing this thesis the Australian Law Reform
Commission (ALRC) recommendations surrounding privacy remained unaddressed.
The need for universal privacy principles specifically for the healthcare sector also
remains unaddressed, despite the finalisation of the 2010 Healthcare Identifiers Act
which allocated a unique individual healthcare identifier to every Australian.
The Privacy Framework proposed here calls for a far more sophisticated
interpretation of privacy than that generally adopted in the healthcare sector. Locking
information away, de-identifying it and then claiming privacy has thus been
delivered to consumers is woefully inadequate.
External controls and privacy guidelines have seen a plethora of glossy brochures
with legal language appear in health service provider waiting rooms. Enabling the
proposed Privacy Framework privacy engagement levels 1-3 is a far more substantial
and genuine treatment of privacy than printing out shiny brochures that provide
privacy statements that tell healthcare consumers that their data is ‘safe’. In addition,
requesting that consumers agree to data management policies at the point-oftreatment is also a shallow attempt at privacy management. The power balance is
heavily against consumers at such vulnerable times. The most ideal time to engage
with consumers on privacy issues is when they are reasonably well and capable and
interested in engagement on secondary use matters.
The proposed Privacy Framework could be used to capture consumers secondary use
instructions and could be attached to the Individual Healthcare Identifier. There
would be then no doubt about the consumers’ secondary use and privacy directives
and wherever the Individual Healthcare Identifier is used the individual privacy
directives on secondary use would also be available.
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7.5

Limitations of the proposed Privacy Framework

The lifecycle of data can see personal information travel many pathways and this can
provide a challenge for the proposed Privacy Framework. Support could be provided
through an organisation taking on a data governance role overseeing data that
Australians would make available for secondary purposes. Currently there is no such
data governance authority and successful operation of the Privacy Framework would
rely on oversight and responsibility resting within the portfolio of an independent
data governance body. Another Government agency would not be appropriate
because, as illustrated above, the Australian Government, and associated agencies,
likes to be the data sender, data receiver and authoriser of all matters pertaining to
health information and this is a government surveillance issue that goes to the heart
of

the

concept

of

privacy

in
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21st

Century

Australian

society.

7.6

Chapter Summary

This Chapter began by constructing the skeleton of the Privacy Framework from
existing privacy theory – predominantly the work of Nissenbaum (2010), Tavani and
Moor (2001). The inclusion of Moor and Tavani’s RALC theory was supplemented
by hearing the Australian consumer voice that was heard through the surveys
described in Chapters 4 and 5.
A new conceptualisation of privacy for secondary use of medical data was
introduced through the Levels 0-3 of consumer engagement. These Levels of
engagement assisted in describing the data attributes and sensitivity levels and the
terms and conditions for data flow that was first introduced by Nissenbaum.
Intangible RALC principles underpin the Privacy Framework as evidenced through
the scenarios used to illustrate the framework.
The inadequacy of external privacy controls (legislation and policy) in the Australian
context was highlighted and limitations of the Privacy Framework were considered.
The Introduction chapter considered the role consumers play as stakeholders in the
development of electronic health records (EHR) and reflected on the marginalisation
of consumers in early phases of the system development life cycle guiding the
development of the Australian EHR. The Privacy Framework proposed here is the
product of a deep engagement with consumers to determine their requirement
regarding secondary use of their medical data and could inform physical
implementation of health systems and supporting business processes.
The next Chapter offers a summary of the conclusions that can be drawn from this
study, links to earlier research, limitations of the study and future research directions.

273

8 CONCLUSION
8.1

Introduction

This study investigated the application of privacy theory from Tavani and Moor
(2001) and Nissenbaum (2010) to secondary use of medical data. In addition, the
opinion of citizens in Australia and Canada were investigated, through selfadministered postal surveys, regarding the secondary use of their medical data
particularly considering privacy matters. A privacy framework for secondary use of
medical data was proposed. The foundation of the privacy framework was existing
privacy theory with refinements based on consumer survey findings. The privacy
framework addressed concerns and diverse expectations of stakeholders involved in
the secondary use of medical data. The privacy framework also encouraged
engagement with consumers on secondary use matters. Upon deployment, the
privacy framework could facilitate a paradigm shift away from the ‘limited access’
approach to consumer privacy to a more sophisticated engagement with interested,
capable consumers. This study is the first to have:


combined the privacy theory of Tavani and Moor (2001) and Nissenbaum
(2010),



applied these theories to the secondary use of medical data context,



investigated Australian consumers views regarding secondary use of their
medical data,



compared Australian and Canadian consumers views on these matters, and



proposed a privacy framework as a mechanism to assist in engagement with
consumers regarding secondary use of their medical data.

This chapter presents the principal conclusions of the present study, links to earlier
research, limitations of the study and future research directions.
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8.2

Principal Conclusions

The principal conclusions of this study make a contribution to the problem
definition and improved understanding of foundation privacy matters pertaining to
secondary use of medical data. The conclusions from this study inform the early
analysis stage of the system development life cycle associated with development
of health information systems. This study purposefully engaged with the
traditionally under represented consumers (Townend 2010; Buckley, Murphy et
al. 2011) to aid in the inclusion of their ‘voices’ in the important preliminary
SDLC analysis. The principal conclusions of this study address the two
overarching research questions which are:
Research Question 1
What are consumer’s expectations and concerns regarding secondary uses of their
medical data, particularly with respect to privacy matters?
Research Question 2
Does the RALC theory (Tavani and Moor 2001) and the framework for contextual
integrity (Nissenbaum 2010) offer privacy concepts that can: (1) be applied in the
secondary use of medical data context and (2) gain support from interested
consumers?
With respect to Research Question 1 the principal conclusions are:
For Australia:


There are statistically significant differences of opinion across
consumers’ age, highest education level, and status as self-reported
healthcare workers. Rather than generalising Australian consumers as a
homogenous group, when referring to secondary use privacy matters, the
consumer group can be stratified as discussed in thesis section 5.2.1.



The healthcare sector have long been proponents of the concept of
privacy being equivalent to ‘limited access’ but many consumers are not
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aware of this being a priority within the healthcare sector as discussed in
thesis section 5.2.1.2.


Consumers express attitudes of concern regarding the secondary use of
their medical data and associated privacy issues particularly when the
insurance and pharmaceutical sectors are the secondary users as presented
in thesis section 5.2.1.4.



Responses to the concept of a ‘right’ to privacy differ with statistical
significance across consumer gender and age, with women responding
more positively to this concept than men, as discussed in thesis section
5.2.1.5.



There are statistically significant differences across consumer education
level and age regarding the concept of needing to re-use medical data to
aid in ‘getting-the-balance-right’ to deliver benefit to society through
secondary use of data, as discussed in 5.2.1.5.

In comparison to Canada:


In terms of the privacy concept there are statistically significant
differences between Australians and Canadians on anxiety about medical
receptionists and IT professionals having access to an individuals’
medical data, withholding data from secondary use due to potential
misuse, and anxiety over insurance sector misuse of data.



In terms of privacy justification there are statistically significant
differences between Canadians and Australians regarding citizens
‘rights’. Qualitative analysis concluded Australians engage more with the
altruistic donation of data to benefit society.



In terms of privacy management statistically significant differences exist
between Canadian and Australian consumers regarding the facility for a
consumer to view and correct medical information.
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The discussion regarding these comparative conclusions is found in thesis
sections 6.1.5 and 6.1.6. Canada is further progressed in the deployment of
electronic health records than Australia and citizens may therefore have more
experience and awareness of the issues surrounding secondary use of the
collected data. This may account for some of the variation between the survey
results. The response rate to the Canadian survey included in this study is low
hence caution is required when considering the results.
The principal conclusions concerning Research Question 2 are:


The outcomes from the investigation into the tripartite components of
privacy concept, privacy justification and privacy management indicate
that the hybrid Restricted Access Limited Control (RALC) could be
applied to the secondary use of medical data context.
The pilot and final surveys deployed in Australia and Canada as part of
this study included thirty attitudinal statements that investigated the
concept, justification or management of privacy. The 1,573 consumers
who responded to the survey were able to engage with the attitudinal
statements and analysis of quantitative results, classified according to
privacy concept or justification or management, provided reliable results
as discussed in thesis section 3.5.2. There was no expectation that survey
respondents would conceptualise the tripartite components of the privacy
theory. Each of the carefully selected attitudinal statements, many first
trialled in the pilot surveys, sought to engage consumers on one particular
tripartite component. The classification was transparent to the respondents
and relied upon the researcher to compile constructs appropriately as
discussed in thesis sections 3.5.3.2 (pilot survey) and 3.5.5 (final survey).



The essential components of the Contextual Integrity privacy theory
(Nissenbaum 2010) - actors, attributes and transmission principles – can
be applied to the secondary use of medical data context.
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Without specifically defining these theoretical constructs for consumers,
it was possible to identify these Contextual Integrity components within
Australian and Canadian consumer survey respondent’s open-ended
comments. The survey comments identified different actors, attributes
and transmission principles. The Canadian and Australian consumer
open-ended comments, particularly those regarding components of
Contextual Integrity, enabled refinement of the Privacy Framework and
definition of the Levels 0-3 of consumer engagement as discussed in
thesis section 7.3.1.


The response to the consumer survey instrument used in this study
indicates that combining and applying RALC and contextual integrity
privacy theory to the secondary use of medical data would gain support
from interested consumers with many seeking further engagement on
secondary use matters.
The survey response rate and the clarity and volume of qualitative and
quantitative survey data indicate support for applying RALC and
Contextual Integrity theories. The level of support and engagement
amongst consumers is diverse and the proposed Privacy Framework,
incorporating Levels 0-3 consumer engagement, supports this diversity.

8.3

Links to Earlier Research

This study is linked to earlier research from across a variety of domains including
legal, philosophical, health and health informatics, and information systems. Links
are particularly strong to the privacy theories proposed by Tavani and Moor (Moor
2000; Tavani and Moor 2001; Tavani 2007b) and Nissenbaum (2004; 2010) with
their theories forming the ‘initial skeleton’ of the secondary use of medical data
Privacy Framework proposed here. The consumer survey instrument deployed in
both Australia and Canada drew heavily on the tripartite approach to privacy
proposed by Tavani and Moor (Tavani and Moor 2001).
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Earlier Canadian joint investigations (2003; Willison, Keshavjee et al. 2003;
Willison, Schwartz et al. 2007; Willison, Emerson et al. 2008; Willison, Steeves et
al. 2009) into consumers’ attitudes towards secondary data use provided very useful
initial insights. Willison’s published criticisms of the Lowerance Nuffield trust report
Privacy, confidentiality and related notions provided a link to the study described in
this dissertation by providing an insightful, alternate point of view which encouraged
pursuit of the consumer opinion. Statements 8, 9 and 27 echo questions used in
Willison’s earlier consumer research.
Magnusson’s (2004) conceptualisation of the loss of individual privacy includes
Concept 3:Trans-Organisational Health Data Flows which, when published in 2004,
warned of ‘function creep’ with personal data moving to become part of public
health infrastructure and with value in a national surveillance architecture.
Magnusson (Magnusson 1995b) also published on the loss of consumer rights
apparent through the Australian Breen V Williams legal action. Statements 24 and 30
in the consumer survey directly relate to the earlier research of Magnusson and
consumer responses gathered through this study build on his earlier publications by
collecting primary data from consumers. The attitude consumers recorded in the
survey re-enforce the validity of the issue previously raised by Magnusson.
This research links with recent calls for more meaningful engagement with
consumers on secondary use of their medical data (Buckley 2008; Ruyter, Louk et al.
2010; Shelton 2011; Showell 2011) and calls for more research into the opinions of
the under-represented healthcare consumers (Townend 2010; Buckley, Murphy et al.
2011).
The Privacy Framework proposed in Chapter 7 links with earlier reports concerning
the need for a mechanism to assist Human Research Ethics Committees (HREC) in
managing the approvals for research involving medical information (Croll and Croll
2006; Croll 2007). The Privacy Framework can also assist in overcoming
inconsistencies in operation of Research Ethics Boards (REB) (Willison, Emerson et
al. 2008; Elger, Lavindrasana et al. 2010) through reference to consumer specified
privacy directions.
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8.4

Major Implications

Implications for medical researchers:
This study has investigated a paradigm shift away from ‘limited access’ privacy
theory towards a more contemporary approach to consumer privacy in terms of
enhanced engagement with consumers regarding secondary use of their data. This
work coincides with very recent calls from within the medical research community
for enhanced levels of understanding and engagement with the general public
concerning medical research.
The Australian and Canadian consumers who participated in this study have provided
important insight into their attitudes, concerns and expectations regarding secondary
use of their medical data and associated privacy matters and the information thus
gained provides valuable input for decision makers involved in developing national
health information systems. Human research ethics committee members and
researchers involved in medical, health service and population health research may
also gain valuable insight into what consumer think regarding privacy and secondary
use of medical data through the results of this study.
Implications for Consumers
The Privacy Framework proposed in Chapter 7 meets the dual purpose of aiding
medical researchers in their engagement with consumers while simultaneously
offering consumers an opportunity to provide secondary use directions. The Privacy
Framework assists consumer by clearly stating whether they allow medical
researcher access but deny access to their data for other stakeholder purposes, such
as commercial organisations. Another implication for consumers is that this study
has documented their diverse views and demonstrated their capacity and interest in
discussing secondary uses of their medical data. Hopefully this will encourage
meaningful engagement and opportunities for decision making in collaboration with
other stakeholders.
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Implications for Government and policy makers
In democratic nations Government entities and policy makers are called upon to
make decisions in the best interest of citizens. The discussion of privacy issues from
multiple perspectives in the literature review of this dissertation provides policy
makers and government with a concise insight to diverse interests.
The qualitative and quantitative data from the consumer survey is also available and
valuable for future planning, legislation and decision making, particularly in the
Australian context.
Implications for Privacy Researchers and Privacy Advocates
This study demonstrates, for the first time, the combination of Tavani and Moors
(Tavani and Moor 2001) (RALC) with Nissenbaum’s contextual integrity privacy
theories. These theories are then applied to the secondary use of medical data
context, also for the first time, thus applying the theories in the ‘real-world’.
This study provides qualitative and quantitative data about Australian and Canadian
citizens’ views regarding secondary use of their medical data and their associated
privacy concerns and expectations. This is valuable attitudinal information of use to
privacy advocates in their various projects and campaigns to raise societal awareness
of the importance of privacy issues in the sensitive area of healthcare.
Implications for Information Systems Professionals
This dissertation gives voice to consumers and the implications for system analysts
are substantial as they can no longer simply listen to the healthcare stakeholders who
have, to date, dominated health information systems design.
System analysts and designers are presented with real world problems seeking
technological solutions. Frequently the technological solutions must be accompanied
by organisational or business enhancements or substantial change. The problem in
the secondary use context relates to privacy and there are many IT solutions
wrestling with the delivery of solutions that implement ‘restricted access’
functionality and detailed consent mechanisms as if they were the ‘silver-bullet’ for
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addressing privacy issues. This study has taken a step back from the technological
solutions and has reframed the privacy challenge. Organisational and business
changes, particularly in terms of moving the healthcare sector beyond ‘restricted
access’ = ‘privacy’, need to be tackled by systems and business analysts. The answer
does not lie in micro management of consumer consent attached to small components
of the consumers EHR. The answer lies in treating consumers as equal partners and
building meaningful long term partnerships as called for by Ruyter et al. (2010). This
poses a challenge for information systems professionals who need to partner with
forward looking clinicians to bring about privacy changes.

8.5

Limitations of the Research

The consumers who responded to the survey could be described as interested in
secondary use of medical data and privacy issues given their dedication of time and
effort to complete the survey. The lack of engagement with young consumers, aged
eighteen to twenty-five years is a particular limitation to the study. This is a similar
limitation to that found by the recent Irish consumer survey (Buckley, Murphy et al.
2011). Hence the survey results do not necessarily represent the views of all
Australians. This is acknowledged and the proposed Privacy Framework has been
designed to be as flexible as possible to allow those consumers with no interest in
engagement to be protected, by default, by existing secondary use protections.
The low response rate to the consumer survey in Canada has been a limitation to this
research. With only 203 Canadians responding, and with most of them located in
Ontario, it is not possible to claim they are representative of Canadians. Therefore
care was taken when comparing the results to Australian survey results. The MannWhitney U test used to gauge statistical significance between two sample populations
is tolerant of the different sample sizes hence the statistically significant results
found are valid. The Mann-Whitney U test however does not attempt to identify what
the differences are between the two populations. Hence the drawing of conclusions
on the Canadian and Australian Comparison is very conservative.
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Changes in levels of consumer engagement over time have not been incorporated
into the Privacy Framework. Future research regarding the Privacy Framework could
address the important temporal aspects associated with changing consumer opinion.
8.6

Future Research

Future research arising from this study can be grouped according to the tripartite
approach to privacy and extended to trials of the proposed Privacy Framework.
Privacy Concept
The Privacy Concept construct of the Australian consumer survey resulted in 11
statistically significant results across age, highest education level and self-reported
healthcare worker status. The Chi-Square test results are summarised in Table 46.
Anxiety levels about privacy varied substantially for citizens with those of higher
education levels less anxious and older Australians more anxious about privacy.
Further research could investigate the reasons behind these differences as they may
have impact on future privacy policy and guidelines.
Future Research Questions on Age: Why does anxiety over privacy vary across age
groups? What are the specific concerns for each group? What is the impact of
familiarity with social networking and living on-line on the level of anxiety over
privacy?
Future Research Questions on Education Level: Why are postgraduate educated
Australians less anxious about the privacy of their medical information? Given that
most healthcare professionals making decisions about secondary use, are
postgraduate educated are they ‘out-of-step’ with the broader community?
Future Research Questions for non-Healthcare Workers: Why is it that non
healthcare workers do not understand the ‘restricted access’ approach to privacy
adopted by the health sector? Why are healthcare workers in Australia more worried
about the insurance sector access to secondary use of medical data? Is it their
knowledge of the potential abuse that makes them register stronger views than those
registered by the non-healthcare workers?
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Privacy Justification
The Privacy Justification construct of the Australian consumer survey resulted in 6
statistically significant results across gender, age and highest education level with
Chi-Square test results summarised in Table 46.
Future Research Questions across Gender: Why do women express stronger views on
a ‘right to privacy’ and a ‘right to share information’ than do men?
Future Research Questions across Age: Why are older citizens less concerned with
‘rights’? Why are citizens who are older than 66 years more inclined towards
altruism rather than individual ‘rights’?
Future Research Questions across Education: Why are tertiary (Bachelor and
Postgraduate) educated Australians less altruistic in terms of using their medical data
to help others (Statement 12) than are less educated Australians?
Privacy Management
Future Research Questions by Gender: Why is it that women have stronger views on
shared data stewardship than men? Why do women seek more control over their
medical data than men? What are the implications for future secondary use?
Combined with the questions about postgraduate educated decision makers, what are
the implications of there being fewer women at the senior decision making level in
the health sector? Why women are more accepting than men about allowing a person
withhold their medical record from secondary use?
Future Research Questions by Age: Why are citizens younger than 25 years and
older than 66 years happier to let their doctors have stewardship over their data? As
the younger Australians suffer more medical problems will their attitudes change?
What are the implications on secondary use in the future? Will there be less
opposition from younger Australians to secondary access without consumer
engagement?
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Future Research Questions by Education Level: Why do the higher educated
Australians seek more engagement on consent than just a single, on-going consent to
data use? What is the implication for future secondary use?
Future Research Questions for Healthcare Workers: What motivates the strongly
expressed desire to have control over the third parties with access to their own
medical data for secondary purposes? Have they witnessed the misuse of data? How
would they respond to a consumer/patient wanting to release their data to a third
party that the healthcare worker was not prepared to support?
Instantiation of the Privacy Framework
Future research starting in 2012 includes the application of the Privacy Framework in
two scenarios; the first in Australia and the second in Canada. The first opportunity
builds on the results of the consumer survey indicating that women are more
interested in engaging in secondary use matters and involves a General Practice
based trial of the Privacy Framework with female consumers. Discussions are
underway regarding a trial at a large New South Wales south coast General Practice.
Using the knowledge gained through the consumer survey the trial proposes to invite
women aged over 26 years to participate by using the Privacy Framework to record
their secondary use directions. The General Practice context acts as a hub to
collecting patient data that spans an extended periods of time. The data to be
collected includes data from specialist consultations, lifestyle and family history
information. This dataset, combined with secondary use direction gathered in a
manner trialling the Privacy Framework, will provide an important medical research
resource.
The second opportunity relates specifically to the secondary use of physiological
readings captured by life support devices. While patients in critical care are attached
to various monitors and life support devices visually displaying second by second
physiological readings, historically critical care documentation of this information
has been limited to paper charting of hourly at best spot readings. In addition to the
move from paper to electronic charting of this information, recent research is
highlighting the need to progress from the 3600 (60 seconds * 60 Minutes) to one
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spot reading order of magnitude of data loss to the storage of the second by second
readings. The research is proposing new approaches to the real-time analysis of that
high frequency physiological data for greatly improved clinical decision support.
This second trial proposes to explore the application of the Privacy Framework
proposed in this thesis to support the capture, storage, transmission and analysis of
this data to the secondary use context for population based retrospective analysis.
The Chapter 2 Literature Review raised a future research area regarding
consideration of the importance of privacy in various cultures, and the underlying
moral philosophy (Croll 2008; Cullen 2008; Maurushat 2008). Pursuit of this area of
research would be valuable as results would inform the debate about globalisation of
data management. Cross-border cultural differences concerning adequate privacy of
stored data were also raised by consumers through the surveys.
8.7

Conclusion

The research study presented in this dissertation is the first to combine Nissenbaum’s
(2010) framework for contextual integrity and Moor and Tavani’s (2001) restricted
access/limited control (RALC) privacy theory to propose a Privacy Framework. The
consumer pilot and final surveys regarding secondary use of medical data developed
and deployed in this research study, attracted 1,573 respondents. This is the first
study

to gather primary data from consumers within the tripartite approach to

privacy (Tavani and Moor 2001). The consumer survey results and proposed Privacy
Framework for secondary use of medical data make a valuable contribution to a clear
problem definition, requirements analysis, and logical model as required in early
phases of the system development life cycle. The findings of this research are well
suited to inform the future physical implementations of health information systems.
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